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Abstract
Protein (mis)folding into highly ordered, fibrillar structures, amyloid fib-
rils, is a hallmark of several, mainly neurodegenerative, disorders. The
mechanism of this supra-molecular self-assembly reaction, as well as its
relationship to protein folding are not well understood. In particular,
the molecular origin of the metastability of the soluble state of proteins
with respect to the aggregated states has not been clearly established.
In this dissertation, it is demonstrated, that highly accurate kinetic ex-
periments, using a novel biosensing method, can yield fundamental in-
sight into the dynamics of proteins in the region of the free energy land-
scape corresponding to protein aggregation.
First, a section on Method development describes the extension and
elaboration of the previously established kinetic assay relying on quartz
crystal microbalance measurements for the study of amyloid fibril elon-
gation (Chapter 3). This methodology is then applied in order to study
in great detail the origin of the various contributions to the free energy
barriers separating the soluble state of a protein from its aggregated
state. In particular, the relative importance of residual structure, hy-
drophobicity (Chapter 4) and electrostatic interactions (Chapter 5) for
the total free energy of activation are discussed.
In the last part of this thesis (Chapter 6), it is demonstrated that
this biosensing method can also be used to study the binding of small
molecules to amyloid fibrils, a very useful feature in the framework of
the quest for potential inhibitors of amyloid formation. In addition, it is
shown that Thioflavin T, to-date the most frequently employed fluores-
cent label molecule for bulk solution kinetic studies, can in the presence
of potential amyloid inhibitor candidates be highly unreliable as a means
to quantify the effect of the inhibitor on amyloid formation kinetics.
In summary, the work in this thesis contributes to both the fundamental
and the applied aspects of the field of protein aggregation.
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Chapter 1
Introduction
1.1 Protein folding and misfolding
Proteins are the primary functional molecules of life. They fulfil a large variety of
tasks, from acting as enzymes, hormones and chemically selective channels through
membranes to scaffold materials and building blocks of muscles. The principle that
enabled evolution to use this class of molecules for such a variety of functions is
simple: proteins are bio-polymers built from a limited amount of chemically very
distinct building blocks, the amino acids. The linear sequence of amino acids de-
termines all the properties of the protein; however, in order to be able to perform
its function in the organism, the majority of the proteins has to fold into a highly
specific 3-dimensional structure. The question how the newly assembled amino acid
chain attains its final structure, ”the folding problem”, is one of the big problems
in chemical biology [1]. Figure 1.1 shows a scheme (from [2]) that illustrates that
a protein, after having been synthesized by the ribosome, has a large number of
possible conformations it can take.
In fact, the number of theoretically possible conformations is astronomical, as
has first been pointed out by Levinthal [3]. In his famous ”back of an envelope”
calculation, he showed the impossibility of a protein folding mechanism where the
polypeptide samples the entire conformational space, as this would lead to folding
timescales comparable to the age of the universe, whereas experimentally determined
folding rate constants are often of the order of 1s−1 and can be more than thousand
fold higher [4]. As an alternative for the random search of conformational space, the
so called ”folding funnel” [5; 6] was proposed (Figure 1.2).
In this picture, a protein moves on a free energy surface, a multidimensional
mathematical construct where the total Gibb’s free energy of the protein (including
the solvating water molecules) is a function of all conformational degrees of freedom.
The shape of this energy landscape here resembles a funnel, such that the large en-
semble of unfolded initial states corresponds to the mouth and the folded final state
to the spout. The energetic downhill nature of folding is here explained by assum-
ing that all native-like intra molecular contacts are on average more favourable than
non-native ones, leading to an ever decreasing free energy during the folding. How-
ever, this picture does not imply the complete absence of any free energy barrier
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Figure 1.1: This scheme, taken from [2], illustrates the folding process of a newly
synthesized polypeptide chain, showing that there can be intermediates on the way
from the unfolded to the folded protein, especially for large complex proteins. Many
potential side tracks exist, some of them dead ends, like the formation of insoluble
fibrillar structures, amyloid fibrils, a process referred to as ”misfolding”.
for folding. The loss of conformational freedom leads to a decrease in chain entropy
that, together with the decrease in energy, can produce a free energy barrier. The
cooperativity of folding increases the funnel-like character of this landscape: the
formation of native contacts makes the folding polypeptide more compact, therefore
further reducing the conformational space that needs to be sampled. Potential ki-
netic trapping of the folding protein in intermediate minima, in analogy to a similar
process in spin glasses [8] called ”frustration” is minimized in this view of folding
by evolutionary pressure to select amino acid sequences that show minimal frustra-
tion. On a more quantitative level, the crucial issue of the relative importance of
the various fundamental forces that govern the kinetics and thermodynamics of the
folding of a polypeptide chain into a functional protein structure is still a topic of
great current interest and debate [9]. Thus, for example, the single most important
factors in the determination of folding rates and stabilities have been reported to be
as varied as protein size [10; 11], side chain interactions [12], and hydrogen-bonded
2
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a) b)
Figure 1.2: From [7]. a) Idealized ”folding funnel” energy landscape. As the chain
forms increasing numbers of intra-chain contacts, and lowers its internal free energy,
its conformational freedom is also reduced. b) Rugged energy landscape with ki-
netic traps, energy barriers and some narrow through-way paths to the native state.
Folding can be multi-state.
backbone-interactions [1]. This variability is in part a result of the fact that the
absolute free energy differences between different states (e.g. folded and unfolded)
on the free energy surface of a polypeptide are typically very small, whereas the
component enthalpic and entropic contributions are usually much larger and com-
pensate each other [9].
Going back to Figure 1.1, it can be seen that amongst the many potential side-
tracks on the way from an unfolded to a folded protein, there is one that leads
to the formation of ordered fibrillar structures, called amyloid fibrils [13]. Due to
the well defined structural properties of the end product, this process was dubbed
”misfolding”. Amyloid has first been discovered in the connection with diseases, as
early as several centuries ago [14]. Initially the material was thought to consist of
carbohydrates, due to the possibility to stain it with iodine (hence the name) [14].
Only much later, the fibrillar nature of the protein aggregates was recognized [15].
Interestingly, it was known as early as 1944 that insulin, upon heating and acidifica-
tion reversibly self-assembles into fibrillar structures [16]. However, the connection
that the structure adopted by the protein within the fibrils was very similar to the
structure of the proteins within disease associated aggregates was made much later.
Today, several dozens of diseases, most of them neurodegenerative disorders (e.g.
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, the prion diseases),
but also diseases affecting other organs (e.g. type 2-diabetes, systemic amyloidosis)
can be linked to amyloid [17] in that fibrillar proteinacious deposits are hallmarks
of these disorders. Table 1.1 gives an (incomplete) overview over various human
disorders associated with amyloid.
Amyloid fibrils are highly ordered, linear structures that can be viewed as (pseudo)
one-dimensional crystals and that consist of thousands of individual protein molecules,
leading to a high aspect ratio of the fibrils, with diameters ranging up to 10 nm and
3
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amyloidogenic
peptide or
protein
associated disease associated function
Aβ and τ Alzheimer’s disease n/a
Prion protein
(PrP)
Spongiform en-
cephalophaties
n/a
α-synuclein Parkinson’s disease n/a
Huntingtin Huntington’s disease n/a
Lysozyme Lysozyme systemic amyloi-
dosis
n/a
Pro-islet amy-
loid polypeptide
Diabetes type 2 n/a
β2-
microglobulin
Hemodialysis-related amy-
loidosis
n/a
Transthyretin Senile systemic amyloidosis n/a
Ig light chains Primary systemic amyloido-
sis
n/a
Serum amyloid
A
Secondary systemic amyloi-
dosis
n/a
Fibrinogen Fibrinogen α-chain amyloi-
dosis
n/a
Calcitonin Medullary carcinoma of the
thyroid
n/a
Curlin n/a in curli of E. Coli
Yeast Ure 2p n/a nitrogen metabolism regula-
tor
Yeast Sup35 n/a translation termination fac-
tor
Fungal Het-S n/a regulator of vegetative cell
fusion
Pmel 17 n/a Melanin biosynthesis
Table 1.1: List of disease related (from [17]) and functional (from [18]) occurrences
of amyloid in nature. In total, more than 30 amyloid diseases have been reported to
date. The number of identified functional occurrences of amyloid is much smaller,
but steadily growing.
maximum lengths of more than thousand times this value. In the last decade and pi-
oneered through work carried out in Cambridge, it is becoming increasingly evident
that the amyloid phenomenon is not restricted to disease, but that a large variety
of proteins can be made to form amyloid fibrils in vitro under appropriate condi-
tions (see e.g. [19]). Amyloid fibrils are stabilized through intermolecular hydrogen
bonds and contain mainly β-sheet as secondary structure element [20]. To obtain
atomic resolution structural data of amyloid fibrils has proven to be a major chal-
4
CHAPTER 1. INTRODUCTION
lenge. Electron and atomic force microscopy allow the determination of the overall
topology (length, width, twist) [21; 22] and mechanical properties [20] of mature fib-
rils. X-ray fibre diffraction yields characteristic distances within the proto-filaments,
such as the characteristic reflections at 4.7 A˚ and 10 A˚ that stem from the inter-
strand and inter-sheet distances respectively [13; 23]. When the fibrils are aligned,
the X-ray pattern shows two sets of perpendicular crescent shaped reflections; the
origin of this scattering pattern is the arrangement of the protein subunits within
the fibrils, the tertiary and quaternary structure, that has been dubbed ”cross β”
structure [24]. The β-strands are here orthogonal to the long fibril axis (see Figure
1.3).
A slightly higher level of detail can be achieved with the limited proteolysis [25] and
hydrogen exchange [26; 27] methodologies. These techniques provide insight into
the parts of the polypeptide sequence that are more or less structured and therefore
accessible in the fibrillar fold. Yet higher resolution can be achieved with experi-
mental approaches that have experienced a dramatic improvement in the last years,
namely cryo electron microscopy [28; 29] and solid state NMR spectroscopy [30].
The large size of amyloid fibrils (MDa) renders classical solution state NMR exper-
iments infeasible. The highest resolution to date (atomic resolution) was achieved
by performing X-ray crystallography of micro-crystals formed from short peptide
sequences [31] that are part of the amyloidogenic sequence of larger polypeptides
and proteins. These short peptides can form both fibrils and microcrystals, and the
structure of the monomeric unit within the crystal is thought to be very similar to
the structure of the fibril. Figure 1.3 gives an illustration of the architecture of an
Aβ (1-42) amyloid fibril.
The generic nature of the interactions stabilizing amyloid fibrils together with
findings on the relative stabilities of amyloid and folded proteins led to the hypothe-
sis that in fact any polypeptide sequence can form these structures that might even
represent the global free energy minimum of the polypeptide [2; 34]. The initial
hypothesis of the entirely aberrant nature of amyloid fibrils had to be reconsidered
after the discovery of functional amyloid. Nature seems to make use of the remark-
able mechanical properties [20] and self assembly of amyloid in a range of different
circumstances, ranging from a scaffold for melanin bio-synthesis [35] over fungal
coatings [36] to non-genetic inheritance [37]. The bottom of Table 1.1 gives several
examples for proteins that are believed to form amyloid in a functional context.
Figure 1.1, illustrates that many of the possible conformations of the polypeptide
chain are interconnected through open (mis-)folding pathways. This picture suggests
that the fundamental driving forces that govern the formation of amyloid fibrils are
the same as those governing protein folding: the formation and breakage of hy-
drogen bonds [31] and of hydrophobic [38] and electrostatic interactions [39]. The
remarkable structural similarity of amyloid fibrils formed from a variety of polypep-
tides with unrelated primary structures [40] suggests that the thermodynamics and
kinetics of their formation could be more straightforward to understand than the
equivalent quantities in protein folding, a process leading to a large number and
variety of different final structures [41]. Such a study is attempted in this thesis,
mainly relying on highly accurate measurements of the kinetics of amyloid fibril
5
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a) b)
c)
e)
d)
Figure 1.3: The cross-β structure of an Aβ amyloid fibril (a-c from [32] and [33]
and d-e from [29]). a) A single Aβ (1-42) monomer in the fiber conformation is
shown down the fiber axis. The N-terminal β-strand and the C-terminal β-strand
are labeled β 1 and β 2, respectively. b) A view of Aβ (1-42) fiber structure from the
side, perpendicular to the fiber axis. A single Aβ (1-42) monomer is shown in red,
with the neighbouring monomer in grey. This illustrates how the side chains from
one unit in this structure (Aβ 3, strand β 2) form an interface with the neighbouring
molecule (Aβ 4, strand β 1). c) Full structure of Aβ (1-42) viewed perpendicular
to the fibre axis. A single monomer is displayed in red, with the others in grey,
together forming a piece of an Aβ proto-filament. d) It is indicated how the proto-
filaments wrap around each other to form the mature fibril. e) The global topology
of a mature Aβ (1-42) amyloid fibril.
elongation. This approach, that aims to elucidate the molecular mechanisms of this
self-assembly reaction not only has implications for the quest to fight the disorders
associated with it, but due to the intricate links between folding and misfolding can
contribute to the solution of the above stated ”folding problem”. Before attacking
this problem, in the following two sections a historical perspective on the develop-
ment of the notion of ”reaction kinetics” will be given, followed by a more specific
focus on the development of the measurement of protein aggregation kinetics.
6
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1.2 History of chemical kinetics
As outlined in the previous section, kinetic measurements of a macromolecular self-
assembly reaction, amyloid fibril elongation, are the central theme of this thesis. It
therefore seems in place to give a brief historical overview how the notion of reaction
kinetics and dynamics arose. The first part of the following section closely follows
the discussion in [42].
The qualitative notion of duration of a chemical reaction or the rapidity with which
it proceeds certainly is very old. It was necessary for man to be able to predict
the duration of processes such as fermentation, combustion or metal oxidation, in
order to exploit them optimally. However, records of systematic measurements start
comparatively late. In the second half of the 18th century, the German chemist Carl
Friedrich Wenzel qualitatively described the dependence of the rate of dissolution of
metals in acid on the concentration of acid [43]. Even though this study was not the
only one in these early days of the discipline, no serious quantitative attempts were
made to study reaction rates. However, this changed in 1850, when the German
physicist Ludwig Ferdinand Wilhelmy studied the rate of inversion of sucrose [44].
Wilhelmy for the first time set up a differential equation for this reaction that he
had found to be proportional to both the sugar and added acid. He then integrated
this equation and showed that the mathematical solution was consistent with his
experimental results. In 1864, Guldberg (mathematician) and Waage (chemist) in
Norway published their law of mass action, where they arrived at an expression for
the equilibrium concentrations of chemical species by equating the rate equations of
forward and backward reaction [45]. However, they had deduced these rate equa-
tions, incorrectly, from the stoichiometric equations, arriving at the correct final
expression. At about the same time, another collaboration between a mathemati-
cian and a chemist proved fruitful for chemical kinetics, this time in Oxford. George
Vernon Harcourt performed important kinetic experiments (e.g. between hydrogen
peroxide and hydrogen iodide). However, he needed the help of his colleague and
mathematician William Esson to analyse the data correctly. Together, they de-
scribed what we would today call first and second order reactions and consecutive
reactions [46].
However, the greatest contributions to chemical kinetics in the 19th century were
made by the Dutch chemist Jacobus Henricus van’t Hoff. In 1884 he published a
book [47], where he summarized the research that had been published to this date
and completed it with data that had been acquired in his Amsterdam laboratory in
the three previous years. Despite the sparse available data, van’t Hoff managed to
extract many new fundamental principles and to obtain deep insight into chemical
kinetics. Among many other things, he introduced the symbol ”” to express the
notion of a dynamical equilibrium, he studied the influence of the surface of the
reaction vessel on the kinetics of gas phase reactions, he properly defined the order
of a reaction and he introduced logarithmic plots of kinetic data to determine the
order of a given reaction. However, probably his most important contribution is the
expression for the so-called ”van’t Hoff isochore”:
7
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dlnK
dT
=
∆q
RT 2
(1.1)
where K is the equilibrium constant and the heat of reaction q is written today
as ∆H0. Even though this equation is concerned with chemical equilibrium, van’t
Hoff extended it by using the relationship between the forward and backward rate
constants and the equilibrium constant K = k1
k−1
:
dlnk1
dT
− dlnk−1
dT
=
q
RT 2
(1.2)
He regarded the heat of reaction as the sum of two terms q = E1 −E−1, so that
dlnk1
dT
− dlnk−1
dT
=
E1
RT 2
− E−1
RT 2
(1.3)
Identifying the first and second terms on either side of the equation, van’t Hoff
obtained the following general relationship for the influence of the temperature on
a rate constant (integrated with respect to temperature):
lnk = − E
RT
+ const. (1.4)
which is equivalent to writing k = Ae−E/RT . van’t Hoff already realized that the
energy E is not necessarily temperature independent. Even though this equation is
normally attributed to Svante Arrhenius, a Swedish chemist and close collaborator
of van’t Hoff, his contribution was the interpretation of a variety of experimental
results using this equation [48]. In addition, he proposed a physical interpretation
of this equation in terms of an equilibrium between reactant and active molecules,
that undergo reaction readily. Despite the fact that Arrhenius acknowledges van’t
Hoff’s priority in his article, this equation is now generally known as the ”Arrhenius-
equation”.
Conceptually, it was easy to apply this equation to simple gas-phase reactions, where
the collision frequency could be calculated in a straightforward manner using kinetic
theory of gases, even though the exact physical origin of the (activation) energy term
remained unclear.
However, before such an approach could be used to improve the descriptions of
reactions in the condensed phase, the stochastic (Brownian) dynamics of particles
or molecules immersed in liquid had to be understood. This task was completed
independently by Albert Einstein [49] and Marian von Smoluchowski [50]. For the
simple case of two reactive spheres A and B of concentrations [A] and [B], diffusion
coefficients DA and DB and radii RA and RB, the diffusion limited reaction rate is
given by [51]:
r = 4pi(DA +DB)(RA +RB)[A][B] (1.5)
an equation that was, for example, used much later to predict the maximum
theoretical rate for enzymatic reactions [52]. In order for the next conceptual leap
in reaction kinetics to be possible, quantum mechanics had to be developed, as a
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means to calculate the energy surface and therefore the energy of activation in the
Arrhenius equation from first principles. The first such attempt was made in Berlin
by Michael Polanyi and his postdoc Henry Eyring in 1931 for the simple reaction [53]:
H + H2 → H2+H (1.6)
where they themselves dubbed their approach semi-empirical, using experimental
data and quantum chemical calculation to describe the energy landscape. However,
it should take three more years, until what we now know as transition state theory
(TST), was born. In 1934 Eyring, by that time back in the US, published a paper
where he used the combination of quantum mechanics and statistical mechanics to
compute absolute reaction rates [54]. Quantum mechanics again serves the construc-
tion of the energy landscape and therefore the energy difference between the lowest
energy state of the reactants and the highest energy state on the pathway towards
products, and therefore the (pseudo)equilibrium concentration of ”activated com-
plex”. Statistical mechanics then allows to calculate the frequency of decay of this
activated complex into products. The final expression for the reaction rate constant
as computed with TST is
k =
kBT
h
QTS
QR
e
− Ea
kBT (1.7)
where QTS and QR are the partition functions of the transition state (”activated
complex” in Eyring’s words) and of the reactants respectively, Ea is the activation
energy, kB is the Boltzmann constant and h is Planck’s constant. The pre-factor
kBT
h
has dimensions of a frequency and gives the rate of decomposition of the TS.
It is derived from the fact that in the TS one vibrational mode changes from being
bound to dissociative. Up to this day, TST and its applications and variations is a
very active field of research within the physical chemical community.
At about the same time as the birth of TST, and rather independently of it, a
Scandinavian school, under the guidance of Niels Bohr, worked on the problem of
the origin of the ”activation” of the reactants. In the years between 1915 to 1928,
the so-called ”radiation hypothesis” was fiercely debated, mainly advocated by Jean
Perrin [55].1 Among the researchers not convinced by this hypothesis was a young
Chemist, Jens Anton Christiansen, who came to work with Niels Bohr in Copen-
hagen after his PhD thesis. There, he met Hendrik Anthony Kramers, a Dutch
Physicist who had done his PhD with Bohr. Their approach to tackling chemical
reaction dynamics and kinetics was inspired by Einstein’s and Smoluchowski’s work
on diffusion mentioned earlier; instead of the activation of the reactants by (black
body) radiation, they favoured the collisional mechanism. The collaboration be-
tween Christiansen and Kramers ultimately proved very fruitful, as it culminated in
1940 in the publication by Kramers of a paper entitled ”Brownian motion in a field
of force and the diffusion model of chemical reactions” [56]. In this work, Kramers
1With great regret, but for the sake of brevity, a discussion of the work of Lindemann and Hin-
shelwood, and subsequently of Rice-Ramsperger-Kassel-Marcus (RRKM) on the theory of collision
induced unimolecular reactions in the gas phase, obviously of great importance, will be omitted
here.
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examines the problem of escape of a particle from a metastable state by diffusional
barrier crossing. The necessary energy for the barrier crossing, the ”activation en-
ergy” is provided by the thermal energy of a bath of solvent molecules, that, at the
same time also exerts friction on the particle with friction constant ξ = kBT
D
. The
rate of barrier crossing (for moderate to strong friction) can be expressed as [56]:
r =
[(√
ξ2
4
+ ω2b
)
− ξ
2
]
ω0
2piωb
e
− Eb
kBT (1.8)
where ω0 and ωb are the frequencies characterizing the curvature of the energy
as a function of the one dimensional reaction coordinate at the bottom of the well
and at the barrier top, respectively. This expression reduces to r = ω0ωb
2piξ
e
− Eb
kBT in
the limit of high friction (r → 0 for ξ →∞). For low friction, equation 1.8 reduces
to r = ω0
2pi
e
− Eb
kBT , a result analogous to transition state theory with only one degree
of freedom. Despite its high relevance for chemical problems, Kramer’s theory re-
mained largely unnoticed in the chemical community until the late 1970s [57].
The second half of the twentieth century did not yield any major conceptual advances
in the field of chemical kinetics. However, more and more advanced experimental
methods led to the possibility to carry out kinetic experiments with an ever bet-
ter temporal resolution, and therefore to directly measure what had hitherto been
rather theoretical concepts. This development culminated in the work of Ahmed
Zewail (Nobel Laureate 1999), who, by means of femtosecond pump-probe laser
spectroscopy, was able to obtain a direct spectroscopical signature of a transition
state structure of a gas phase reaction [58]. For experimental studies of macro-
molecular (protein) dynamics in condensed phases, the last decades proved equally
spectacular, leading from the first systematic studies of refolding kinetics [59; 60]
in the late 1960s, to the very fastest single molecule folding kinetic studies possible
today [61].
1.3 Protein aggregation kinetics
The aggregation of proteins into ordered fibrillar structures is by no means restricted
to amyloid fibril formation. Both in a functional, as well as in a disease context, this
phenomenon is prominently involved in several cases. Examples for the former class
are the polymerization of actin (the study of which was pioneered by Oozawa [62])
and flagellin (from the flagella of bacteria), the most prominent example for the
latter class is the polymerization of sickle cell hemoglobin, that was studied in detail
by William Eaton [63]. These early studies of aggregation kinetics were performed
using techniques such as turbidity measurements, sedimentation assays, calorimetry,
measurements of the changes in linear birefringence or viscosity and one-dimensional
NMR. The systematic study of amyloid fibril formation kinetics in vitro in order to
obtain deeper insight into the disease mechanisms started when it was discovered
that Thioflavin T, a fluorescent dye that had been used since the late 1950s to stain
amyloid in tissue sections [64], could also be used as a convenient means to study
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amyloid formation in vitro [65; 66; 67]. It is interesting to note that systematic
in vitro studies of amyloid formation kinetics started much later than comparable
studies for other fibrillar proteins (see above), despite the fibrillar nature being dis-
covered at around the same time.
In addition to the dye label assay, specific for amyloid, the experimental techniques
that had been established for the study of other fibrillar forms of proteins, and that
are mentioned above, were subsequently also applied for amyloid studies. Those
are for example turbidity [68], time-dependent sedimentation [69], light scatter-
ing [70; 71] and various spectroscopic techniques. Very important fundamental in-
sight into amyloid formation kinetics was and is still today being gained from these
experiments, and will be discussed in later chapters. However, most of these ex-
perimental techniques have severe drawbacks, such as very complex analysis (light
scattering), sensitivity to non-fibrillar aggregation (light scattering, turbidity, cen-
trifugation) and reliance on a label molecule the labeling mechanism of which is
poorly understood (ThT-fluorescence). Several of these assays, together with their
associated drawbacks will be discussed in more detail and contrasted to the biosens-
ing methods developed here later in this thesis. Despite its late start, the field of in
vitro amyloid kinetics soon reached a level that by far exceeds any of the research
programs dedicated to other fibrillar proteins. This development is obviously due to
the high medical relevance of amyloid formation, the phenomenon being linked to
multiple diseases, as shown in Table 1.1. This high interest inevitably led, around
the turn of the millennium, to the development of new ways to measure amyloid
formation kinetics, mainly based on the monitoring of amyloid elongation on sur-
faces. There had been studies as early as the late 1990s, where the incorporation of
radio-labelled amyloidogenic peptide into surface-bound amyloid deposits had been
monitored, mainly in order to simulate the behaviour of brain plaques [72]. Two
parallel routes of surface-bound measurements were developed, single molecule (or
better ”single fibril”) elongation experiments and ensemble experiments. The single
molecule experiments consisted of total internal reflection fluorescence microscopy
(TIRF) [73] and atomic force microscopy (AFM) [74]. The first surface-based en-
semble measurements relied on surface-plasmon resonance (SPR, discussed in detail
in the Methods chapter) [75]. Finally, in 2007, the first reports on the use of quartz
crystal microbalances for the study of amyloid fibril elongation kinetics were pub-
lished [76; 77]. This thesis contains the description of the further development and
of multiple applications of this new technique. It will be demonstrated here, that
this novel route to measuring amyloid kinetics, due to its highly quantitative nature,
is capable of providing valuable new insight into this extensively studied complex of
problems.
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Experimental Section
2.1 Proteins
The proteins used for the formation of amyloid fibrils and the kinetic experiments
of fibril elongation were either expressed according to standard protocols (human
α-synuclein [78], bovine PI3K-SH3 [19]) or purchased from commercial suppliers
(bovine insulin and its B-chain, hen egg white and human lysozymes, bovine β-
lactoglobulin, bovine and human α-lactalbumins, from Sigma Aldrich (Dorset, UK)
and Aβ (1-42) from Bachem (Basel, Switzerland). The Ure2p yeast prion protein was
a kind gift from Dr Yiqian Wang, Beijing, human β2-microglobulin from Professor
Vittorio Bellotti, Pavia, and human glucagon from Novonordisk, Denmark. Aβ (25-
35) was synthesized via solid phase peptide synthesis by Dr Myriam Ouberai and
purified by reverse phase HPLC, similarly to the protocol for the synthesis of Aβ (1-
40) described in [79]. After purification, the eluted Aβ (25-35) was frozen in liquid
nitrogen and lyophilized. During the lyophilisation, the peptide solution melted
partly and had to be refrozen; this partial melting explains the presence of small
seed fibrils in the peptide, as observed during the experiments described in Chapter
4. Peptides and proteins were usually stored in dry form at -20. Exceptions are
Ure2p (concentrated stock solutions in 50 mM Tris buffer pH 8.4, with 200 mM
NaCl added stored frozen at -20) and the B-chain of bovine insulin (peptide as
received was dissolved in water and snap frozen).
All received or purchased peptides and proteins, except for Aβ (1-42), were used
as received. The Aβ (1-42) peptide from Bachem had to be specifically treated, as
described in detail in [80]. 1 mg of the peptide was dissolved in 1 ml trifluoroacetic
acid (TFA), and sonicated with a probe sonicator for 30 s. Then the peptide solution
was snap frozen in liquid nitrogen and lyophilized over night. The pellet was redis-
solved in 1 ml hexafluoroisopropanol (HFIP); this process sometimes took several
minutes during which the solution was stored on ice. The solution was then divided
into aliquots of 50 µl and the HFIP evaporated in a speed-vac for several hours. The
dry aliquots were then stored at -20. This treatment was shown to break up pre-
existing aggregates contained in the commercially available peptide, that strongly
accelerate fibril formation (see discussion in the section on Method development).
The quantity of pre-existing aggregates seems to depend on the particular batch of
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peptide. It could in all cases be minimized by the chemical treatment described
above. Figure 3.1 demonstrates that the frequency shift induced by contact with
the TFA/HFIP treated Aβ peptide is minimal, indicating that no large aggregates
are present (see subsection on biosensing for details).
2.2 Buffers and solutions
Many of the experiments described in this thesis were carried out in 0.01 M HCl.
This solution was prepared by adding 2 ml of 1M HCl (Sigma Aldrich, Dorset, Uk)
into a glas bottle and filling the bottle with de-ionised water to the 200 ml mark.
The experiments with human lysozyme were carried out in HCl pH 1.2; here the pH
was adjusted with the help of a pH electrode. For the experiments in Chapter 5,
concentrated stock solutions (100 mM or 1 M) of the different salts were prepared
in 0.01 M HCl, that were diluted with 0.01 M HCl and the protein stock solution for
the measurements. Phosphate buffer saline (PBS) was prepared by disolving PBS
tablets (Sigma Aldrich, Dorset, UK). This PBS buffer contains 10 mM phosphate
buffer pH 7.4, 137 mM NaCl and 2.7 mM KCl. The 100 mM phosphate buffer
(PB) for the Aβ (1-42) experiments was prepared by diluting a 500 mM PB stock
solution 1:5 with DI water. The stock solution had been prepared by weighing out
the appropriate amount of Na2HPO4 and NaH2PO4. Usually, solutions were not
filtered or degassed.
In most cases, concentrated protein stock solutions of 1 mg/ml or higher were
prepared, that were subsequently diluted to the appropriate concentrations for the
QCM or other experiments. In most cases, the concentrated protein stock solu-
tions were prepared in the same buffer in which the measurements were carried out.
However, in the case of human lysozyme, stock solutions in water were used. The
concentrations of protein solutions were measured and controlled either by weigh-
ing out the dry protein (large volumes and concentrations) or by measuring the
absorption at 280 nm and using published absorption coefficients. In the case of
human lysozyme protein stock solutions in water were prepared, the concentrations
measured and the solutions aliquoted, lyophilized and the aliquots stored at -20.
In the case of the Aβ (1-42) peptide, after each round of TFA/HFIP treatments,
one aliquot was sent for exact concentration determination by ninhydrin amino acid
analysis (Department of Biochemistry).
For the ThT experiments of insulin fibril elongation (Chapter 5), the DLS ex-
periments of insulin fibril elongation (Method development and Chapter 5) and for
the ITC experiments (Future work chapter) of insulin fibril elongation, both the
seed fibril suspensions and the solutions of monomeric protein were filtered through
a 220 nm syringe filter (Millipore), to avoid the introduction of dust particles that
can disturb the measurements through light scattering (DLS and ThT) or enthalpic
effects (ITC).
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2.3 Seed fibril formation
The transformation of the soluble monomeric proteins into insoluble amyloid fibrils
also followed the published protocols in most cases: PI3K-SH3 [19], α-synuclein [81],
bovine insulin [76], insulin B-chain [82], hen egg white [83] and human lysozyme [84],
bovine β-lactoglobulin [85], α-lactalbumin [86] and yeast Ure2p Sc/Sp [87]. In other
cases, where the protein under study formed amyloid particularly readily under
acidic conditions (e.g. human glucagon and human β2-microglobulin), it was usually
dissolved in 0.01 M HCl. In most cases the final pH was not adjusted to compensate
for the buffering effect of the protein. Therefore, if different protein concentrations
were used, the ionic strength, rather than the solution pH was controlled, as the
influence of this variable was studied in detail in Chapter 5.
In most cases, the protein solutions were stirred magnetically, considerably ac-
celerating the fibrillization reaction. In particular for α-synuclein, some mechanical
action like shaking or stirring was indispensable - quiescent samples never became
fibrillar, as judged by AFM imaging. In general, stirring appeared to be more effi-
cient in inducing fibrillization compared to shaking. For the Aβ (1-42) a particular
procedure was applied. The observation that the commercially available peptide
contained pre-formed aggregates was exploited by producing aliquots in NaOH that
were subsequently diluted into 100 mM phosphate buffer at pH 7.4 (see Aβ (1-42)
surface attachment protocol at the beginning of the next chapter for details). Aβ (1-
42) and α-synuclein fibrils were in most cases freshly prepared for each experiment,
as the fibrils were not stable for prolonged times. The Ure2p Sc and Aβ (25-35)
fibrils could be stored at 4 for several weeks. All other fibril samples (under acidic
conditions) were stored at room temperature.
2.4 Reduction and passivation of disulphide links
in human lysozyme
In order to probe the influence of the disulphide links on the stability and amyloido-
genicity of a protein (see Chapter 4), the 4 disulfide links in human lysozyme were
cleaved by reduction and passivated. The protein was incubated for 2 h with an
80-fold excess of tris(2-carboxyethyl)phosphine (TCEP) in 50 mM Tris, pH 8.5 and
6 M GndHCl for 2 h, while shaking. An 80-fold excess (with respect to protein) of
iodoacetamide (IAA) was added and the solution was again stirred for 2 h. Finally,
the solution was dialysed for 24 h against 10 mM formic acid, and the resulting pro-
tein solution was lyophilized for several days. Mass spectrometric analysis confirmed
the quantitative cleavage of the four disulphide bonds and subsequent passivation
of the thiols (Figure 2.1). This protocol was provided by Dr Anne Dhulesia.
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Figure 2.1: Mass spectra of WT human lysozyme. a) Native form b) reduced and
alkylated form.
2.5 Calculation of entropies of transfer of pep-
tides and proteins as a measure of their hy-
drophobicity
The basis of the calculation of the average free energies of transfer of the core
residues of amyloid fibrils (for Figures 4.8 and 4.10) are the partition coefficients be-
tween water and octanol of N-acetyl-aminoacid-amides, as reported by Fauchere and
Pliska [88] and the free energy values that Eisenberg and McLachlan have calculated
from these coefficients [89]. The original measurements had been carried out at neu-
tral pH. In the case where the kinetic measurements of amyloid growth were carried
out at acidic pH, error bars were therefore added in the hydrophobicity dimension,
that are proportional to the number of acidic amino acids in the respective core re-
gion of the protein. An estimate of the magnitude of such errors was performed by
comparing the partitioning coefficients measured by Kim and Szoka [90] for several
amino acids (within tripeptides) at different pH values. In addition, for the reduced
form of human lysozyme, the free energy of transfer of glutamine, rather than that
of cysteine was used for the 8 modified cysteine residues, as the introduced modi-
fication, that prevents the disulphide bonds from reforming, resembles a glutamine
residue.
In order to compute the average free energies of transfer for folded proteins, the
interior of proteins and the exterior of proteins of mesophilic bacteria (see top of
Figure 4.8 b), the average amino acid composition of these respective parts was
taken from [91], averaging between intracellular and extracellular proteins.
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2.6 Spectroscopic techniques to study protein un-
folding and aggregation
2.6.1 CD spectroscopy
The circular dichroism experiments described in Chapter 4 were carried out us-
ing a Jasco J-810 spectropolarimeter equipped with a Peltier holder. Spectra were
recorded using cells of 0.1 and 1 cm path length for the far- and near-UV, respec-
tively, with a protein concentration of ca. 20 µM, at 35.
2.6.2 Thioflavin T fluorescence
As discussed in the introduction, Thioflavin T is the most commonly used label
molecule in kinetic assays of amyloid fibril formation and growth. When ThT
molecules bind to amyloid fibrils, the excitation spectrum undergoes a characteristic
red-shift that allows to excite the fluorescence around 440 nm and to measure the
emitted fluorescence at 480 nm [67]. When ThT is used in kinetic assays, usually
the fundamental assumption is made that its fluorescence reports accurately on the
quantity of amyloid fibrils present in a given sample. In Chapter 6 of this the-
sis, a case will be discussed where this assumption is severely invalidated, strongly
underlining the necessity for label-free alternatives to probe amyloid fibril forma-
tion kinetics. Here, the discussion will be restricted to two observations that have
implications for the following chapters. In Figure 2.2, it is demonstrated that, all
other conditions being equal, the ionic strength and the temperature influence the
fluorescence efficiency of ThT bound to amyloid.
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Figure 2.2: a) The dependence of the fluorescence of ThT bound to insulin amyloid
fibrils on the concentration of NaCl was probed. It can be seen, that even small
concentrations of this salt can enhance the fluorescence by 20% (details in the main
text) b) a similar experiment was performed to probe the temperature dependence of
the fluorescence efficiency of ThT bound to amyloid fibrils, in this case formed from
the protein hen lysozyme. The drastic decrease in fluorescence over the temperature
range studied stresses the need for appropriate normalization of the fluorescence data
when the temperature dependence of amyloid formation is studied.
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Figure 2.2 a) shows an experiment, where increasing quantities of NaCl were
added to aliquots of an insulin fibril suspension (0.06 mg/ml in 0.01 M HCl). It can
be seen that the fluorescence level varies by more than 20%. It is important to note
that this variation cannot be explained through a change in the equilibrium between
free soluble protein and fibrils, as the equilibrium is already very much shifted to-
wards the fibrillar state [34] in the absence of added salt, with much less than 20%
free monomer that would be required to explain the increase in fluorescence with
a shift in equilibrium. In addition, the change in fluorescence is immediate upon
addition of salt (time resolution of experiment < 1 min) and a shift of the equilib-
rium would take longer to complete, as estimated from measurements of absolute
elongation rates (see Chapters 4 and 5). In Figure 2.2 b), a similar experiment
is shown, but here, the change in fluorescence with temperature is probed for hen
lysozyme amyloid fibrils (∼ 5 mg/ml fibrils, 100 µM ThT). The fluorescence of a
given aliquot decreases to 20% of its initial value in the temperature range from
25-70. Taken together, these findings indicate that care has to be taken in the
analysis of fluorescence data from experiments probing the influence of these factors
and appropriate normalizations have to be carried out. Interestingly, ThT does not
show the same strong temperature dependence of its fluorescence efficiency for all
proteins (see discussion of Aβ (25-35) experiments).
Below, the exact protocols for the elongation assays that are quoted in later chap-
ters are given. All kinetic experiments with ThT were performed using an Optima
platereader, with bottom optics. 96 well plates with low protein binding were used.
The measured fluorescence per data point was the average of 50 excitation flashes.
Excitation wavelength was 440 nm, emission was recorded at 485 nm. Maximum
amplitude shaking was employed after each cycle, and no additional shaking was
used.
Temperature dependence of human Aβ (25-35) amyloid elongation:
After initial experiments had shown that seeding the peptide sample did not notice-
ably accelerate the fibrillation kinetics, AFM imaging of the supposedly monomeric
synthesized peptide revealed that very short seeds were already present (see Figure
4.4). The seeds probably formed during the freeze drying process, where the mix-
ture of acetonitrile and water (from the elution of the reversed phase column) melted
partly, and had to be refrozen. During the melting, presumably very high peptide
concentrations were sampled, leading to the formation of aggregates. Therefore,
subsequent runs were performed without seeding. This raises the question, whether
the assay can still be considered as a pure elongation assay or if primary nucleation
contributes significantly to the kinetic profile. However, as can be seen from the
fluorescence traces in Figure 4.4, no acceleration of the reaction is observed, and
the overall profile corresponds very well to that of a seeded reaction (see e.g. [92]).
In addition, the fact that the fluorescence increased by more than an order of mag-
nitude during the time course of the reaction indicates that the initial proportion
of seeds must be of the order of 10 % or less. Therefore, aliquots of 0.1 mg Aβ
(25-35) in 180 µl of water were prepared, and 5 µl of a 2 mM ThT stock solution
in water were added. The aliquots were snap frozen in liquid nitrogen and stored
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at -20. Such an aliquot, when melted and monitored in the platereader, did not
show any increase in fluorescence over several hours. Therefore, 20 µl of PBS were
added, which led to the traces shown in Figure 4.4. At this stage, an additional
crucial point has to be mentioned, emphasizing the care that has to be taken in
using ThT for kinetic studies. If the PBS was added before the addition of ThT,
the fluorescence traces had a completely different character. The total fluorescence
increase was only of the order of 50% and this increase was completed after 30-60
min. It was crucial to add the PBS last, in order to get the curves of Figure 4.4.
These experiments were carried out in the temperature range from 28 to 40; in
this case the temperature dependence of the final fluorescence level was not pro-
nounced; therefore no normalization was carried out. As can be seen from Figure
4.4, a clear difference in elongation kinetics could not be resolved in the temperature
range studied. It is therefore concluded that the enthalpy of activation ∆H‡ must
be of the same order as for the proteins with the smallest measured values by QCM
(see Chapter 4), i.e. of the order of 25 kJ/mol, or smaller.
Temperature dependence of human glucagon amyloid elongation:
Separate aliquots for monomer and fibrils were prepared. 50 µl of 5 mg/ml sonicated
(1 min) seed fibrils were diluted with 1500 µl 0.01 M HCl. 50 µl of 1 M NaCl in HCl
were added, and the fibril suspension divided into 10 aliquots that were snap frozen
in liquid nitrogen and stored at -20. 1.8 mg glucagon was dissolved in 300 µl of
HCl 0.01 M and 50 µl of a 2 mM ThT stock solution in water was added. The so-
lution was divided into 10 aliquots, snap frozen and stored at -20 as well. For the
measurement, the aliquots containing the fibrils were pre-heated to the temperature
that was to be studied and the small volume of concentrated monomer solution was
added. This strategy allowed to minimize initial non-linearities of the data, due to
the opposing effects of fibril elongation, leading to an increase in fluorescence and
the decrease of fluorescence due to the temperature increase. Glucagon showed a
strong dependence of the endpoint fluorescence on the temperature, therefore the
fluorescence traces had to be normalized on the same final level of fluorescence. The
initial slope was then taken as being proportional to the elongation rate.
Ionic strength dependence of bovine insulin amyloid elongation:
Seeded ThT fluorescence experiments with bovine insulin were performed at 40.
The aliquots contained 0.01 mg/ml seed fibrils (sonicated for 10 min as described
in more detail in the section on Method development, 0.5 mg/ml protein monomer,
and 0.2 mg/ml ThT in 0.01 M HCl. The fluorescence curves were scaled to the
same maximal fluorescence value, in order to account for different final levels (see
raw data in Figure 2.2). Then the initial linear part of the curves were fitted with a
linear function and the slopes were taken to be proportional to the elongation rates.
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2.7 Biosensing measurements of fibril elongation
One of the objectives of this thesis is to demonstrate that surface-based measure-
ments of amyloid elongation kinetics are a powerful means of getting fundamental
insight into the regions of free energy landscapes of proteins corresponding to or-
dered aggregation. These measurements, where an ensemble of surface-bound seed
fibrils is brought into contact with a solution of soluble protein are in contrast to the
more traditional solution state assays, such as light scattering and Thioflavin T flu-
orescence, that are discussed elsewhere in this chapter and in the introduction. The
large majority of kinetic experiments described in this thesis have been performed
by using quartz crystal microbalances (QCM). However, another surface-based tech-
nique has been examined in less detail for its suitability of being used for kinetic
elongation assays: surface plasmon resonance (SPR).
2.7.1 Surface plasmon resonance (SPR) measurements
Surface plasmon resonance has been used for almost 30 years now to study biomolec-
ular interactions [93; 94]. SPR is routinely used to study in a qualitative way the
interactions between different macromolecules, one of which is attached to the sur-
face (”ligand”) and the other (”analyte”) is flushed over the surface and potentially
captured by the ligand. It can also be used for more quantitative studies of the
association and dissociation rates of the two interacting partners, as well as for
measurements of the binding equilibria, that are closely connected to the on- and
off-rates.
The physical basis of SPR is illustrated in Figure 2.3.
When a light beam falls onto a glass surface with a sufficiently large angle, it
will be totally reflected. However, if the glass is covered with a gold layer, a cer-
tain angle θr exists, under which the reflected light is less intense than the incident
beam. This is due to the absorption of some of the electromagnetic energy by the
electron gas of the gold layer. If a certain resonance condition is fulfilled (energy and
momentum conservation) between the incident photons and oscillations of the elec-
tron gas along the surface, so called plasmons, then the incident beam excites these
plasmons. Due to the fact that the electromagnetic field oscillations can penetrate
a certain distance (∼ 300 nm) into the liquid that covers the gold surface (as expo-
nentially decreasing evanescent waves), the refractive index in the liquid layer close
to the surface influences the resonance condition of the surface plasmons. When
molecules such as proteins attach to the surface, this leads to a change in refractive
index and therefore to a shift in the resonance condition. The incident angle of
least reflected intensity will be slightly shifted and it is this shift that is measured.
The relationship between the quantity of absorbed material and the induced shift in
angle can be empirically calibrated. The angle shift is quoted in so called response
units (R.U.), and one response unit corresponds to a shift in resonant angle of ∼
10−4◦ [95].
In the framework of the studies described in this thesis, SPR was used to monitor
the elongation of surface-bound insulin seed fibrils. Here, the seeds play the role
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Figure 2.3: a) Illustration of the geometry of an SPR set-up. The incident beam
is totally reflected at the boundary between glass and a thin gold layer, and the
reflected beam is weakened in intensity compared to the incident beam, at a certain
angle θr. The gold layer is covered with the ligand and the analyte solution is
brought into contact with the surface. b) If the analyte interacts with the ligand,
the refractive index of the layer closest to the surface increases and this change in
refractive index leads to a shift in the resonance condition of the incident beam with
the surface plasmons. This shift in angle of least reflected intensity is measured.
of the ligand and the soluble protein that of the analyte. The addition of soluble
protein onto the seeds induces the required shift in resonant angle. SPR has been
used in a number of studies to study protein aggregation [75; 96; 97; 98]. In all of
these studies, the protein (aggregates and soluble) was brought into contact with
the SPR surface via the flow system. In the present study, however, the sensor
surface was incubated with the seed fibrils ex situ, similar to the QCM experiments,
in order to avoid contamination of the flow system with protein aggregates, and also
in order to be able to control more accurately the fibril attachment process. Below,
the detailed protocol is given for these experiments.
Protocol for an SPR measurement of insulin amyloid fibril elongation: The sur-
face attachment of the insulin seeds was performed in analogy to the preparation
of QCM sensors (see section on cysteine attachment in the following chapter). The
gold substrates used were 10x12 mm gold substrates from Ssens, Netherlands, and
they were glued into the original cassette from Biacore with double sided tape. The
sensor was inserted into a Biacore 3000 (GE Healthcare) and equilibrated in 0.01 M
HCl (filtered and degassed) until a stable baseline was established. The elongation
of the seed fibrils on the SPR sensor was monitored at 40, the maximum tempera-
ture achievable with this system. The seeds were repeatedly incubated with insulin
monomer solution under varying conditions and the rate of net shift in ”response
units” during an incubation (see Figure 5.1) was taken to be proportional to the
elongation rate, and fitted with a linear function, similar to the QCM measurements
(see below).
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2.7.2 Quartz crystal microbalance (QCM) measurements
Quartz crystal microbalances have been used to measure thicknesses and masses of
thin films for more than 50 years now. Sauerbrey in 1959 [99] first realized that the
frequency of a quartz oscillator vibrating in shear-mode linearly decreased for small
added masses, according to:
∆f ≈ f0
ρ0h0A
∆m (2.1)
where ∆f is the frequency change induced by the added mass, f0, ρ0 and h0
are the resonant frequency, density and thickness of the quartz disk, respectively,
A is the active area of the disk and ∆m is the small added mass. However, this
simple relationship is only valid for thin films on a quartz resonator that is otherwise
in contact with vacuum or air. In the 1980s, it was empirically realized that the
damping induced by contact of the quartz with liquid did not prevent the use of a
QCM in liquid. The theoretical framework for operation of QCM in liquid was then
established by Kanazawa [100]. He showed that the viscous drag that the liquid
exerts on the QCM leads to an additional frequency shift, compared to operation in
vacuum or air, that depends on the density and viscosity of the liquid:
∆f = −f
3
2
0
√
ρlηl
piρ0µ0
(2.2)
where ρl and ηl are density and viscosity of the liquid, and µ0 is the shear mod-
ulus of the quartz. The shear waves decay exponentially into the liquid, with decay
constant δ =
√
ηl
piρlf
[100]. δ is of the order of 250 nm in water. This develop-
ment opened up the possibility to use a QCM for biosensing. Further conceptual
advance in respect to biosensing applications was made when it was understood,
how the viscoelastic properties of layers of material attached to the surface of the
QCM influence the oscillatory behaviour of the quartz disk. Voinova et al. solved
the problem for two viscoelastic layers on top of the QCM surface that is in contact
with a Newtonian fluid [101]. The continuum mechanical approach presented in
this work is more readily accessible to non-specialists than the alternative descrip-
tion in terms of Butterworth-van-Dyke (BvD) equivalent circuits (see e.g. [102]), as
no analogy between a physical parameter of the oscillator and a lumped element of
the equivalent circuit has to be drawn. One of the most important consequences
of the viscoelastic properties of biological materials in the context of QCM biosens-
ing is the so-called ”missing mass” effect [103]; the finite rigidity of the attached
biological material (e.g. proteins or lipids) can lead to an underestimation of the
attached mass from the induced frequency shift, when it is interpreted according to
the Sauerbrey equation (2.1). The non-validity of the Sauerbrey-equation can of-
ten already be inferred from the observation that the normalized higher harmonics
show a different frequency shift; in the framework of Sauerbrey’s simple theory, no
difference is expected. It is therefore in principle possible to characterize in detail
the viscoelasticity of a surface-bound layer through an analysis of the differential
mass sensitivity of the frequency overtones. All of these theoretical descriptions
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are, however, only valid for smooth homogeneous layers of added material. The
most recent conceptual advance in the development of liquid QCM is the attempt
to understand the influence of surface and add-layer roughness on the frequency
shift and energy dissipation of the QCM. Experimental [104] and theoretical [105]
studies show that solvent trapped within the groves formed by a rough add-layer
can lead to an additional frequency shift, leading, in turn to an overestimation of
the attached mass. Figure 2.4 illustrates the principle of QCM operation in liquid,
in a mode of operation where the crystal is periodically excited to vibrate and the
frequency of vibration, as well as the damping and associated decay constant is
measured (QCM-D).
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Figure 2.4: a) The gold-coated quartz crystal is immersed in liquid, and excited
to vibrate in shear mode (1). An analyte is brought into contact with the surface
and the attachment of this analyte to the surface is monitored in real time (2). b)
The time domain signal is shown, a damped harmonic oscillation. Attachment of
viscoelastic material to the surface leads to a more strongly damped, lower frequency
vibration of the crystal, compared to the situation before the attachment. c) The
frequency domain signal. The dissipation manifests itself in a broadening of the
peak, and the frequency is shifted.
The use of QCM to study protein aggregation and amyloid formation is quite
recent, and was pioneered in Cambridge [76]. However, several other groups are
using QCM as well to study various stages in the pathway from soluble protein to
ordered aggregates, [77; 106; 107], as well as the chemical and mechanical properties
of these aggregates [108; 109].
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General protocol and indications for QCM measurements : The initial experi-
ments were carried out with a QCM D300 (Q-Sense, Va¨stra Fro¨lunda, Sweden),
where only one sensor could be monitored at one time and the liquid was introduced
into the cell via a gravity flow system. However, the majority of the experiments
was carried out with the more recent model E4 (also Q-Sense), where 4 sensors could
be monitored simultaneously and the liquid was introduced via a peristaltic pump
where the flow rate can be more easily controlled. In all cases, gold coated QSX 301
sensors were used (Q-Sense), due to the ease of functionalization of the gold. The
surface functionalization and amyloid seed fibril attachment is described in detail
below in the section on Method development. After introducing the sensor into the
microbalance, the system was left to equilibrate for a minimum of 12 h (D300) or 3
h (E4) to allow for a stable baseline to be established (drift smaller 1 Hz/h). If the
sensor had already been incubated in buffer before inserting it into the microbalance,
the establishment of the baseline was faster. The protein solutions were introduced
from Eppendorf tubes, usually 300 µl at a flow rate of 150 µl/min. The volume used
was much larger than the volume of the QCM flow cell (40 µl); this was necessary in
order to ensure that the sample had completely replaced all of the previous solution
from the flow system. The rates of frequency shift induced by the elongation of the
surface-bound fibrils varied by several orders of magnitude, ranging from a few Hz
per hour to several dozens of Hz per minute, depending on the protein under study
and the conditions employed. Measurements were carried out in the absence of flow,
therefore for the very lowest concentrations and the fastest growing protein fibrils,
depletion effects could be observed. As discussed below, the quantitative depletion
of the cell can be used to calibrate the frequency response.
For data analysis, the fundamental frequency was never used; it is well-known [110]
that due to the lack of energy confinement to the centre of the sensor in the case of
the fundamental frequency, boundary effects, such as the way the sensor is mounted,
as well as external perturbations such as pressure and temperature changes affect
the fundamental frequency more than the higher overtones. Usually, the harmonics
with N = 3,5,7 were used for analysis; this is justified below. The frequency response
of the different overtones was usually not identical, and fibrils made from different
proteins showed different degrees of divergence of their frequency response. This
observation, in combination with the possibility to monitor the energy dissipation
of the oscillations with this set-up (the dissipation D = 1
pifτ
is defined in terms of the
time decay constant τ of the quartz oscillations; the QCM-D technology is based on
pulsed excitation of the quartz resonator, rather than continuous excitation) might
allow in principle to extract material properties of the surface-bound fibril layer.
However, as can be seen from many AFM images in this thesis, the surface-bound
fibrils do not form a smooth homogeneous layer, but rather a dense network leading
to an increase in roughness compared to the uncoated sensor. In addition, the elon-
gation of the seed fibrils is likely to lead to a different degree of coupling between
the sensor surface and the liquid, compared to the coupling between the passivated
sensor surface and the liquid, due to the different hydrophobicity of protein and
passivation layer. Taken together, the effects stemming from the viscoelasticity of
the protein fibrils and the changing roughness and surface chemistry will lead to a
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proportionality coefficient between attached fibril mass and induced frequency shift
that is very difficult, if not impossible to calculate from first principles. Therefore, it
was decided early on in the work that led to this thesis, that an empirical approach
where the mass sensitivity coefficient is calibrated, will be adopted. This approach
is described in the chapter on method development. However, much of the work
described in this thesis (Chapters 5 and 6) relies on the measurement of relative
changes in rate, rather than absolute rate measurements; in these cases the diver-
gence of the harmonics did not have much impact, as the relative change in rate
was in most cases virtually independent of the particular overtone under considera-
tion. A given sensor can only be used for a series of measurements up to a certain
total frequency shift; this total frequency shift ranged from ∼ 50 Hz to ∼ 200 Hz,
depending on the protein and the seed fibril length and surface density. The higher
the fibril surface density, the more total frequency shift could be induced without an
observable decrease in mass sensitivity. This range was empirically determined by
reproducibility tests; at the end of a series of elongation experiments under chang-
ing conditions, the seed fibrils were again incubated with monomer under the same
condition as in an initial experiment, and the reproducibility was assessed. Outside
this usable range, the divergence between different harmonics increases strongly. The
physical origin of this limited usability of a single sensor is likely to be crowding of
the elongated seed fibrils that prevents them from elongating further. Additionally,
the finite rigidity of the fibrils together with the fact that only the seed fibrils were
covalently attached to the surface, and not the freshly elongated parts, it is possible
that the entire fibril does not follow the vibration of the crystal any more when the
total fibril length exceeds a certain threshold.
At the end of a QCM experiment, the flow cell and tubing system was cleaned
with 1 N NaOH solution for several minutes and then extensively flushed with
DI water. In the cases where QCM fibril elongation experiments were carried out
with low concentrations of soluble protein (of the order of 10 µM), it sometimes
took several injections of soluble protein to obtain a reproducible rate of frequency
shift. This observation indicates that some of the protein was absorbed in the
freshly cleaned flow system, such that the concentration of soluble protein inside
the cell and in contact with the QCM sensor was not well controlled. Once the flow
system is saturated with a coating of protein, the experiment regains its usual high
reproducibility.
2.8 Cleaning and reuse of QCM sensors
The gold coated QCM chips to which amyloid fibrils were attached in this study
were cleaned and reused. To remove the protein fibrils, the crystals were immersed
in 7 M sodium hydroxide solution at 80◦C for 2 h. The self-assembled monolayers
(SAM) of either PEG thiol or cystamine on the gold surface were removed electro-
chemically [111]. A voltage of -2 V was applied to the gold surface of the crystal
for ca. 1 min against a gold counter electrode in 100 mM phosphate buffer. The
chips were then rinsed with distilled water and dried with nitrogen for reuse. Alter-
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natively, after the removal of the proteinacious material by the NaOH treatment,
the sensors were UV/O3 cleaned by exposing them for 10-20 min to the intense UV
light (172 nm) in an Excimer photon source sample cleaner. The reactive oxygen
species that form will etch off any organic contaminations. The cleaning results
from the use of this method yielded larger contact angles (estimated) compared to
the electrochemical cleaning.
2.9 Dynamic light scattering
2.9.1 Size measurements
The basis of dynamic light scattering is the measurement of the auto-correlation
function of the light scattered by particles or molecules in solution and collected
by a light-sensitive detector [112]. The idea is that the fluctuations of the detected
light reflect the erratic thermal motion of the scattering centers. The autocorrelation
function of a property A (e.g. the light intensity at the photodetector) is defined
as [112]:
〈A(0)A(τ)〉 = lim
T→∞
1
T
∫ T
0
dtA(t)A(t+ τ) (2.3)
For many random physical processes, the auto-correlation function decays ex-
ponentially, due to the short term memory of such (Markoff) stochastic processes.
If the fluctuation of the quantity A is defined as δA(t) = A(t) − 〈A〉, where 〈A〉 is
the mean of the quantity A, the correlation function of the fluctuation then simply
decays according to:
〈δA(0)δA(τ)〉 = 〈δA2〉e− ττr (2.4)
as δA(0) has zero mean. τr is called the correlation time of the system. In a
homodyne light scattering experiment, the scattered light is only correlated with
itself. In a heterodyne experiment, on the other hand, the scattered light is super-
imposed to a small portion of the initial light beam that had been separated via
a beam splitter. The set-up used in the experiments described in this thesis were
all homodyne scattering experiments. It can be shown that for a spherical parti-
cle performing Brownian motion, the homodyne correlation function can be written
as [112]:
F (q, t) = 〈N〉2 + 〈N〉2e−2q2Dt (2.5)
where N is the number of scattering centres in the scattering volume, and q is a
vector defined in terms of the wavevector of incident and scattered light according
to q = ki− ks; q is constant and known for a given scattering geometry. Therefore,
a fit of the correlation function to an exponential function allows the determination
of the diffusion coefficient of the spherical particle. This diffusion coefficient can
then be related to the size of the particle via the Einstein relation:
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D =
kBT
ξ
(2.6)
where the friction coefficient ξ is given by the Stokes equation for a sphere with
sticky boundary conditions ξ = 6piηR, with R the radius of the sphere.
2.9.2 ζ-potential measurements
If a particle or molecule in solution is subjected to an external force, its motion will
be a superposition of the motion induced by the force and its intrinsic Brownian
motion. In the case of a charged particle in an electric field E, the terminal velocity v
of the particle induced by the field is v = µE, where the mobility µ is given by µ = Q
ξ
,
with Q the charge of the particle. However, if the solution contains an electrolyte,
this simple relationship does no longer hold. As was shown by Helmholtz and Debye
and Hu¨ckel [113], some counter ions will attach to the particle and form the so called
Helmholtz-plane. In addition, a cloud of counter-ions will form around the charged
particle and the potential drops exponentially around the charged particle, according
to:
V (r) =
Qeff
4pi0rr
e−κr (2.7)
where κ is the inverse of the screening length and depends on the ionic strength
of the solution (see the appendix to Chapter 5 for a derivation). If the particle is
subjected to an external field, it will start to migrate and only the tightly attached
ions will be able to follow this movement. There will be a slip plane between ions
that follow the movement and those that don’t and the potential difference between
this slip plane and the bulk of the solution is called the ζ-(zeta-) potential. For a
given composition of the suspension medium, the ζ-potential is a measure of the
surface charge of the particle. In the presence of a double layer of counterions, the
mobility of the charged particle under the influence of an external electric field is
reduced. It was shown by Henry [114], that the mobility can then be written:
µ =
2ζ
3η
f(κR) (2.8)
where the cgs units of Henry’s original paper have been converted to SI units, and
where ζ is the ζ-potential, and f(κR) is called Henry’s function. This function varies
between 1.0 to 1.5 for variations of the product κR of the inverse Debye screening
length (a measure for the thickness of the double layer) and the particle radius from
0 to ∞. The former situation corresponds to Hu¨ckel’s approximation, the latter
to Smoluchowski’s approximation. Smoluchowski’s approximation is valid for most
cases, where charged particles are immersed in aqueous electrolytes. However, in
the case of short amyloid fibrils or even monomer in low conductivity media, such
as is the case in the measurements carried out for this thesis, the product κR is of
the order of one, in a region where neither of the approximations is strictly valid.
In addition, the above discussion based on a simple picture of the electrical double
26
CHAPTER 2. EXPERIMENTAL SECTION
layer is only strictly valid for moderate surface charges (< 25 mV). However, for
the qualitative comparison between the charge state of fibrils and soluble protein
attempted in Chapter 5, the similarity in the systems will lead to a reasonable
comparability.
2.9.3 General protocols for size and ζ-potential measure-
ments of proteins
The use of dynamic light scattering to follow the elongation of seed fibrils is de-
scribed in detail at the end of the next chapter. Here the description is limited to
the measurement of sizes of soluble protein. DLS measurements were carried out,
using a Malvern zetasizer nano (Malvern, Worcestershire, UK). Usually, 300 µl of
sample were filled into a small volume disposable plastic cuvette (Fisher scientific).
The standard settings of the zetasizer were used for the automatic data analysis.
In most cases (except for very monodisperse samples), the maximum of the number
distribution by size was taken as the size of the particles. In cases where the scatter-
ing was very much dominated by a single population of particle sizes, the Z-average
(cumulant mean) value of the size was used. DLS size measurements were often
used for qualitative checks of the aggregation state of protein solutions, that were
the starting point for aggregation assays.
Dye interaction experiments of Chapter 6 : Concentrated stock solutions of CR (2
mM) and ThT (1 mM) in water were prepared and these stock solutions were di-
luted with 100 mM PB to the appropriate concentrations of 50 µM (CR) and 30
µM (ThT). The dye solutions were not filtered, as some of the dye was absorbed in
the filter, and therefore the concentrations would be changed upon filtering, but in
order to minimize interference with the measurement by dust particles, the PB was
filtered before the dilution. Then the size distribution of the dilute dye solutions
was measured. The ThT solution was weakly scattering and could not readily be
distinguished from pure buffer. A 1:1 mixture of these solutions was then prepared,
i.e., a solution containing 25 µM CR and 15 µM ThT, and the size distribution was
again measured. The concentration of the ThT solution was chosen lower than that
for the CR solution, because a ThT solution at 50 mM already showed the presence
of aggregates. Therefore, to facilitate the detection of the formation of ThT-CR
clusters, a 30 µM solution of ThT was used.
The ζ-potential of sonicated fibrils and soluble protein (bovine insulin) was mea-
sured using clear disposable zeta cells (Malvern, UK). The acidic solution conditions
necessary to induce insulin fibrillation made the use of the dip cell with Pd elec-
trodes (Malvern) impossible, as electrode blackening occurred immediately and a
black precipitate was formed at the electrodes. However, the gold coated electrodes
of the disposable cells were less prone to induce the formation of this precipitate.
In addition, it was attempted to load a small volume of the sample with a gel load-
ing tip to the bottom of the cell, that had previously been filled with buffer. This
method, if carefully performed will minimize the contact between the protein so-
lution and the electrodes. However, as an additional complication, that could not
be avoided, gas bubbles formed at the electrodes, probably due to outgasing and
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electrolysis occurring in the acidic solution due to the application of high voltages.
The bubbles had to be periodically removed after a few measurements, as long term
reproducibility was impaired by the gas bubbles at the electrodes. In general the
measurements of the ζ-potential of sonicated amyloid insulin fibrils (100-200 nm)
were characterized by a good reproducibility, and the size distribution was not al-
tered by the application of the voltage, as confirmed by size measurements before
and after the ζ-potential measurements. The ζ-potential of soluble protein was more
difficult to measure, and the reproducibility was less good. In addition, small ag-
gregates formed during the application of the voltage; therefore the results have to
be interpreted more carefully. All these difficulties have been reported before and
discussed and analyzed in detail in [115]. However, the qualitative conclusion drawn
in Chapter 5, that soluble protein and fibrils have similar charge densities is unlikely
to be affected by these considerations, as the fibrils were found to have systemati-
cally higher ζ-potential (> +35 mV); this finding allows to draw the conclusion that
amyloidogenic proteins do not have to be globally neutral in order to incorporate
into amyloid fibrils, contrarily to recent reports [116].
2.10 Atomic force microscopy (AFM)
All AFM images shown in this thesis were acquired with tapping mode in air using a
Molecular Imaging PicoPlus (Tempe, AZ) atomic force microscope. The cantilevers
employed were NSC36 SiN cantilevers (MikroMasch, San Jose, CA), with a resonant
frequency of ∼ 150 kHz.
In most cases where AFM images of the fibril-coated gold surfaces of QCM sensors
were taken, the surfaces had been imaged after the end of the experiment. However,
it is also possible to dry the sensor surface directly after seed fibril attachment for
imaging. If the sensor is afterwards immersed back into buffer, the seeding efficiency
is not appreciably decreased. Therefore, intermediate drying (not exceeding several
hours) does not seem to induce irreversible structural changes in the amyloid seed
fibrils.
2.11 Mass spectrometry
All mass spectrometric experiments the results of which are presented in this thesis
were carried out by Asha Boodhun at the mass spectrometry facilities of the De-
partment of Chemistry.
In order to determine the degree of chemical modification of the activated amyloid
fibrils, they were dissociated either via abrupt changes in pH (2.0 to ca. 12.0 in the
case of PI3K-SH3 and 7.4 to ca. 0.5 in the case of α-synuclein) or via suspension in
DMSO (α-synuclein) and then examined by mass spectrometry. The protein sam-
ples were purified from buffer salts and excess reagents with Ziptip C18 (Millipore,
MA) and eluted in 50% acetonitrile and 0.1% formic acid. 2 µL samples were elec-
trosprayed from a gold-coated borosilicate capillary (Proxeon, Odense, Denmark).
Mass spectra were recorded on a QSTAR Pulsar instrument (Applied Biosystems,
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Foster City, CA) with a capillary voltage of 1200 V and declustering potentials of 45
V and 15 V. De-convoluted protein spectra were generated using Bioanalyst software
(Applied Biosystems).
2.12 Preparation of gold surfaces with different
roughnesses
Template-stripped gold (RMS roughness ca. 0.5 nm) was produced as described
previously [117]. Rough gold surfaces (RMS roughness ca. 1.5 nm) were prepared
by evaporating on to a freshly cleaved mica surface an adhesion layer of 2 nm of
chromium followed by 100 nm of gold using a BOC Edwards Auto 306 evaporator
(Crawley, UK). The biosensors used had a variable roughness between 0.8 nm and
2 nm, the largest roughness being observed for sensors after cleaning (see below).
2.13 Differential scanning calorimetry (DSC)
The calorimetric experiments shown in Figure 4.9 were performed with a VP-DSC
calorimeter (Microcal, Amersham, UK). Solutions of the native and reduced forms of
human lysozyme (in independent experiments) were introduced into the sample cell.
The protein concentrations were 33 µM, the solution pH 1.2 and the total chloride
concentration 200 mM (adjusted with NaCl). The reference cell was filled with a
solution of the same composition, but lacking the protein. Then the temperature
was scanned from 25 to 70. The raw data was treated with the Origin software
provided with the instrument. Both the signal of the reference cell and the baseline
were subtracted from the signal, yielding the traces as shown in Figure 4.9.
2.14 Isothermal titration calorimetry (ITC)
The basic principle of ITC is that a cell containing the sample and a reference cell
are kept at constant temperature by controlled heating. When a reaction takes
place in the sample cell that consumes or releases heat, the heating rate has to be
changed in order to keep the temperature of the sample equal to the temperature
of the reference cell. The time integral over the differential heating rate gives the
total heat released or consumed by the reacting species. ITC has experienced an
impressive boost in development and application in recent years [118], however, the
present discussion will be limited to its application for the study of amyloid fibril
elongation. Several studies have been published, where the authors have studied the
enthalpy release associated with the elongation of amyloid fibrils [116; 119; 120]. In
these experiments, a small amount of soluble protein is titrated into the sample cell
that contains seed fibrils, and the heat released by the incorporation of the soluble
protein into the seed fibrils is monitored. Alternatively, the sample cell is filled
with soluble protein and a small quantity of seed fibrils is titrated into the sample
cell, leading to the conversion of the soluble protein in the cell to insoluble fibrils.
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Initial experiments along these lines were performed for this thesis; the results are
mentioned and discussed in the chapter on future work. Below, the experimental
protocol is given.
Protocol for ITC measurement of the enthalpy release from insulin amyloid fibril
elongation: A solution of 0.5 mg/ml insulin monomer and a suspension of 0.5 mg/ml
sonicated (10 min at 100 W, 3s pulses, 3s off) insulin amyloid fibrils (both in 0.01 M
HCl) were dialysed overnight at 4 against a large volume of HCl 0.01 M, in order
to ensure that the pH values were identical in both solutions, and that any residual
salts (from the protein) were sufficiently diluted such that their heat of dilution upon
titration would not interfere with the calorimetry experiment. The sample cell of
the isothermal titration calorimeter (VP-ITC, Microcal, Amersham, UK) was filled
with 1.5 ml of the soluble insulin solution and the injection needle was loaded with
the fibril suspension. After the establishment of a stable baseline, 100 µl of the fibril
suspension were injected, and the fibrillization reaction monitored. After the signal
had recovered to the baseline, a second injection of 100 µl was performed in order
to check whether all the monomer in the sample cell had been consumed. These
experiments were carried out at 50 and at 55; the results are shown in the Future
work chapter.
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Method development
3.1 Fibril surface attachment
This section is mainly based on the paper ”Surface attachment of protein fibrils via
covalent modification strategies”, Buell et al., J. Phys. Chem. B 2010, [121]. Con-
tributions of co-authors will be indicated appropriately.
In order for the biosensing methods described earlier to be able to develop their
full potential, it is necessary to ensure an irreversible linkage of the amyloid seed
fibrils, the elongation of which is studied, to the surface of the sensor. If this require-
ment is not fulfilled, one of the key advantages of this experimental approach is not
realized, namely the fact that a constant number of seed fibrils is monitored during
the time course of an experiment, enabling a particularly straightforward analysis
of the change in aggregation kinetics upon a change in conditions.
These considerations highlight the need for an approach where the attachment of
amyloid fibrils to surfaces, in particular gold surfaces due to their widespread use
in biosensing, can be carefully controlled. In most cases where attachment of a
macromolecule to gold is required, the general approach is to use a linker molecule
containing a thiol group and to exploit the high propensity of the latter to form a
covalent gold-sulphur bond [122]. Subsequently, the attachment of amyloid fibrils or
other protein structures to the layer of linker molecules can be achieved either via
an amide coupling reaction [96; 97] or through antibody-antigen interactions [107].
Both methods have been applied to amyloid fibrils under solution conditions (e.g.
pH and temperature) where the particular fibrils under investigation are stable. In
most cases where QCM experiments with Aβ (1-42) were performed for the work
described in this thesis, a variant of this surface attachment method was applied,
that is illustrated in Figure 3.1. In this method, it was made use of the fact that
in the commercially available peptide (in this case TFA salt from Bachem, Basel,
Switzerland), pre-formed aggregates seem to be present that can act as seeds. When
the peptide is dissolved in buffer (100 mM PB or PBS), fibrils can be seen (by AFM
imaging) a few minutes later. This behaviour is very useful for the preparation of
seed fibrils, but the peptide that is to be used for the actual fibril elongation mea-
surements has to be pre-treated (see the precise protocol in the section on proteins
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at the beginning of this chapter) especially to break down the pre-existing aggre-
gates. Also, due to the rapid formation of the fibrils from the untreated peptide,
the QCM sensors have to be incubated with the Aβ solution ex situ, rather than
brought into contact with the solution through the flow system of the QCM device.
Initial attempts of in situ fibril deposition experiments, were characterized by a
lack of reproducibility and control over the quantity of fibrils deposited; this was
presumably due to a varying degree of absorption of the fibrillar peptide inside the
tubing. From these experiments, it was concluded that all the fibril depositions on
QCM and SPR sensors had to be carried out ex situ.
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Figure 3.1: a) Covalent attachment of Aβ (1-42) amyloid fibrils to the gold surface
of a QCM crystal (see protocol in text for details): 1) formation of a self-assembled
monolayer (SAM) of mercaptoundecanoic acid (MUA); 2) activation of the SAM
with a mixture of EDC and NHS; 3) coupling of Aβ (1-42) amyloid fibrils to the
activated SAM; 4) passivation of the remaining surface with ethanolamine. b) AFM
image of the QCM crystal after attachment of the amyloid fibrils. c) QCM experi-
ment monitoring the growth of the surface bound Aβ (1-42) amyloid fibrils. After
ca. 10 min, a 2 µM solution of the Aβ peptide in 100 mM phosphate buffer pH
7.4 was introduced and the elongation of the surface bound fibrils monitored via
the decrease in resonant frequency (overtone at 15 MHz, corresponding to n = 3,
is shown). After 40 min, the liquid cell was flushed with buffer, which stopped the
elongation. For comparison, a typical frequency trace where soluble Aβ (1-42) is
brought into contact with a QCM-chip with no attached fibrils, only covered by a
passivated SAM, is shown as well (red line).
Protocol of attachment of Aβ (1-42) fibril attachment to a SAM of a mercap-
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toacid :
All chemicals were from Sigma Aldrich (Gillingham Dorset, UK) unless stated other-
wise. Gold coated QSX 301 QCM crystals (Q-Sense, Va¨stra Fro¨lunda, Sweden) were
immersed in a solution of 0.5 mg/ml mercaptoundecanoic acid (MUA) in ethanol for
24h. The crystals were rinsed with ethanol and dried with nitrogen gas. Then, they
were immersed in an aqueous solution of 0.3 mg/ml N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC) and 0.5 mg/ml N-hydroxy succinimide for
20 min, rinsed with water and dried with nitrogen gas.
Aliquots of 50 µg Aβ (1-42) (Bachem, Basel, Switzerland) in 10 µl 0.01 M NaOH
were diluted into 400 µl of 100 mM phosphate buffer pH 7.4 and 100 µl of the re-
sulting solution were put onto each biosensor for ca. 15 min in an atmosphere of
100% humidity. Then the crystals were rinsed with water, and incubated with 100µl
of a 0.7 M ethanolamine solution (pH adjusted to 9 with HCl) for 20 min. Finally,
the crystals were rinsed with water and either put into the microbalance flow cell
(Q-Sense E4) for a QCM measurement or they were dried for AFM imaging.
Before a measurement was performed, the sensors were left to equilibrate over night
in 100 µM phosphate buffer pH 7.4. When a stable baseline was attained, the QCM-
measurements were carried out.
For the dye-binding experiments described in Chapter 6, the surface coverage of
fibrils had to be maximized, in order to obtain a measurable signal from the binding
of the dye. In order to achieve this aim, the surface-bound seed fibrils were brought
into contact with a solution of the Aβ (1-42) peptide for approx. 30 min (Figure 3.1
c), allowing the seed fibrils to elongate. Figure 3.1 shows the record of this growth
period followed via the decrease in resonant frequency. The crystals with the Aβ
(1-42) fibrils attached were then used for the study of the dye-amyloid interactions.
The common attachment methods for proteins, like the one described above, rely on
the fact that side chain amines and carboxylic acids are usually abundant. A funda-
mental challenge, however, is that the reactivity of these groups is highly dependent
on the pH value of the solutions involved. Thus, for example under acidic condi-
tions, where many amyloidogenic proteins form fibrils particularly readily [40], the
amine groups are mostly protonated and the number of accessible non-protonated
nucleophilic amines available for amide coupling is very low. A change of solu-
tion conditions after fibril formation is not always possible, as pre-formed fibrils
can dissociate if these conditions are changed [123]. Extensions to the commonly
used methodologies are therefore required to establish general methods that cover
a wide range of pH values. In addition, it is also advantageous to enlarge the tool-
box of available attachment chemistries, at neutral pH in particular, because, as is
demonstrated below, given methods of surface attachment can have very different
efficiencies for fibrils assembled from different proteins.
3.1.1 Fibril attachment via naturally occurring cysteine residues
Attachment of amyloid fibrils to gold surfaces is straightforward and largely inde-
pendent of solution pH when cysteine residues or disulphide bridges are present in
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the polypeptide sequence, provided they are exposed on the surface of the fibril. The
attachment efficiency is not likely to depend on the formation of disulphide links by
the cysteine residues, even though it still is a topic of debate as to whether a disul-
phide bond remains intact when attached to gold or whether it is cleaved [124; 125].
This strategy has been used previously and its efficiency was shown in the case of
amyloid fibrils formed from bovine insulin [76] (Figure 3.2 a) that contains three
disulphide bonds in its native state. Hen lysozyme can form amyloid fibrils under
similar solution conditions to insulin and possesses two additional cysteine residues,
8 in total, all present as disulphide bonds in the native state in solution. However,
the surface coverage that can be achieved by simple incubation is generally lower
for lysozyme than for insulin, when incubated at the same fibril concentration for
the same length of time; this low coverage is indicative of weaker binding and the
latter suggests that the cysteine residues in the lysozyme fibrils are less accessible for
attachment than those in the insulin fibrils (3.2 b). A similar observation holds for
bovine α-lactalbumin (Figure 3.2 d), a structural homologue of lysozyme, and for
a cysteine mutant of the PI3K-SH3 domain (Figure 3.2 c) a protein which contains
no cysteine residues in its natural sequence.
The covalent links between the fibrils and the gold surfaces are sufficiently stable
such that the fibrils are not displaced from the surface even, for example, following
a subsequent incubation with a thiol that forms self-assembled monolayers (SAM)
on gold surfaces (Figure 3.2 e). This requirement is important for the attachment
process, as the production of such a SAM on the regions of the surface not occupied
by the fibril ends is important for biosensor measurements [76]. In particular, in
the absence of such a layer, monomeric proteins are frequently capable of attaching
directly on to the exposed gold surface, making it difficult to dissect the measured
signal into the parts stemming from fibril elongation and from direct surface attach-
ment of the monomeric building blocks.
3.1.2 Functionalization of fibrils that form under acidic so-
lution conditions
In order to control the attachment of amyloid fibrils formed from proteins without
natural cysteine residues to surfaces in acidic solution, minimally invasive chemical
modification of pre-formed fibrils offers a convenient strategy. Low pH conditions
are known to be favourable for the in vitro preparation and study of many amyloido-
genic proteins. However, these conditions can present a particular difficulty for any
reaction involving protein functional groups because any basic amino groups within
a polypeptide chain (at the N-terminus or the side chains of lysine residues) are
largely protonated and therefore not nucleophilic. Furthermore, the typically small
quantity of amyloid fibrils that can be suspended acts to limit the maximal concen-
tration of peptide amine groups in solution, resulting in a low attachment efficiency.
In order to circumvent this problem, a strategy has been developed that is based on
the well established attachment of cystamine [H2N(CH2)2SS(CH2)2NH2] molecules
to monomeric proteins [126], where the aim is to introduce sulphhydryl groups into
a specific molecular system (Figure 3.3). Reductive cleavage of the disulphide bonds
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Figure 3.2: Attachment of amyloid fibrils from proteins containing cysteine
residues/disulphide bridges in the amino acid sequence. In the case of bovine in-
sulin a), good surface coverages can be achieved [76] with this strategy. However,
hen lysozyme b), although having 8 cysteine residues compared to 6 for insulin,
attains a lower surface coverage under similar experimental conditions, suggesting
that the cysteines are largely buried inside the fibrils. Low surface densities of fibrils
were also observed for a mutant of PI3K-SH3, where a cysteine residue has been
artificially introduced (M1C) c), as well as for bovine α-lactalbumin d), contain-
ing 8 natural cysteines. Image size in all cases 4x4 µm. e) Schematic diagram
of cysteine-attachment, including the subsequent passivation of the remaining gold
layer.
within the attached cystamine molecule to form free thiol groups was omitted in the
case of the fibrils, as disulphides appear to be as capable as free thiols of attaching
to gold surfaces as discussed above.
The pH optimum for the initial step in the coupling reaction, the activation of
carboxylic acid groups with N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hy-
drochloride (EDC), is at low pH values [127] as protonated carboxylic acids and
not carboxylate ions attack the EDC. Nevertheless, acidic conditions are generally
unfavourable for the formation of an amide bond as a result of the low reactivity
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of amines at pH values several units below the normal range of pka values of amine
groups (ca. 9-11). Under these conditions, only a small fraction of these functional
groups is unprotonated and therefore nucleophilic enough to attack an activated
carboxylate group before it is hydrolysed. This problem can be circumvented, how-
ever, with the approach described here, as a large excess of cystamine can be used
to promote the coupling reaction. But even by using excess cystamine, the fraction
of carboxylic acid groups in a given protein that reacts with cystamine molecules is
small. Indeed, in the case of PI3K-SH3, only ca. 5% of the polypeptide molecules
within a fibril are modified (see mass spectrum in Figure 3.3; estimates of relative
populations based on the assumption of equal ionization efficiencies). Qualitative
examination of mass spectra acquired from dissociated activated fibrils of other pro-
teins (β-lactoglobulin, hen lysozyme) indicated similarly small reaction yields.
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Figure 3.3: Schematic diagram of the surface attachment strategy that was used
under acidic conditions where many proteins readily form amyloid fibrils [40]. The
method uses a large excess of cystamine because almost the entire population of
amine groups is protonated at pH 2. This fact explains the low yield (≤ 5%) of
functionalized molecules, as shown in the mass spectrum. [(*) is native protein, (**)
corresponds to protein molecules carrying one cystamine molecule]. Nevertheless,
even this level of modification enables stable interactions of the amyloid fibrils with
the surface to be achieved.
Even though the yields are limited, they are sufficient to achieve efficient surface
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attachment of the fibrils because not every protein molecule within the polymeric
assembly needs to interact with the surface. Moreover, as the cystamine molecules
can react only with those carboxylic acid groups that are exposed on the surface of
the fibrils, the disulphide bonds that have been coupled to the fibrils are likely to
be in ideal positions to interact with the gold surface as soon as the modified fibril
fragments diffuse towards it. The number of available carboxylic acid groups per
unit length of fibril is likely to be variable between different proteins, as a result
of differences in the number of acidic amino acids in the sequence and of different
fractions of such residues that are exposed on the fibril surface. In the present study,
for example, the surface coverage achieved varied from a value of the order of 20
µm−2) for bovine α-lactalbumin to one of ca. 100 µm−2 for hen lysozyme (see Figure
3.4 and Table 3.1.
Indeed, in the case of the B-chain of insulin, mass spectrometric analysis could
not identify a population of cystamine-containing molecules and, in agreement with
this observation, no statistically significant increase in surface coverage was achieved
relative to that obtained with unmodified fibrils. In this 30 residue peptide, the nat-
urally occurring cysteine residues had been oxidized to sulphonic acids that are
unable to form covalent bonds with gold. The small number of carboxylic acid
groups in this short sequence, two side chains and the C-terminus all of which are
potentially buried in the fibril core, appears to be unable to react with the cys-
tamine groups to a significant extent under these reaction conditions. In all cases,
the presence of unmodified fibrils on the gold surface even after rinsing (see Figure
3.9) can be attributed to adsorption resulting from non-covalent interactions; this
phenomenon will be discussed in detail below. The excess of cystamine and the
hydrolysis-products of EDC generated during the reaction need to be removed af-
ter the reaction is complete, and this was achieved by repeated centrifugation and
re-suspension cycles to isolate the now modified fibrils from the reaction medium.
Fibril purification was terminated at a stage where approximately 10-50 µM of cys-
tamine remained in solution (see protocol below) with the fibrils, as the residual
cystamine molecules provide a source of a self-assembled monolayer (SAM) on the
unreacted gold surface, analogous to the polyethylene glycol (PEG) layer produced
in the case of attachment of fibrils via cysteine residues.
In conclusion, this method of covalent attachment of cystamine molecules to pre-
grown fibrils can increase the surface coverages attained for the majority of amyloid
fibrils generated from a range of different proteins compared to the surface coverages
achieved with the non-modified fibrils (compare Figures 3.2 and 3.4, and see Table
3.1) under identical acidic conditions. The increase in surface coverage between the
unmodified and modified fibrils is largest in cases where no cysteines are present (e.g.
PI3K-SH3). However, even in cases where cysteine residues are naturally present,
the increase in surface density of fibrils can be a factor of two or more as a result of
the fibril modification process, reducing the quantity of protein needed for a given
coverage. In addition, if a higher number of fibrils per unit surface is achieved, it
will lead to higher signal-to-noise levels in experiments involving the study of the
surface bound fibrils, especially in the case of species with a lower propensity to
convert from the soluble into the fibrillar state.
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Figure 3.4: The attachment strategy presented in Figure 3.3 used for a range of
amyloid fibrils formed at acidic pH. Examples are shown where sonicated (for details
see protocol below) fibrils of a) PI3K-SH3, b) hen lysozyme, c) bovine α-lactalbumin,
d) bovine β-lactoglobulin were functionalized and attached to gold-surfaces of QCM
chips. The surface coverages achieved in this way, as well as their increase compared
to non-functionalized fibrils, varied greatly between the different proteins. This
result is likely to be a consequence of variations in the number and accessibility of
carboxylic acid groups in the amyloid fibrils under study, as these groups are first
activated by EDC and subsequently react with the added cystamine.
Protocols for fibril modification at acidic pH : The detailed protocol for modifying fib-
rils at low pH is illustrated for PI3K-SH3; the modification of bovine β-lactoglobulin,
the α-lactalbumins and the lysozymes was carried out in an essentially identical man-
ner. 100 µl aliquots of 1 mM fibril suspension (in 0.01 M HCl) were mixed with
100 µl of 1 M cystamine dihydrochloride (Sigma) solution and 1 mg of EDC (N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride, Sigma), and then made
up to 2 ml with 0.01 M HCl. The solution was centrifuged at 20◦C for 2 h at 12
krpm (ca. 8500 g), the supernatant removed and the remaining pellet redissolved in
2 ml 0.01 M HCl. This procedure was carried out three times in order to minimize
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any excess cystamine which could compete with the fibrils for surface attachment.
The final pellet was re-suspended in 500 µl of 0.01 M HCl. In order to calculate the
remaining cystamine and EDC in the final fibril suspension, it was assumed that
in every centrifugation step 90% of these reagents were removed together with the
supernatant (from estimated relative volumes of pellet and supernatant).
3.1.3 Fibril modification under physiological conditions
As discussed in detail above, if accessible natural cysteine residues are present in a
sequence, amyloid fibrils could be attached to a surface via those thiol groups. Many
amyloidogenic proteins, however, especially naturally unfolded polypeptides such as
the Aβ peptide and α-synuclein that are implicated in disease, do not have cysteines
in their sequence. The strategy that has been applied almost exclusively to date to
attach amyloid fibrils under physiological conditions to gold surfaces is the coupling
of unmodified amyloid fibrils to a chemically activated layer of molecules carrying
a carboxylic acid group. This strategy has been applied several times successfully
with the Aβ peptide ([96; 97; 128], and see Figure 3.1) and attachment to glass is
also possible by using a similar procedure. It was shown above that the chemical
functionalization of amyloid fibrils is a convenient strategy to enable their attach-
ment to gold surfaces. As the surface coverages that can be achieved with a given
attachment method can vary strongly, it is useful to investigate the applicability of
the general approach of covalently modifying amyloid fibrils in such a way that they
can be attached to a surface at physiological pH values and so studied under more
biologically relevant conditions.
For this purpose a small molecule, 2-iminothiolane (”Traut’s reagent”), was cho-
sen that has previously been used to introduce thiol groups into monomeric pro-
teins [126; 129]; this method is efficient and elegant because it is based on a one-step
reaction (Figure 3.5). This cyclic electrophilic reagent is typically attacked by a nu-
cleophilic amine group of the protein with good yield, resulting in the opening of
the ring and the exposure of a free thiol group, ideal for surface attachment. It has
been shown [130], however, that a subsequent reaction can occur that leads to the
loss of ammonia and the formation of an N-substituted 2-iminothiolane, a species
that is not capable of forming a gold-sulphur bond, a result in accord with studies
on alkane sulphides that have been shown to adsorb only non-covalently to gold
surfaces, and not to form covalent links as do thiols or disulphides [131]. The half
life of the free thiol form of the attached Traut’s reagent that is prone to this type
of secondary reaction depends on the nature of the specific amine involved, and on
the pH and the temperature of the solution [130].
In order to test whether this secondary reaction would interfere with the purpose
of surface attachment, the interaction of Traut’s reagent with fibrils formed from
human α-synuclein and Amyloid β (1-42) was studied. A high fibril surface coverage
(as shown in Figure 3.6) was achieved when the gold surface was incubated with
fibrils shortly after functionalization (see protocol below), indicating that the re-
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Figure 3.5: Attachment strategy, using 2-iminothiolane (Traut’s reagent) to func-
tionalized amyloid fibrils. Pre-grown fibrils were incubated with an excess of Traut’s
reagent (see protocol below for details), and then the fibrils were attached to gold
surfaces. The mass spectrum shows α-synuclein fibrils functionalized for 15 min-
utes and then dissociated by suspension in HCl at pH 1.0. The spectrum shows
an 11.3 kDa peak illustrating the truncation of the α-synuclein sequence (see text
for a discussion) that can occur after prolonged time and a series of peaks differing
by 84 Da corresponding to the masses of attached 2-iminothiolane-molecules after
re-cyclization and loss of ammonia.
cyclization reaction does not occur within minutes and that the free thiol is available
for a sufficient amount of time to ensure covalent attachment to the gold. The finding
that a molecule of α-synuclein can carry several modifications (as can be seen in the
cascade of peaks with ∆M= 84 Da in a mass spectrum of dissociated modified fibrils,
Figure 3.5) is a consequence of the fact that the full length sequence contains 15
lysine residues and a considerable part of the sequence appears not to be in the fibril
core [132]. AFM imaging shows in addition that the modified fibrils attached to the
surface are essentially identical in morphology to unmodified ones and are still able
to elongate after incubation with a solution of unmodified monomer, indicating that
the modification does not interfere with the capability of the protein molecules to
seed fibril growth (see Figure 3.6). In these experiments, sometimes amyloid fibrils
that contained truncated sequences (see Figure 3.5) were found, probably due to
starting protein degradation. The part of the protein sequence that is not burried
within the core of an amyloid fibril has been shown for other proteins [133] to be
readily cleaved off under certain conditions; in the present case, the strong decrease
in pH used to dissociate the fibrils is likely to enhance this cleavage. However, the
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fibrils containing truncated α-synuclein showed no detectable difference in surface
attachment, morphology or seeding efficiency relative to fibrils consisting of full
length α-synuclein; the two types of fibrils behave identically in all experiments
carried out.
a) b)
c) d)
Figure 3.6: AFM images showing short fragments of amyloid fibrils of α-synuclein
a) and Aβ (1-42) c) that were attached to a gold surface via Traut’s reagent. The
α-synuclein fibrils were then incubated with a 20 µM solution of monomeric α-
synuclein in PBS for ca. 1 h. The Aβ-fibrils were brought into contact with a 7
µM Aβ monomer solution, also for ca. 1 h. The images demonstrate that, in both
cases, the attachment of Traut’s reagent did not interfere with the capability of the
fibrils to elongate in the presence of monomeric protein (see b and d).
When a large excess of Traut’s reagent is used, its hydrolysis product, a thiol,
can react with the gold surface, even though it has been shown that the half-life of
the intact cyclic compound at neutral pH is several days [134]. Therefore, in order
to ensure complete passivation of the surfaces within a much shorter time scale, the
gold surfaces were incubated with a methoxy-PEG-thiol after fibril attachment, in a
manner analogous to that adopted with the natural cysteine attachment described
above. This approach, where pre-grown amyloid fibrils were modified with Traut’s
reagent under physiological conditions, also yielded good results in the case of fib-
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rils formed by the Amyloid β (1-42) peptide (Figure 3.6). As before, no differences
in morphology or seeding efficiency were observed compared to fibrils attached via
the well established amide coupling to an activated SAM [96; 97; 128]. In princi-
ple, therefore, comparable surface coverages can be achieved with both methods,
although the relative mobilities of the activated groups are different. The coupling
to an activated SAM requires a high surface density of activated groups, such that
the fibrils, which have a limited mobility will come in contact with such an activated
surface group. This requirement no longer applies if the fibrils are able to attach
directly to gold via a sulphur-containing linker whenever they come in contact with
the surface.
The reactivity of Traut’s reagent is very strongly pH dependent, as it relies on re-
action with an unprotonated amine group. This reagent is therefore ineffective in
modifying fibrils which are only stable at acidic pH and another approach is required
to achieve efficient functionalization of such structures (eg in the case of the B-chain
of bovine insulin, where the modification with cystamine was unsuccessful). This
observation led to the exploration of an alternative approach; monomeric peptides
were modified at neutral pH with Traut’s reagent and then, in a second step, pre-
formed seed fibrils were elongated with these modified monomers at acidic pH (see
Figure 3.7 and protocol below).
With this method, however, and in contrast to the functionalization of assembled
fibrils discussed above, amino acid residues that are crucial to the self-assembly pro-
cess can be modified and therefore the structure and mechanism of formation of the
amyloid fibrils can potentially be altered. Indeed, it was found that in the case of hen
lysozyme, the morphology of the fibrils formed from functionalized monomers can
be different from the morphology of fibrils formed entirely from unmodified protein
(Figure 3.7 c). These differences are highlighted by the finding that some function-
alized fibrils (e.g. hen lysozyme fibrils where the monomer had been functionalized
with a 3-fold excess of Traut’s reagent) wind up into spirals, indicating that the
monomer modification introduces stress into the amyloid scaffold, leading to lower
persistence length or increased inherent curvature. This morphology is not normally
observed. In many cases, however, the morphology of fibrils grown from functional-
ized monomers are indistinguishable by AFM from unfunctionalized structures; in
such cases this approach represents a very effective strategy to achieve functionality
in protein nanostructures. Indeed, using this method, the surface coverage of fib-
rils formed from the B-chain of bovine insulin was increased by 200-300% (compare
Figures 3.7 d and e). The modified monomers (4-fold excess of Trauts reagent at
pH 7.4) were analysed by mass spectrometry (Figure 3.7 c) and it was found that
the population of modified monomer (M ca. 3600 Da) is small compared to the
population of unmodified monomer (M ca. 3500), similar to the situation where
fibrils were modified with cystamine. The Trauts reagent is likely to react with the
N-terminus, as it represents the least basic amine within a protein. Therefore, the
lack of apparent alterations in the morphology of the structures in this case can be
readily understood as a consequence of the small proportion of modified monomers
within the final fibrils. A further factor that is likely to reduce the effects of the
modification on the filament structure stems from the fact that this modification
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Figure 3.7: Covalent modification strategy involving attachment of Traut’s reagent
to monomeric protein at neutral pH followed by elongation of pre-grown fibril seeds
with these modified monomers at acidic pH and then attachment of the modified
fibrils to the gold surface. b) mass spectrum of the modified B-chain monomers,
indicating the small yield of the modification (unmodified monomer around 3500
Da and modified monomer around 3600 Da). Due to the acidification of the peptide
solution after incubation with Traut’s reagent (see protocol), the Traut’s reagent
is still intact after more than one day, and has not undergone the subsequent re-
arrangement reaction described in the text. c) This strategy, however, can lead to
alteration of fibril morphology, as residues crucial for the protein self assembly can be
modified. This AFM image shows that in the case of hen lysozyme pre-modification
of the monomer can lead to more highly curved fibrils, in extreme cases forming
spirals (Fibrils modified and image acquired by Dr Christoph Meier). Despite this
potential drawback, this method enabled to increase very strongly the surface cov-
erage of bovine insulin B-chain fibrils: d) highest surface coverage achieved with
unmodified fibrils; e) surface coverage achieved with modified fibrils.
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predominantly occurs at the extremity of the polypeptide chain which is likely to be
less important in the assembly mechanism than a position within the sequence. The
mass spectrum acquired for the functionalized insulin B-chain monomer solution,
shows only modified peptides where the attached Traut’s reagent has not undergone
the subsequent reaction leading to the elimination of ammonia, as shown by the
measured masses of M + 103 instead of M + 84. The stability of this functional
group is due to the lowering of the pH from 7.4 to 1 (see protocol below) 5 min
after the addition of the Traut’s reagent, conditions that quench the subsequent
rearrangement reaction. This quenching stems from a significant decrease in the
population of the thiolate, which is the nucleophile for the intramolecular nucle-
ophilic attack.
Therefore, the covalent modification of pre-formed amyloid fibrils with a small
molecule, 2-iminothiolane, under physiological conditions is a very convenient and
effective strategy for surface attachment of fibrils formed from the naturally unfolded
polypeptides Aβ (1-42) and α-synuclein. The modification is fast and efficient and
does not normally alter the morphology or seeding capacity of the amyloid fibrils.
Compared to the alternative method of coupling the fibrils to an activated SAM,
this novel strategy involves less steps and can be controlled more accurately through
variation of the concentration of Traut’s reagent and the incubation time.
Protocol for activation of seed fibrils with Traut’s reagent : For α-synuclein, 50 µl
aliquots of a ca. 100 µM solution of fibrillar form of the protein were diluted with
water to 1 ml and then 1 mg of 2-iminothiolane (Traut’s reagent) was added. The
solution was then left to react for at least 5 min. The extent to which the fibrils are
modified depends on the relative concentration of Traut’s reagent and the time of
incubation. In fact, two hours of incubation of the α-synuclein fibrils with Traut’s
reagent led to complete disappearance of the unmodified peak in the mass spectrum.
For Aβ (1-42), 100 µl aliquots of approx. 30 µM solutions of amyloid fibrils formed
from Aβ (1-42) in PBS buffer were centrifuged at 90 krpm for 1h. The supernatant
was removed and the remaining sample (no pellet was visible) was re-suspended in
200 µl of water. The fibril solutions were then reacted with 1.5 µg 2-iminothiolane
for ca. 15 min.
Protocol for elongation of seed fibrils with modified monomeric protein: A solution
of 10 mg (0.7 µM) hen lysozyme in 1 ml 100 mM phosphate buffer pH 7.5 was
prepared, then 10 µl of 3 mg (22 µmol) 2-iminothiolane (Sigma-Aldrich) dissolved
in 100 µl 100 mM phosphate buffer pH 7.5 were added. The solution was incubated
for 1 h at RT, then acidified to pH 2 with 210 µl 1M HCl and incubated at 65 C for
6 days. (Protocol from Dr Christoph Meier)
1 mg of the B-chain of bovine insulin was diluted in 700 µl H2O. First 20 µl of 100
mM phosphate buffer pH 7.4 and then 4 equivalents of Traut’s reagent were added.
After 5 min, the reaction was quenched with 10 µl of 1N HCl. To seed the fibril
formation, 20 µl of pre-formed (see above) unmodified B-chain fibrils were added to
the monomer solution which was then stirred overnight at 30.
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3.1.4 Protocols for attachment of activated fibrils to the
biosensor surface
Protocol for attachment under acidic conditions : The only step that differs in the
protocols used for the various proteins that form amyloid fibrils particularly read-
ily under acidic conditions is the duration of the ultrasonication that results from
the different mechanical stability of the fibrils formed from different proteins. The
sonication, that is carried out in order to maximize the number of growth sites was
carried out in all cases after functionalization of the fibrils; longer fibrils can more
readily be separated from the excess reagents (cystamine etc.) by centrifugation.
The sonication was carried out with a 500 W ultrasonic homogenizer (Cole Parmer,
Hanwell, UK), at 20% maximum power. Different numbers of identical cycles with
3 s pulses and 3 s breaks were used (in order to avoid excessive heating of the sam-
ple) and the total sonication times were: insulin, 10 min; insulin B-chain, 2 min;
PI3K-SH3, 30 s; lysozymes, 15 s; β-lactoglobulin, 3 s; α-lactalbumins, 3 s. 100 µl
aliquots of each fibril solution were then pipetted on to a biosensor surface that was
kept in an atmosphere with 100% humidity. Then the surfaces were rinsed with 0.01
M HCl and the sensors were either inserted into the QCM for measurement or dried
for AFM imaging. No additional passivation layers were required in this protocol,
as it was found that non-specific attachment was small even after the first incuba-
tion of a biosensor with monomeric protein, suggesting that the excess cystamine
forms a charged layer that is very effective in preventing monomeric protein from
non-specific attachment.
Protocol for attachment under physiological conditions : The gold surfaces of biosen-
sors were incubated for 1h in an atmosphere of 100% humidity with 100 µl of a
solution containing freshly activated α-synuclein fibrils that had been sonicated for
a total of 4 min. The chips were then rinsed with water. Even though Traut’s
reagent has been shown to have a slow hydrolysis rate at neutral pH [134], the high
molar excess of the compound will lead to a partial coverage of the surface by its
hydrolysis product, a thiol amide. In order to ensure complete passivation for the
biosensor measurements, however, the surfaces was incubated with a 0.5 vol.% so-
lution of an inert PEG thiol (CH3O(CH2CH2O)6SH, Polypure, Oslo, Norway) for
1 h, also at 100% humidity. Then the chips were rinsed with water and dried for
AFM imaging. In the case of Aβ (1-42), the fibrils already had a length distribution
appropriate for a biosensor measurement, and no sonication step was therefore re-
quired. A clean biosensor was incubated with 100 µl of the solution of re-suspended
fibrils for 1 h in an atmosphere of 100% humidity. The sensor surface was rinsed
with water and dried for AFM imaging.
3.1.5 Comparison between covalent and non-covalent sur-
face attachment of amyloid fibrils
Non-covalent interactions between charged molecules and metal surfaces can be
strong because of the high polarizability of metals; a charged compound in contact
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with a metal surface can induce an opposite (mirror) charge which leads to strong
Coulombic attractions [135]. Non-covalent interactions between the soluble forms
of proteins and surfaces of different chemistry and topography have been studied
in detail, especially in the framework of potential biomedical applications [136; 137;
138]. These interactions are likely to play an equally important role in the case of
amyloid fibrils, as the protein monomers that form the fibrils are often very highly
charged under the acidic denaturing conditions where many proteins most readily
form amyloid structures (see Chapter 5). Figure 3.8 demonstrates that non-covalent
interactions depend on the roughness of the surface by comparing the outcome of
incubating of WT PI3K-SH3 fibrils on very smooth template-stripped gold [117]
(RMS roughness ca. 0.5 nm) and on a gold substrate with a roughness comparable
to that of commercially available biosensors (RMS roughness ca. 1.5 nm). As the
fibrils are very stiff [20] and do not necessarily follow the features of a surface, the
roughness determines the average distances between the charges and the polarizable
surface and, in addition, the larger contact area between the fibrils and the surface
with decreased roughness also increases van-der-Waals attractions and hydrophobic
interactions.
It was found that rinsing the surface with a solution of high ionic strength (≥
10−1 M) detaches a larger proportion of non-covalently attached fibrils than occurs
when rinsing with a solution of lower ionic strength (10−2M) (Figure 3.8). This
result indicates that the majority of the interaction energy in such cases is likely
to result from electrostatic forces. The shear stress σ = η · ∂u
∂z
experienced by the
fibrils during the rinsing can be estimated to be of the order of 1 N/m2 (assuming
maximum shear rates ∂u
∂z
of 1000 s−1 and a dynamic viscosity of 10−3 Pa s). With
a fibril diameter of roughly 10 nm, this leads to a force per unit length of fibril of
10−8 N/m. If this value is compared with an order of magnitude estimate of the
unscreened electrostatic forces, F/l = λ·q
4pi0rr2
= n
l
· q2
4pi0rr2
≈ n
l
· 2.9 · 10−12N (where l
is the unit length of fibril and λ = Q
l
= nq
l
is the one-dimensional charge density, r is
here taken to be 1 nm and the value of r for water is used), the two opposing forces
are only of the same order of magnitude for an unrealistically low charge density of
104 m−1. A realistic charge density can be expected to be at least 105 times higher
than this value1, due to the high density of protein molecules within the amyloid
fibrils, all of them carrying several charges. Therefore, the forces due to rinsing will
not be sufficient to overcome the unscreened Coulomb attraction. If, however, op-
positely charged counter-ions are present, as is always the case, although in varying
quantities depending on the ionic strength of the buffer, these ions can diffuse into
close proximity with the fibril/surface interface and thereby reduce the electrostatic
forces via a Debye-type screening and the formation of ion pairs (see Chapter 5
for details). The remaining electrostatic, van-der-Waals and hydrophobic forces are
then of a comparable order of magnitude as the forces from the mechanical action
of rinsing, such that rinsing at high ionic strength is able to remove the fibrils (3.8).
It is interesting to note that in the case of fibrils formed from bovine insulin and
1or ∼104 times if r of protein is used instead of the value for water in the calculation of the
electrostatic force, but this variation does not change the qualitative conclusions
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a) b)
flat gold
+ + + + + + +- - - -- - - +- flat gold
+ + + + + + +- - - -- - -rinsing with high
ionic strength
rinsing with high
ionic strength
+ + + + + + + ++- - - -- - - - -rough gold rough gold
Figure 3.8: Stability of non-covalent interactions between gold surfaces of different
roughness and PI3K-SH3 amyloid fibrils. In the case of the smooth (RMS roughness
ca. 0.5 nm) template-stripped gold (top), the difference between rinsing with 10 mM
HCl a) and 10 mM HCl + 100 mM NaCl b) is small, with only short fibrils in general
being removed. However, the interaction forces are weaker in the case of the gold
surface with higher roughness (RMS roughness ca. 1.5 nm, substrates prepared by
Dr Tuomas Knowles) (bottom). Here, the fibrils were entirely displaced by rinsing
the surface with a solution of high ionic strength (compare c and d).
its B-chain fragment, the charge density of the two types of fibrils is very similar
(assuming that the monomeric building blocs carry the same charge within the fib-
rils as in solution; this assumption will be discussed in Chapter 5). The B-chain
at pH 2.0 carries the same net charge as the intact protein (i.e. the combined A-
and B-chain) assuming that the pKa values of all residues are independent of each
other, an assumption that is consistent with calculations with the protein pka cal-
culator PROPKA [139]. The presence of two sulphonic acid residues in the oxidized
B-chain decreases the charge from +5 to +3 at pH 2.0 but the sequence length of 30
residues compared to 51 in full length insulin and the similar fibril diameters imply
that the overall charge density of the B-chain fibrils at acidic pH is likely to be
very similar to that of fibrils formed from intact insulin under the same conditions.
The large difference between the surface attachment of full length insulin amyloid
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(3.2 a) and the isolated B-chain (highest surface coverage achieved is shown in Fig-
ure 3.7 c) can therefore unambiguously be attributed to the formation of covalent
bonds with the gold surface in the case of full length insulin as a result of the pres-
ence of cysteines/disulphides compared to the sulphonic acid residues in the B-chain.
3.1.6 Applications of covalent surface attachment
In Table 3.1, a summary of the surface attachment methods presented above and
their efficiencies is given.
Protein pH Method Surface Coverage
Enhancement Fac-
tor
bovine insulin 2 natural cysteine at-
tachment [76]
no modification re-
quired to achieve high
surface coverage
bovine PI3K-SH3 2 attachment via cys-
tamine
> 10
HEW/human
lysozyme, bovine
β-lactoglobulin,
bovine/human
α-lactalbumin
2 attachment via cys-
tamine
2-5
human A β 1-42,
human α-synuclein
7.4 attachment via Traut’s
reagent
5-10
bovine insulin B-
chain
7.4/1.0 pre-modification of
monomer with Traut’s
reagent, subsequent
elongation of seed
fibrils with modified
monomer
ca. 3-5
Table 3.1: Summary of attachment methods for the proteins under study. The
surface coverage enhancement due to the covalent modification of fibrils is reported
as a comparison between an incubation of the gold surface with a solution of modified
and non-modified fibrils and extensive rinsing of the surface with the respective
(buffer-)solution: PBS for Aβ 42 and α-synuclein, HCl pH 2.0 for all the others.
In order to demonstrate at this point the usefulness of these novel attachment
methods, Figure 3.9 shows a comparison between QCM measurements carried out
with non-covalently and covalently attached PI3K-SH3 amyloid fibrils. It can be seen
in Figure 3.9 a) and b), that in the case of only non-specifically adsorbed fibrils,
the fibrils are almost quantitatively removed when the sensor surface is flushed with
a solution of moderate ionic strength, and a subsequent elongation measurement is
made impossible. On the other hand, covalent attachment using cystamine enables
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an experiment probing the influence of an increase in ionic strength on the rate of
PI3K-SH3 amyloid fibril elongation ( Figure 3.9). The AFM image in Figure 3.9 d)
shows long fibrils of a surface density at least an order of magnitude higher than
in Figure 3.9 c). These experiments were performed with the old QCM system D-
300, where the protein solution is introduced into the liquid cell via a gravity flow
system, reaching quite high flow rates (of the order of 10 ml per minute). The lower
flow rates reached with the peristaltic pump of the newer system E4 make fibril
detachment a slightly less dramatic problem. However, irreversible attachment is
under any circumstances the preferable approach and in the remainder of this thesis,
the high reliability of the covalent surface attachment methods described above will
be explored. In particular, the opportunity to probe the influence of ionic strength
on the elongation rate will be exploited extensively in Chapter 5.
3.2 Mass sensitivity calibrations for QCM exper-
iments of amyloid fibril elongation
For the detailed analysis of the free energy barriers against protein aggregation pre-
sented in Chapter 4, the average absolute rate of addition of monomers to every
fibril end has to be measured. It is important to note that with the analysis that
will be described in the following, it is not possible to capture behaviour such as the
stepwise growth of amyloid fibrils that has been reported for several amyloidogenic
proteins [140; 141; 142]. Relying on the interpretation of ensemble kinetic experi-
ments, the present analysis will yield an average over the active and inactive periods.
In order to be able to estimate the numbers of protein molecules that incorporate
into single fibrils per unit time with QCM experiments, the numbers of fibrils on
the surface of each QCM sensor has to be estimated. This was achieved via AFM
imaging of the sensor surface on several independent areas of usually 4 µm x 4 µm,
manually counting the number of fibrils. Averages over the different areas on a
single sensor were then taken. An example is given in Figure 3.10 a) where the
fibril density was estimated to be 500±200 µm−2. Figure 3.10 illustrates an exper-
iment where the surface-bound seeds shown in a) had been exposed repeatedly to
a solution of 0.2 mg/ml soluble insulin in 0.01 M HCl at 40. The rate of change
of frequency due to the elongation of the seeds of this series of identical repeats is
highly reproducible, a general characteristic of surface bound techniques, where a
constant ensemble of seeds is repeatedly probed.
However, in order to determine the absolute elongation rate, the QCM frequency
response needs to be calibrated, i.e. the observed rate of change of frequency has to
be correlated with the equivalent rate of mass addition to the surface of the QCM
sensor. The overall rate of mass addition divided by the number of fibrils then yields
the property of interest. In the case of growing amyloid fibrils, that form a rough
visco-elastic layer on the surface of the QCM sensor (see section on QCM experi-
ments above), the proportionality constant between the changes in surface-bound
mass ∆m and resonant frequency ∆F is not simply given by the Sauerbrey equation
([99] and see Experimental section); indeed in some cases the normalized frequency
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Figure 3.9: QCM measurements of PI3K-SH3 amyloid growth, illustrating the ad-
vantages of covalently attaching the fibrils to the biosensor surface. a) fibrils have
been exposed to PI3K-SH3 monomer solution at pH 2.0: before (red line) and after
(black line) flushing the cell with 40 mM NaCl solution at a flow rate of ca. 10
ml/min. The reversible spike in frequency at t = 3 min is due to the injection
of sample into the QCM-cell. The frequency shift of the red line indicates growth
of the surface bound fibrils, whereas the absence of a shift in resonant frequency
for the black line is characteristic of a lack of any fibril elongation. Indeed, AFM
imaging of the chip after the experiment revealed that very few fibrils were left on
the surface; the contact of the chip with a solution of moderate ionic strength had
removed most of them (see b). c) Similar experiment to the oen shown in a) with
seed fibrils covalently attached via the modification scheme of Figure 3.3. Frequency
shift due to fibril elongation in the absence of NaCl (red line) and in the presence
of 20 mM NaCl, after having been flushed repeatedly with solutions of moderate
ionic strength (black line). AFM-imaging reveals that at the end of the experiment,
after repeated contact with solutions of different salts and of similar ionic strengths
as in a), the surface coverage of fibrils remains high (see AFM image in d)). The
reliable covalent attachment therefore allows for the probing of the influence of ionic
strength on the elongation rate; this possibility will be explored in detail in Chapter
5.
response of the different overtones can differ by up to an order of magnitude, a
feature not predicted by the Sauerbrey equation. An empirical calibration method
that has been proposed earlier [76] relies on the determination of the proportionality
factor between ∆F and ∆m by AFM imaging and correlation of the observed length
increase with a measured frequency increase. The method will be illustrated by car-
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Figure 3.10: The AFM image on the left hand side shows seed fibrils of the protein
insulin attached to a QCM sensor surface, before the series of experiments shown
on the right hand side of the figure were carried out. The surface number density is
estimated to be 500±200 µm−2. On the right hand side a typical QCM experiment,
in this case a test of the intrinsic reproducibility, is shown. The surface-bound seed
fibrils are repeatedly exposed to a solution of 0.2 mg/ml insulin in HCl pH 2 at
40. The red lines indicate the sections of the frequency trace (here the frequency
overtone with N = 5) that were fitted with a linear function in order to extract
the rates of frequency change. The average rate of the five repeats shown here is
0.96±0.01 Hz/min.
rying out an example calculation. Figure 3.11 shows a gold substrate with attached
sonicated insulin amyloid fibrils before a) and after b) having been incubated for the
same duration of time at 40 with 0.2 mg/ml soluble insulin as the QCM chip that
was used for the measurement in Figure 3.10. The average length increase per fibril
is estimated from Figure 3.11 to be 200±100 nm. The number density of seed fibrils
(Figure 3.10) is estimated to be 500±200 µm−2. The diameter of a fibril is 5 nm,
and the density is assumed to be 1.2 g/cm3, as for a globular protein. The active
area of a QSX-301 sensor is 1 cm2. Therefore, the observed frequency shift of ca. 50
Hz corresponds to between 70 and 500 ng of added fibrillar protein, yielding a mass
sensitivity coefficient of between 1.4 and 10 ng/Hz. If this value is compared to the
Sauerbrey mass sensitivity of the sensor of 17.7 ng/Hz (as quoted by the supplier),
it can be seen that an additional contribution to the frequency shift, not stemming
from dry mass, occurs.
The accuracy of the calibration calculation outlined above is not very satisfying,
and it would certainly be possible to improve on it, for example by increasing the
number of measurements and analysing the fibril length increase automatically on
a large number of fibrils. However, in the following, an alternative approach is
presented that is more accurate, as it does not require estimation of the seed fibril
density and of the fibril length increase. In the case of the very rapidly elongating
fibrils formed from Aβ (1-42) and Ure2p Sc, it is possible to monitor the quantitative
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1 µm 1 µm
a) b)
Figure 3.11: These two AFM images were used to estimate the length increase that
the surface-bound insulin seeds had undergone in the experiment shown in Figure
3.10. Gold substrates had been prepared in a similar way to the QCM sensors,
albeit with a much lower surface density, which greatly facilitates estimation of the
length increase. For an actual QCM measurement, the elongation of surface-bound
fibrils at such a low surface density would not give rise to a measurable signal. a) At
the beginning of the experiment b) After incubation for 1h at 40 with an insulin
solution of 0.2 mg/ml in HCl pH 2. The average length increase is estimated to be
200±100 nm.
depletion of monomer from the liquid cell of the QCM, as the measurements are
performed in the absence of flow, and therefore no new soluble protein is supplied
during the duration of a measurement. This was possible because the concentrations
required to observe fibril elongation were of the order of 1 µM, a concentration so low
that the total available precursor was consumed within ∼10 min (Aβ) to 1h (Ure2p
Sc) (see Figure 3.12, where the rate of change of frequency decreases to almost
zero over these durations). These different timescales are caused by the different
diffusion coefficients of Aβ (1-42) (∼ 2.4·10−10m2
s
, estimated from the value reported
in [143], and corrected for the temperature dependence of viscosity) and Ure2p Sc
(∼ 0.9 · 10−10m2
s
, from DLS measurement of Ure2p solution, and conversion of the
apparent hydrodynamic radius into a diffusion coefficient using Stokes formula).
The diffusion of the protein from the bulk of the QCM liquid cell toward the sensor
surface corresponds to a 1-dimensional diffusion current. The height of the cell is
4 · 10−4m. The time it takes for a particle with the diffusion coefficient of an Aβ
peptide to travel this distance, i.e. the square root of the mean square displacement
can be estimated from t = <r
2>
D
≈ 1.6·10−7
2.4·10−10 s ≈ 11 min. This time scale corresponds
almost exactly to the observed time scale of depletion. This observation indicates
that the fibril elongation of Aβ (1-42) proceeds without a significant free energy
barrier. Indeed, it will be shown in Chapter 4 that this peptide has the lowest free
energy barrier against aggregation of all studied peptides and proteins. Interestingly,
the time scale of Ure2p Sc depletion is over-proportionally longer, suggesting that
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its free energy barrier is higher, such that the formation of a concentration gradient
away from the sensor surface is less pronounced, leading to a smaller flux of protein
towards the surface. This qualitative observation is also confirmed by the accurate
measurement of the free energy of activation for this protein in Chapter 4. In both
cases, the sensor was incubated twice with the same protein concentration to probe if
the observed decrease in the rate of change of frequency was indeed due to monomer
depletion, as opposed to the fibril crowding phenomenon mentioned in the general
section on QCM measurements above. The exact reproducibility of the frequency
response confirmed that depletion was at the origin of this phenomenon.
These interesting depletion phenomena were not observed for any other peptide
under study, due to the higher concentrations used in combination with higher free
energy barriers. Indeed, a linear rate of change of frequency was usually observed,
that was stable for up to hours, indicating a steady state situation in the cell without
noticeable depletion. However, the clear signature of depletion in the case of Aβ
(1-42) and Ure2p Sc was used to calibrate the mass sensitivity of the QCM for
fibril elongation. Numerical simulations of the one-dimensional diffusion equation
with a sink at the sensor surface confirmed that the content of the liquid cell was
quantitatively (of the order of 90%) depleted; therefore the observed frequency shift
(the average of the first three overtones n = 3,5,7) was taken to origin from the
attachment of all the available peptide, the latter being calculated from the protein
concentration and the known volume of the liquid cell (40 µl). Assuming that a
negligible fraction of the peptide or protein is absorbed at the walls of the cells
or elsewhere in the flow system, the values of the mass sensitivity coefficient for
amyloid fibril elongation thus obtained therefore represent an upper bound of the
mass sensitivity. It is unlikely that a significant amount of peptide is absorbed in
the flow system, given the good reproducibility of the frequency shift traces shown
in Figure 3.12.
Performing the analysis as described above, it was found that the mass sensitivity
coefficients for both Ure2p (∼10ng Hz−1) and Aβ 42 (∼7ng Hz−1) are very similar.
Given the fact that these two polypeptides differ considerably in size (4.5 compared
to 40 kDa) and fibril structure, it is reasonable to assume that the mass sensitivity
coefficients for amyloid seed fibril elongation by other polypeptides are similar to the
ones measured here. Therefore, the average of the values measured for Aβ (1-42) and
Ure2p Sc, (8.5±2 ng Hz−1), was used as the global mass sensitivity coefficient for
all proteins and peptides studied in this work. This value is included in the possible
range from the AFM calibration experiments detailed above and corresponds to
∼50% of the Sauerbrey mass sensitivity coefficient, i.e. a mass sensitivity that is
twice as high as expected from the dry mass of the protein. In conclusion, therefore,
the typical underestimation of the absorbed mass that arises from the viscoelastic
properties of the attached material [101] is not observed in QCM experiments of fibril
elongation, but rather the hydration water of the protein, as well as the increase in
surface roughness due to the growth of the fibril network on the QCM-chip (leading
to additional frequency shifts from the drag of water trapped in the groves [104])
seem to play an equally important role.
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Figure 3.12: a) A QCM sensor covered with Aβ (1-42) seed fibrils was repeatedly
incubated with a solution of 1.7 µM soluble Aβ peptide at 40 and the cell was
only flushed with PBS buffer when the rate of change of resonant frequency had lev-
elled off. The black trace is from the first incubation, the red one from the second
b) a similar experiment as in a), but with the yeast prion Ure2p Sc. The induced
frequency shift scales with the molecular mass and concentration of protein, indicat-
ing that the mass sensitivity coefficients are very similar for these two polypeptides.
Note also the different time scales of the depletion phenomena, that are due to the
different diffusion coefficients of the two proteins (see text).
3.3 DLS measurements of fibril elongation
The most widely used assay for amyloid formation kinetics in bulk solution is based
on the shift of the fluorescence spectrum of the dye Thioflavin T (see above). How-
ever, as mentioned there, the fluorescence intensity of ThT depends on factors other
than just the quantity of amyloid fibrils present. In addition, as will be demonstrated
in the last chapter of this thesis, this method is highly prone to artefacts, such as
fluorescence quenching by small molecules etc. It is therefore desirable, to be able
to follow the formation and growth of amyloid fibrils in solution without the use of
a label. Light scattering has long been used for this purpose [70; 71; 144; 145], but
the physical principles governing the scattering of light by small particles render this
method difficult to employ. The scattering intensity scales with R6 [112]; therefore,
in solutions and suspensions with very inhomogeneous particle size distributions,
larger particles contribute the majority of the detected intensity of scattered light,
even if their number concentration is small. If this dominance is too strong, the
multi-modal character of the correlation function cannot be properly resolved. In
such cases, the overall size distribution of all particles in the solution cannot be
determined, and even a quantification of the total amount of aggregated material is
difficult. It shall be mentioned here only briefly, that a label-free determination of
the total quantity of insoluble material can be determined via an ultra-centrifugation
assay, as for example demonstrated recently in [146].
Despite these difficulties, the label-free nature of light scattering techniques has
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potential for aggregation assays, and in Chapter 5, it is shown how the method de-
scribed below can be used to probe the influence of ionic strength on the elongation
rate of insulin amyloid. In the following, a detailed description of the method is
given. The first important aspect to note is that the fibrils the elongation of which
is studied are obviously not spherical, such that the most simple type of analysis
of the data in terms of the Stokes-Einstein equation D = kBT
6piηR
, that relates the
diffusion coefficient to the hydrodynamic radius of a sphere, cannot be employed.
However, the problem of the apparent hydrodynamic radius of non-spherical objects
has been solved for a range of simple shapes of biological relevance [147] and the
results can be used in a straightforward manner. The relationship between apparent
hydrodynamic diameter and fibril length is given for two fibril diameters (5 and 10
nm) in Figure 3.13 a).
a) b)
c)
5 nm
10 nm
Figure 3.13: a) Curves relating the apparent hydrodynamic diameter with the fibril
length for two fibril diameters (5 and 10 nm), calculated according to [147]. b) AFM
image of the seed fibrils at the beginning of the assay c) AFM image of the insulin
fibrils after 45 min growth at 45 with a monomer concentration of 0.15 mg/ml.
The key idea of the elongation assay is to start with a relatively narrow size
distribution of seed fibrils that can accurately be determined with DLS. The evo-
lution of this ensemble of seeds after addition of monomers is then monitored for a
short time during which the initial narrow size distribution is projected onto a size
distribution with larger average length, ideally equally narrow. The overall aggre-
gation rates have to be adjusted such that the reaction is sufficiently fast in order
to avoid sedimentation of the formed fibrils, but also sufficiently slow to be resolved
with the limited time resolution of the instrument. In the case of the assay of the
ionic strength dependence of the elongation rates, this adjustment was achieved by
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varying the temperature. Figures 3.13 b) shows the initial length distribution of
seed fibrils, and c) the result of incubation of these seeds at 45 for 45 min, in the
presence of 0.15 mg/ml insulin monomer. The initial length of the seed fibrils is
100-200 nm (Figure 3.13 b), and the Z-average value of the size is 50-60 nm. Taking
into account the thickness of the fibrils (∼ 5nm), this result is in good agreement
with the calculated prediction (Figure 3.13 a). Before being able to proceed, how-
ever, it must be established that the measured apparent diffusion coefficient is a
purely translational one, as rotational diffusion can play a significant role in rod-like
structures. It was shown by Pecora [112; 148], that the time-correlation function of
the scattered field for a long rigid rod can be written as:
I(q, t) ∝ [S0(qL)e−q2Dt + S1(qL)e−(q2D+6Θ)t + ...] (3.1)
where the right hand side of equation 3.1 is the so-called dynamic form factor
of a single rod-like molecule, D is a unique diffusion coefficient for the translational
diffusion of the rod, that can be calculated according to [147], Θ is the rotational
diffusion coefficient, q is the scattering vector and L is the length of the rod. The
”strengths” S l
2
are defined in terms of the spherical Bessel functions jl, according
to:
S l
2
(qL) = (2l + 1)
∣∣∣∣∣∣ 2n
n
2∑
j=1
jl(qbj)
∣∣∣∣∣∣
2
(3.2)
where n is the number of small segments the rod is divided into for the calculation
of the form factor and bj is the position vector of segment j with respect to the centre
of mass of the rod. Pecora demonstrated that for qL ≤ 3, S1(qL) is completely
negligible. q is defined as: q = 4pin
λ
sinα
2
, where n is the refractive index of the
medium (water, ∼ 1.33) and α is the scattering angle [112]. For the scattering
geometry applied in the instrument used here, the Malvern ”zetasizer nano” (see
Experimental section for details), α = 173 ◦, the laser wavelength λ = 633 nm and
q = 2.64 · 107m−1. At the start of the experiment, the length of the seed fibrils
is approximately 100 nm, therefore qL = 2.64. This calculation explains why the
agreement between the length of the seeds as determined by AFM images and the
value measured by DLS and converted according to the curve in Figure 3.13 a) is
so good. However, at the end of the assay, the fibrils have clearly elongated several
fold (Figure 3.13 c)), and the fibril length now varies between 300-1000 nm. The Z-
average value measured at this point is ca. 100 nm. This value is an underestimation,
as is apparent from Figure 3.13 a). It is clear that at these values of qL the rotational
diffusion of the fibrils contributes significantly to the autocorrelation function of the
scattered intensity. Therefore the interpretation in terms of a purely translational
diffusion is not valid any more.
However, if the same range of Z-average values is explored under different condi-
tions, e.g. with varying salt concentrations, it is a reasonable first order approxima-
tion that the ensembles of seed fibrils will be projected onto very similar final length
distributions regardless of the slight change in conditions. Therefore, this assay can
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then be used to compare relative elongation rates in a label-free manner. In order
to improve on this approximation, it would be possible to fit the raw correlation
data to a sum of two exponentials, or indeed use a different scattering geometry
that minimizes the product qL.
Protocol for insulin elongation assay with DLS : The dynamic light scattering mea-
surements were carried out using a Malvern zetasizer nano (see above). The kinetics
were measured at 45, ensuring the right time scales, as discussed above, were met.
As seeds, 500 µl a suspension of 0.1 mg/ml pre-grown insulin amyloid fibrils were
used, that had been sonicated for 15 min at 125 Watts and filtered through a 220
nm filter. The length distribution of the fibril suspension was measured by DLS
(Z-average value 50-60 nm) and was independently confirmed by AFM imaging to
be quite narrow, and close to the minimum length that insulin fibrils can be broken
down to [149]. Then 0.15 mg/ml soluble insulin were added and the evolution of the
seed fibrils monitored through the change in Z-average size. The measurement was
stopped when the Z-average value exceeded 100nm. The apparent hydrodynamic
diameter was converted into a fibril length according to [147].
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Protein aggregation as a diffusive
process on a free energy landscape
Having established the technical aspects of surface-bound kinetic measurements of
amyloid fibril elongation, the next chapters will demonstrate how these techniques
can be systematically applied to elucidate fundamental aspects of the parts of a
protein’s free energy landscape governing this self-assembly reaction.
Whereas structural studies by methods such as nuclear magnetic resonance (NMR)
spectroscopy [150], X-ray diffraction [23], cryo-electron microscopy [28], or atomic
force microscopy (AFM) [151] are applicable to the study of relatively deep minima
of the free energy surface characterizing the degrees of freedom of a polypeptide
chain, associated for example with the native state, folding intermediates, and the
amyloid form of proteins, kinetic measurements are needed to gain insight into the
energy barriers separating such minima. The extent to which variations in external
conditions or differences in the intrinsic amino acid sequences influence the kinetics
of amyloid assembly is a direct manifestation of the modified free energy surface.
However, at the starting point of such studies, an appropriate physical picture and
conceptual framework has to be established within which the acquired data can be
analysed. A unifying framework for the interpretation of the wealth of data that
links protein misfolding and aggregation to the extensively studied field of protein
folding remains challenging to establish. In the first section of this chapter, a model
considering Langevin dynamics of polymers on a characteristic energy surface is in-
troduced, that establishes close connections between the phenomenon of amyloid
growth and the current view of protein folding ([6; 152; 153], and see Introduction).
Subsequently, this conceptual framework and the analytical expression for the rate
law of amyloid formation derived from it are used to analyse an extensive set of mea-
surements of the temperature dependence of amyloid elongation for a range of very
varied polypeptides and proteins and the corresponding absolute elongation rates.
This analysis provides insight into the molecular origin of the energy barriers that
are responsible for the kinetic stability of many peptides against aggregation [34].
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4.1 Amyloid formation as a diffusive process
This section is partly based on the article ”Frequency factors in a landscape model
of filamentous protein aggregation”, Buell et al., Phys. Rev. Lett. 2010, [154]. The
technical derivation of the frequency factor in the rate equation of amyloid formation
is not reproduced here, as it was carried out by Dr Tuomas Knowles and Professor
Eugene Terentjev.
As has been outlined in the introduction, in every kinetic theory of a molecular
process the rate equation consists of two parts: a kinetic pre-factor and an expo-
nential term, the exponent of which is interpreted as an energy of activation. In the
framework of classical transition state theory, the pre-factor and the entropic part
of the free energy of activation are intricately linked to each other:
k = Γe
∆S‡
kB e
−∆H‡
kBT (4.1)
where k is the rate constant, Γ the kinetic pre-factor, kB the Boltzmann constant
and S‡ and H‡ the entropy and enthalpy of activation respectively. 1 The frequency
factor Γ is for simple gas phase reactions equal to kBT
h
, stemming from the quantum
mechanical treatment of the motion along the reactive coordinate. The enthalpic
part (per mol) can be measured from the temperature dependence of the rate r:
∆H‡ = NAkB
d ln(r)
d( 1
T
)
(4.2)
assuming that Γ is independent of temperature. Even though this is not normally
the case, the weak linear dependence on temperature of the pre-factor can often be
neglected if the temperature dependence is measured over a narrow temperature
range. If in addition the absolute reaction rate can be measured, this measurement
yields a combination of the free energy barrier and pre-factor:
r(T )
e
−∆H‡
kT
= Γe
∆S‡
k (4.3)
Therefore it is useful to have an analytical expression for the pre-factor in the
kinetic rate equation for amyloid formation that allows to compute this pre-factor
from first principles. If this can be achieved, it allows in turn to use measurements
of the absolute aggregation rate together with the enthalpy of activation from the
temperature dependence measurements to determine the entropic part of the barrier
as well.
As has been outlined in the introduction, the modern view of protein folding dif-
fers from the prevailing picture of small molecule reactions. Instead of a unique
1Compared to the equation presented in the historical overview, the quotient of partition
functions has been identified with an entropy term here and the energy of activation is identified
here with an enthalpy. This is approximately valid, as the difference between energy and enthalpy
of activation is small.
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and well-defined reactive trajectory all the way from reactants to products as pic-
tured in a small molecule reaction, such as the prototypical gas phase reaction
H-H + H → H + H-H, protein folding is more appropriately described by diffusive
dynamics on a multi-dimensional free energy landscape. This energy landscape has
in principle as many dimensions as the protein molecule has degrees of freedom.
The number of degrees of freedom depends on the description of the polypeptide
chain, and can range from course-grained descriptions that treat the polypeptide as
a Gaussian chain (see below) to approaches that take the positions and momenta
of each of the atoms into account. In order to fully construct such an energy land-
scape, one has to compute the energy of each of the possible conformations of the
polypeptide chain. However, this has not been achieved to-date at any level of so-
phistication. Course-grained approaches, that do not rely on a complete description
of the energy landscape, but that nevertheless capture key experimental features of
the reaction under study therefore provide a promising route towards the ultimate
goal of completely understanding protein dynamics.
Similar as in corresponding descriptions of protein folding in terms of diffusive dy-
namics, the polypeptides at the starting point of the aggregation process can be
described as Gaussian polymers [155] with N segments, joint by Hookean springs.
The number of segments is smaller than the number of amino acids of the polypep-
tide chain. In a Gaussian polymer, the relative orientation of the different segments
is statistically independent, even though their dynamics are coupled. However, the
geometry of the peptide bond leads to a correlation between the orientation of sub-
sequent amino acid residues. Therefore, a sufficient number of amino acid subunits
has to be taken together to form an ensemble that is statistically independent from
the adjoint ensembles, and that provides the entropic elasticity for the springs join-
ing the segments. As will be seen in the next section, most of the polypeptides
and proteins under study here, and indeed a large part of all known amyloidogenic
polypeptides are, at least partly, unfolded under the conditions where they form
amyloid most readily. For these cases, the Gaussian chain model is likely to cap-
ture the characteristics of the soluble monomeric precursor to amyloid formation
well. However, even the proteins, such as insulin or lysozyme that are still folded
under amyloidogenic conditions will have to unfold considerably at some point on
their reaction coordinate, given the large structural differences between the soluble
and the aggregated protein subunit. The results of the next section show that this
unfolding along the reaction coordinate is likely to take place before the transition
state is reached.
The polymer segments evolve in a potential G1 which results from the interactions
with the fibril end. The physical origin of this potential is in the direct electrostatic
interactions between the charged protein and the fibril end, as well as in contribu-
tions from van-der-Waals and hydrophobic interactions; in addition the breakage
and formation of non-covalent contacts within and between polypeptide chains as
well as with solvent molecules will contribute to this potential. In the second section
of this chapter, as well as in the next chapter, the relative importance of these differ-
ent energetic contributions will be studied in detail. The dynamics of such a system
can be described by the Langevin equation, where the inertial term is neglected
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Figure 4.1: Amyloid growth through diffusive sampling of an energy surface G. The
reaction rate is determined through the flux from the reactants (A := Fj + M) to
the product (B := Fj+1). An arbitrary path γ from A to B in the proximity of the
saddle point ‡ is shown in black. Drawing by courtesy of Dr Tuomas Knowles.
(overdamped case):
ζ∂txi = −∂xiG(x1, . . . , x3N) + ξi(t) (4.4)
where the 3N coordinates of chain segments undergo stochastic motion on the
energy surface
G(x1, . . . , x3N) =
3N∑
i=1
G1(xi) + κ/2
3N−3∑
i=1
(xi − xi+3)2 (4.5)
given by the connectivity-enforcing harmonic potentials and the external poten-
tial G1. The thermal noise ξi satisfies the fluctuation-dissipation theorem 〈ξiξj〉 =
2kBTζδij. The reaction rate is then given by the total probability flux from one
basin of the energy surface, corresponding to a fibril of length i and a separate
monomer, Fi + M , to another basin describing the energetically more favourable
fibril of length i+ 1: Fi+1 (Figure 4.1).
This flux can be computed by going from the Langevin to the corresponding
Fokker-Planck equation [156]:
∂tψ = −divJ (4.6)
with
Ji = −D[∂xiψ + βψ∂xiG] (4.7)
where β = (kBT )
−1 and ψ(x1, . . . , x3N ; t) is the probability density of the polypep-
tide chain in a configuration with the segment coordinates [xi]. The complete deriva-
tion of the rate equation for amyloid fibril elongation starting from this stochastic
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differential equation will not be given here. The analysis follows closely the meth-
ods employed by Kramers [56] and Chandrasekhar [157] and is described in detail
in [154]. The final expression for the kinetic rate equation is:
Φ =
Dreffc
1 + (Dreffc)τR
e−βG
‡
(4.8)
where D is the diffusion coefficient of a chain segment (comprising ∼ 3 amino
acids) D = kBT
ζ
∼ 5 · 10−10m2
s
[158], c is the soluble protein concentration, reff is
a length scale that depends on the reactive geometry of the transition state and τr
is the average residency time of the monomer close to the fibril end, during which
time no other monomer can attempt the barrier crossing. For small concentrations,
this expression simplifies to
Φ = Dreffce
−βG‡ (4.9)
An estimate of reff in terms of parameters of the Gaussian chain can be made
through a self-consistency argument [154], relating the time scales of internal re-
arrangement of the Gaussian chain with its center of mass diffusion. reff can be
computed according to:
reff =
b0
pi
√
6N
(4.10)
where b0 ≈ 1 nm is the length of a segment (”Kuhn length”) of three residues,
and N is the number of segments. This relation is used to compute the kinetic
prefactors for the computations of the free energies of activation in the next section.
For example for a protein with 50 residues a value of reff = 0.3 A˚ is obtained.
As mentioned above, it can be easily seen that Equation 4.8 yields the limit Φ =
Dc reffe
−βG‡ at low concentrations and saturates at Φ = τ−1R e
−βG‡ at high concentra-
tion. It therefore reproduces the well-known sub-linear concentration dependence
of amyloid fibril elongation [70; 76; 159; 160; 161]. The crossover between these two
regimes occurs at c˜ = (DreffτR)
−1.
Having established this conceptual framework, that treats amyloid fibril elongation
as a diffusive process, it can now be used in combination with the highly accurate and
selective surface-based biosensor measurements described in the Methods section to
gain fundamental insight into the molecular mechanisms of protein misfolding and
aggregation.
4.2 Free energy barriers against amyloid forma-
tion
This section is mainly based on the article ”The nature and origin of energy barriers
against protein aggregation”, Buell et al. 2011, in preparation. Contributions of
co-authors are appropriately indicated.
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The starting point for a quantitative determination of the free energy barriers
associated with amyloid growth is the measurement of the temperature dependence
of this process, that allows the determination of the enthalpy of activation, ∆H‡.
Raw data of a QCM measurement of the dependence of the elongation rate of PI3K-
SH3 amyloid fibrils on temperature is shown in Figure 4.2 and used to illustrate the
principle of the experiment. A change in temperature leads to a change in resonant
frequency of the quartz crystal and before the growth rate can be probed at this new
temperature, a new stable baseline needs to be established. The rate of decrease of
frequency is proportional to the aggregation rate, and therefore a linear fit to the
growth period is used to extract the aggregation rate. In all cases, the average of the
rate for the 3 overtones N = 3,5,7 is used; a detailed explanation and justification
of this analysis can be found in the section on mass sensitivity calibration in the
Method development chapter.
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Figure 4.2: This figure illustrates the entire time course of a temperature dependence
measurement of amyloid fibril elongation. In this case, seed fibrils from the protein
PI3K-SH3 that forms amyloid in acidic solution, are repeatedly brought into contact
with a protein solution of 1mg/ml in 0.01 M HCl (green bands). Subsequently, the
liquid cell is flushed with HCl and then the temperature is increased. The increase
in temperature leads to an increase in resonant frequency, and a new baseline will be
established. The aggregation rates are extracted from the data by fitting the linear
decrease of frequency due to fibril growth with a linear function and the average of
the slopes of N = 3 (black), 5 (red), 7 (blue) was used as a measure of the elongation
rate (see Method section for details). The temperature range studied here is 20-45.
If an Arrhenius plot of the logarithm of the reaction rate against the inverse abso-
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lute temperature is linear over a certain temperature range, a well-defined energy of
activation characterizes the pathway from the reactants to the products. It is known
for protein folding, however, that this linearity is often not fulfilled, especially at
higher temperatures, as a result of the difference in heat capacity between the initial
state and the transition state of the reaction [162]. The temperature dependence of
the enthalpy of activation can then be written as:
∆H‡(T ) = ∆H‡(T0) +
∫ T
T0
∆C‡p(T )dT ≈ ∆H‡(T0) + ∆C‡p[T − T0] (4.11)
where ∆H‡(T0) is the enthalpy of activation at a reference temperature ∆C‡p is
the difference in heat capacity between the soluble state of the protein and the tran-
sition state. However, it was found in the present study that, for the peptides and
proteins and the temperature range (15-45) investigated here, no strong deviations
from linearity are observed (see Figure 4.3), indicating that ∆C‡p ·∆T << ∆H‡(T0).
Therefore, linear fits to the Arrhenius plots were performed in all cases to extract
the enthalpy of activation ∆H‡ (Figure 4.3)
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Figure 4.3: Representative Arrhenius plots for the peptides and proteins studied in
this work. PDB structures are shown for the cases where the structure is relevant
under the conditions where the experiments were preformed. For the unstructured
amyloidogenic precursors, random coils were drawn with the persistence length of
the respective polypeptide. These illustrations are intended to demonstrate the
great structural and sequence-diversity of the amyloidogenic polypeptides studied
here. In the case of human lysozyme, the Arrhenius plots for the native, non-
reduced, form and for the form where the disulphide bonds have been reduced and
blocked (see Method section for details) are shown in the same plot and the rates are
normalized with respect to the concentrations of soluble protein and the fibril surface
concentration, such that the absolute differences in rate are directly comparable (i.e.
as vertical shift in the Arrhenius plots). The error bars are in this case not from
repeated measurements, but have been determined from the deviation between the
frequency harmonics with N = 3,5,7. The numerical values of the enthalpies of
activation, ∆H‡, are given in Table 4.2.
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Representative Arrhenius plots for all the peptides and proteins examined in this
study with QCM kinetic experiments are shown in Figure 4.3, and the corresponding
numerical values of the enthalpies of activation are listed in Table 4.2. It can be
noted that there is a considerable variation in this quantity, ranging from values
close to the theoretical minimum for a diffusive reaction in water, stemming from
the activation enthalpy of water viscosity (∼ 16 kJ/mol, [163]), to values greatly
in excess of 100 kJ/mol that are indicative of the need to disrupt a considerable
number of interactions in order to reach the transition state.
A crucial point for the possibility to carry out these experiments was the toolbox
of surface attachment methods the development of which is described in detail in
the Method development chapter. Due to the large range of peptide sequences
and solution conditions that were explored in these experiments, the full range of
attachment strategies had to be exploited. It was an integral part of the design
of this study to be able to investigate the largest possible range of amyloidogenic
sequences and conditions, ranging from very short peptides to folded proteins and
from non-physiological to physiological solution conditions. The reasoning behind
this strategy was the hope that the common factors responsible for the tendency
of many peptides and proteins to form amyloid could be distilled out of a large
data set. However, the attempts to attach seed fibrils formed from the very short
peptides TTR (105-115), GNNQQNY and Aβ (25-35) were not successful. The
surface densities of seed fibrils that were achieved were in all cases too low to yield
a measurable frequency change upon contact with soluble peptide. This finding
could indicate that the parts of the polypeptide’s sequence that are buried inside
the fibril are not available for covalent surface attachment. Although no data is
available on the proportion between buried and accessible amino acid residues for
these short peptides, recent results show that the stability of the amyloid state
per residue increases with decreasing sequence length [34]. This is indicative of
an increasing proportion of buried residues for shorter sequences. In the case of the
three very short peptides mentioned above, this effect could explain why the chemical
functionalization of the fibrils formed from the short peptides is inefficient. In order
to be able to measure the temperature dependence of a short peptide, therefore, an
alternative route had to be explored. Thioflavin T fluorescence, despite the problems
associated with its use (discussed in the Methods section), provides a possibility to
carry out these measurements. However, even these measurements turned out to
be impossible for the TTR and GNNQQNY peptides; for the former due to its lack
of ThT binding and fluorescence and the latter due to its high tendency to form
crystals instead of fibrils. Aβ (25-35) on the other hand did bind ThT and the
temperature dependence of its fibril elongation reaction could therefore be probed
(see Figure 4.4, and Experimental chapter for details).
In these experiments, a temperature dependence of the fibrillization could not
be resolved. Therefore, and due to the difference in technique employed for this
peptide, it is only included qualitatively in the following discussions.
The Arrhenius-plots shown in Figure 4.3 are all based on a single measurement.
However, for the numerical values in Table 4.2, the averages of several repeated
experiments are reported. The reproducibility (see errors in Table 4.2) was very
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Figure 4.4: Thioflavin T fluorescence measurements to probe the temperature de-
pendence of Aβ (25-35) amyloid fibril elongation. The increase in fluorescence with
time at different temperatures was monitored. a) AFM image of the initial mixture
of monomer and seed b) AFM image of an aliquot at the end of the experiment c)
Fluorescence traces (raw data) at different temperatures between 28 and 40 .
good in most cases. However, in the case of glucagon, the reproducibility was not
very satisfying. Therefore, the temperature dependence of fibril elongation of this
peptide was studied using ThT fluorescence in addition to the QCM experiments
(Figure 4.5, Experimental chapter for details on the protocol). Interestingly, the
ThT measurements yielded a stronger temperature dependence than suggested by
the QCM measurements, hence the large error bars associated with this value.
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Figure 4.5: a) AFM image of the seed fibril used for the ThT measurements of
glucagon amyloid fibril elongation b) normalized ThT traces (divided by final flu-
orescence level). The temperature dependence was measured from the slope of the
initial linear part of the fluorescence traces.
As is thus demonstrated, the determination of the enthalpy of activation of amy-
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loid fibril elongation does not require a knowledge of the absolute rate, but rather
its relative change with temperature, this quantity is accessible with a variety of
experimental techniques. Indeed it has been measured for protein aggregation of a
variety of proteins [71; 75; 76; 161; 164; 165; 166; 167; 168]. These literature data
have been included in Table 4.2 to give an overview of most of the values known to
date along with the data measured in the present study. In general where enthalpic
barriers were measured for proteins for which such data have been reported previ-
ously, the values reported here are in good agreement with the earlier values (legend
to Table 4.2).
A unique feature of surface bound techniques such as QCM, however, is that
the substrate can be imaged before and/or after the experiment by AFM (see Ex-
perimental and Method development chapters) and an estimate can be made of the
absolute number of amyloid fibrils whose growth has contributed to the measured
signal (see Figure 4.6). This analysis was in all cases carried out by hand, as it
can not easily be automated; the reason is that in order for the elongation of the
surface-bound fibrils to produce a measurable signal, the fibril density has to be so
high that the fibrils overlap, which makes the use of standard algorithms that trace
the fibrils [22; 169] impossible. An additional complication for this manual estima-
tion of the fibril surface density is created by the relatively high average roughness of
the QCM sensors. Therefore, especially in cases of very high fibril surface densities,
there will be a considerable error associated with the determination of this quan-
tity. However, due to the fact that for each individual measurement, the count was
performed on several independent areas of the sensor surface and that the surface
fibril density enters logarithmically in the calculation of the free energy, these errors
do not affect the determination of the desired quantities to an appreciable extent.
In addition, the free energy of activation was calculated separately for several indi-
vidual measurements and the average of these individual calculations is quoted in
Table 4.2.
This feature of surface-bound measurements therefore enables an estimate of
the absolute elongation rate, φobs, the flux of amyloidogenic precursors adding to a
single fibril end per time unit, to be made. Comparison between the theoretical,
diffusion-limited maximum of the aggregation rate φmax (see previous section for
the computation) and its measured value then permits to calculate the free energy
of activation according to ∆G‡ = RT log(φmax
φobs
). This, in turn, allows to calculate
the entropic contribution to the total free energy barrier according to T∆S‡ = ∆H‡
- ∆G‡; the results of these calculations are shown in Figure 4.7.
As the entire data set shown here has been acquired with the same experimental
technique, these thermodynamic parameters for each system can be easily compared
and correlated with the physical properties of the precursor polypeptides. The so-
lution conditions had been chosen in each case such as to generate a high amyloido-
genicity for each polypeptide, and therefore variations in pH (acidic to neutral) and
ionic strength (10-200 mM) exist between the reaction conditions for the different
systems (see Table at the end of the chapter for details). These factors are known to
be able to modulate the rates of amyloid formation by up to two orders of magnitude
([170; 171] and in particular see Chapter 5), and therefore the free energy barriers
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Figure 4.6: These AFM images were used to calculate the absolute elongation rate
of PI3K-SH3 amyloid fibrils in the experiment shown in Figure 4.2. The surface
fibril density is estimated to be on average 150±50 µm−2.
by several kBT; these effects have to be kept in mind when identifying the physical
origins of these energy barriers.
Several important points can be noted when comparing different polypeptide
systems. First, while the enthalpic contribution to the total free energy barrier is
unfavourable in all cases, the transition state is favoured entropically relative to
the precursor state for all the peptides and proteins in this study, a finding that is
qualitatively different from previous reports in terms of the sign of the entropic con-
tributions [172]. This difference stems in most cases from the use of different physical
models for amyloid formation, in particular leading to very different expressions for
the frequency factor in the kinetic rate equation, such as the expression kBT
h
, which
was derived for simple gas phase reactions. The diffusive model that is outlined in
the previous section, however, is a natural development of the widely accepted model
for protein folding, namely stochastic dynamics on a free energy landscape [174; 175].
The second observation, that the differences in the enthalpy and entropy of activa-
tion between different proteins are much larger than the differences in the overall
free energy barriers, reveals an interesting analogy between protein folding and mis-
folding, the so called enthalpy-entropy compensation ([9] and see Table 4.2). These
quantities are intricately linked, most likely as a result of the important contri-
bution of solvation and desolvation of proteins during the folding and aggregation
processes. Hydration phenomena generally lead to both enthalpic (through breaking
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Figure 4.7: Overview of the measured enthalpies, entropies and free energies of
activation for amyloid growth. The data reveal that all measured proteins have a
positive enthalpic barrier for this process (the enthalpy of activation of the water
viscosity has not been subtracted), whereas the entropy of activation is favourable in
all cases. The phenomenon of enthalpy-entropy compensation is clearly apparent, as
the overall variability in the free energies of activation is much smaller in absolute
terms than the variability in the enthalpies of activation, that range from values
close to the theoretical minimum for a diffusive reaction in water (16 kJ/mol) to
values clearly above 100 kJ/mol, indicative of a major structural reorganization.
and formation of hydrogen bonds) and entropic (due to the lower degree of order of
water molecules in bulk solution compared to a hydration shell) contributions [176].
Therefore, this compensation phenomenon is not restricted to protein reactions, but
rather is a common feature of many chemical reactions in water, e.g metal complex
formation [177]. It should be mentioned at this point that the observation of a
generally rather narrow range of free energies is due to a certain bias of the limited
sample taken in this work from the whole sequence space of known proteins; a study
of the elongation rate is only possible for proteins that have relatively small free
energy barriers for aggregation. Many proteins are in principle capable of forming
the amyloid state, but in some cases the high barriers to conversion prevent them
from doing so on measurable time scales.
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peptide/protein free
energy
of acti-
vation
∆G‡
[kJ/mol]
lower
bound
of free
energy
of acti-
vation
[kJ/mol]
upper
bound
of free
energy
of acti-
vation
[kJ/mol]
enthalpy
of acti-
vation
∆H‡ ± std
[kJ/mol]
entropy
of acti-
vation
T∆S‡
± std
[kJ/mol]
(at 298K)
bovine PI3K-SH3 20.1 18.5 26.1 42.1±8.5 22.0±16.0
human α-synuclein 12.9 11.8 15.2 71.0±5.6 58.1±9.0
human Aβ (1-42) 4.6 3.7 6.1 66.1±8.1 61.5±10.5
human lysozyme (reduced) 8.6 7.0 15.2 68±12 59.4±20.2
human lysozyme (native) 23.7 22.4 26.6 167.7±14.7 144.0±18.9
bovine β-lactoglobulin 30.6 29.4 33.2 83.7± 9.6 53.1± 13.4
bovine insulin 22.5 21.4 24.4 102.5±4.2
[76]
80.1±7.2
bovine α-lactalbumin 12.22 10.6 18.1 107±10 94.8±17.5
bovine insulin B-chain 14.9 14.0 16.4 35.0±10.0 20.1±12.5
yeast Ure2p 8.3 6.9 12.1 27±10 18.7±15.2
human glucagon 14.9 14.1 15.9 20±15 5.1±16.8
human β-2-microglobulin 12.3 11.5 13.5 48.3±8.6 36.0±10.6
yeast Het-S n/a n/a n/a 16±2 [172] n/a
human Ig light chain n/a n/a n/a 153±12
[165]
n/a
human stefin B n/a n/a n/a 112.9±20.9
[168]
n/a
human α-chymotrypsin n/a n/a n/a 208±17
[167]
n/a
Table 4.1: Summary of the thermodynamic parameters of activation measured for all
the proteins examined in this study, along with additional data taken from the liter-
ature. In some cases, the parameters have been reported before and also measured
in this study; the enthalpies of activation agree well with reported data: human
α-synuclein: 84.1±3.3 kJ/mol (from [164]); bovine β-lactoglobulin: 100.4 kJ/mol
(from [161]); human Aβ peptide: 95.4±4.6 kJ/mol (from [71], for the less aggre-
gation prone peptide Aβ (1-40) at acidic pH), 61.9±1.3 kJ/mol (from [166]; also
Aβ (1-40) at acidic pH), or 42.9 kJ/mol (from [75], Aβ (1-40) at neutral pH). The
enthalpy of activation of water viscosity is not subtracted from the measured overall
activation barrier, as some authors in protein folding studies suggest [173] as it is an
arbitrary separation, given that the thermodynamic system is formed by the protein
and the interacting water molecules together. In this table, published values for the
entropy of activation are not quoted, as this quantity is strongly model-dependent
and difficult to compare between different studies.
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At this point, it is instructive, to compare the measured values for the different
energetic contributions to the barriers against aggregation with the corresponding
values for protein folding and therefore to put the present work into a wider context.
To this aim a set of equivalent parameters for protein folding and unfolding have
been collected from the available literature (see Table 4.2). To achieve maximal
comparability with the data on energy barriers for amyloid formation, the enthalpy
of activation of water viscosity (ca. 16 kJ/mol, [163]) was added in the cases where
the authors of the respective study have subtracted it. In the study of Akmal et
al. [178] from which about half of the values are taken, the viscosity of water is as-
sumed to have a polynomial dependence on temperature rather than an exponential
one with an enthalpy of activation. Nevertheless, in these cases 16 kJ/mol were also
added to the values for the enthalpies of activation of folding and unfolding. As a
consequence, the values for the entropies of activation need to be altered as well.
Only studies were included, where the authors have analysed the kinetic data in
the framework of a diffusive kinetic theory [173]. In cases where the authors have
proposed an upper and lower bound of the diffusional pre-factor, the resulting upper
and lower bounds for the free energies and entropies of activation are quoted. As the
numerical values for the diffusional pre-factors span several orders of magnitude, the
results of different studies have to be compared with care. The picture that emerges
from this comparison is that the process of folding seems to be less homogeneous
than misfolding and aggregation, with both positive and negative values for both
the enthalpy and entropy of activation having been reported for folding; this result
can be understood from the fact that protein folding is a more complex process
with a multitude of possible folds, and therefore the data from different proteins
will differ as a result of the varying nature of the interactions within the structures.
In amyloid formation by contrast, the similarity in the structures of fibrils formed
from completely unrelated primary sequences is striking [179], and it is therefore
plausible to expect a more homogeneous set of transition state ensembles.
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Protein ref. temp.
[]
free en-
ergy of
activation
of unfold-
ing ∆G‡u
[kJ/mol]
enthalpy of
activation
of unfold-
ing ∆H‡u
[kJ/mol]
entropy of
activation
of unfold-
ing T∆S‡u
[kJ/mol]
free energy
of acti-
vation of
folding ∆G‡f
[kJ/mol]
enthalpy of
activation
of fold-
ing ∆H‡f
[kJ/mol]
entropy of
activation
of fold-
ing T∆S‡f
[kJ/mol]
RNase A
WT
[180] 45 61.6 440 378.4 41.9 -44 -85.9
Lpp-56 [181] 60 84 501 417 35 -140 -175
M2V
GCN4-p1
[182] 25 51.8 128.7 76.7 17.1 -6.7 -79.6
Hisactophilin [183] 20 79.8 65.2 -14.7 52.7 51.0 -1.6
IgG do-
main of
prot. L
[184] 22 75.2 112.0 36.8 51.8 39.3 -12.3
NTL9 [185] 25 58.5 90.3 31.1 40.1 51.4 11.8
CspTm [173] n/a n/a n/a n/a 10-27 28 1-18
CI2 [178] 25 58.1-69.8 194.9 125.1-136.8 25.5-37.2 74.9 37.7-49.0
CSPB [178] 25 26.8-38.0 106.3 68.3-79.5 19.2-30.5 60.7 30.2-41.5
protein L [178] 25 33.4-44.7 102.5 69.5-71.2 27.2-38.5 56.1 17.7-29.0
FKBP12 [178] 25 56.0-67.3 65.7 -1.6-22.3 32.2-43.9 69.1 25.2-36.9
Table 4.2: This table gives an overview over the range of free energies, enthalpies and entropies of activation that were measured
for protein folding and unfolding. In some cases, the reported data had been altered by addition of the enthalpy of activation
of water viscosity, in order to facilitate comparison between the studies, as well as with the values for the barrier of amyloid
elongation reported here (see text for details). Due to the dependence of the entropy of activation on the model used to analyse
the data, only data has been included, where the authors have analysed their results in the framework of a diffusive theory.
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The next step in the analysis of the origin of the free energy barriers against
aggregation is to try and correlate any particular contribution to the barriers with
structural and sequence properties, such as hydrophobicity and charge of the respec-
tive soluble amyloid precursors.
a)
secondary 
structure
unstructured tertiary 
structure
en
th
al
py
 o
f a
ct
iv
at
io
n 
Δ
H
  [
kJ
/m
ol
]
200
150
100
50
0
250
average free energy of transfer per core residue [kJ/mol]
av
er
ag
e 
en
tro
py
 o
f a
ct
iv
at
io
n 
pe
r c
or
e 
re
si
du
e 
   
   
 [k
J/
m
ol
]
genome wide average free energy of transfer  [kJ/mol]
solvent exposed 
residues
all residues burried
residues
b)
0 1 2 3 4
1.0
2.0
2.5
1.5
0.5
0.0
Δ
S n
Figure 4.8: a) Correlation between the height of the enthalpic part of the free energy
barrier, ∆H‡, and the structure in the protein prior to aggregation. Values above 100
kJ/mol for ∆H‡ are only observed for systems with persistent tertiary structure in
the precursor state. The red zones indicate the means and the standard deviations
respectively (values in Table 4.2). b) The average entropy of activation per core
residue is plotted against the average free energy of transfer (from octanol into
water, values from [88]), error bars in the x-dimension stem from the fact that part
of the data set was acquired under conditions other than the ones in [88], and that in
the case of reduced human lysozyme, cysteine residues were modified with respect to
the reference in [88]) of the core residues. This plot suggests that the physical origin
of the main favourable contribution of the entropy term to the free energy of the
transition state is likely to be the (hydrophobic) collapse of the precursor protein
onto a fibril end and resembles the transfer of a significant portion of its amino
acids into a hydrophobic environment. A linear fit yields a slope of ca. 0.4 and a y-
intercept of 0.03. As an illustration and for comparison, the average free energies of
transfer of the exposed, buried and all residues of proteins from mesophilic bacteria
were included on top of b) (see Experimental chapter for the computation).
The degree of residual structure in the amyloidogenic precursor varies strongly
between the various polypeptides studied here. The majority do not possess persis-
tent tertiary structure under the conditions of the experiments, and in general these
peptides have much lower enthalpies of activation than the group of structured pro-
teins (see Figure 4.8 and Table 4.2, which include data measured in this work along
with data from the literature).
In order to probe this connection between structure and enthalpy of activation in
more detail, not only the native state of human lysozyme was included into the
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analysis, but also the reduced state where the four disulphide bonds are broken
(see Experimental chapter for the protocol). Reduction and alkylation of human
lysozyme gives rise to a monomeric state that lacks a well defined tertiary structure;
indeed, the wavelength of maximum fluorescence emission, λmax, shifts from 337 ±
2 nm to 346 ± 2nm upon reduction and alkylation, and the near-UV CD spectrum
shows that tertiary contacts are no longer native-like (see Figure 4.9 a and d). The
far-UV CD shows that the secondary structure is characterized by a shift to a larger
random coil component after reduction (Figure 4.9 e). In the native form of this
protein, a major unfolding transition is observed by calorimetry and spectroscopy
very close to the temperature range of the experiments described in this chapter
(see Figure 4.9) [186]. The effect of reducing the disulphide bonds, however, is a
complete disappearance of the structural transition of the monomeric protein, as
is evident from DSC and fluorescence experiments (Figure 4.9), accompanied by a
substantial decrease in the enthalpy of activation for amyloid growth. This finding
indicates that unfolding and aggregation are at least partly linked: lowering the
energy required to unfold the protein also lowers the barrier for aggregation [187].
Interestingly, a physico-chemical parameter that is known to contribute to bar-
riers against aggregation, namely charge [39; 188], does not appear to be a major
contributor to the overall value of the enthalpy of activation. Thus, bovine PI3K-
SH3 has a significantly higher net charge (+12) than bovine insulin (+5) and yet
a much lower barrier under identical conditions (pH, ionic strength, temperature
range). Similarly human lysozyme and β-lactoglobulin carry comparable charges at
pH 2 (∼+20), but their enthalpic barriers are very different. This finding does not,
however, contradict the earlier results [39; 188] that show a strong modulation of
aggregation rate with charge. Rather, it reveals that this alteration in the energy
barrier is small compared to the contribution associated with residual structure. In-
deed, in Chapter 5, the dependence of the fibril elongation rate on the ionic strength
of the solution will be investigated in great detail. This dependence is a very sensi-
tive measure for the importance of electrostatic interactions in the transition state
ensemble of amyloid formation.
Another noteworthy observation is that two of the lowest values measured for the
enthalpy of activation are for the two yeast prions HET-s (from [172]) and Ure2p
(this work). Both proteins contain an unstructured prion-forming domain and a
folded globular domain; the latter, however, does not contribute to the amyloid for-
mation mechanism but rather provides function to the protein. Even though no fully
definitive conclusion has been drawn as to whether yeast prions are best classified
as yeast diseases [189] or functional traits [190], there is strong evidence that they
have been optimised to form amyloid structures and a very low enthalpic barrier to
their formation is completely consistent with this picture.
In order to complete the elucidation of the molecular origin of the free energy of
activation, it is necessary to gain an understanding of the origin of the favourable
entropy of the transition state. Intuitively, one might expect an unfavourable en-
tropy of activation for an association reaction, as conformational and translational
degrees of freedom are lost. The translational contribution, however, is much less
important in the solution state than in gas phase reactions, as the mobility of a free
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Figure 4.9: Comparison of structural properties and unfolding behaviour of the
reduced and native forms of WT human lysozyme. The reduced form of human
lysozyme is shown in red and the native form in black. a) Fluorescence spectra
recorded at 20◦C show that the tryptophans are in more hydrophobic environments
in the native form than in the reduced form (lower λmax, see text). b) Thermal
unfolding monitored by fluorescence: an unfolding transition is only observed in the
case of the native form of human lysozyme. c) Differential Scanning Calorimetry
shows a peak in heat capacity for the native form only. d) Near-UV CD spectrum
recorded at 35◦C. e) Far-UV CD spectrum recorded at 35◦C. In d) and e), ‘MRE’
stands for Mean Residual Ellipticity and is expressed in degrees.cm2.dmol−1. These
experiments were performed with the help of Dr Anne Dhulesia and Dr Nunilo
Cremades.
macromolecule in water is substantially restricted by viscosity effects [191]. Despite
this restriction, this contribution to the entropy is likely to be non-negligible, but
close to constant for a class of very similar reactions such as amyloid formation,
as it is independent of the chemical nature of the polypeptide chain, and depends
only on the size of the soluble precursor. This contribution is therefore not consid-
ered further in the analysis. The conformational entropy change of the polypeptide
backbone, however, is known to be a major factor in the overall energetics of pro-
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tein folding [9]. Therefore the native, disulphide-bond containing form of human
lysozyme will be excluded from the following analysis, as it is the only polypeptide
studied here that undergoes a major cooperative unfolding transition close to the
temperature range of the experiments described above, associated with a large in-
crease in conformational entropy. A very important contribution to the total entropy
of fibril growth stems from the fact that both the precursor polypeptide and its fib-
ril counterpart are solvated. When hydrophobic patches of up to 1 nm in diameter
are exposed to water, they induce order in the water molecules in their immediate
vicinity, leading to a loss of entropy of the system, whereas for larger hydrophobic
surfaces, the effect is mainly enthalpic and not entropic in nature [192]. When a
protein molecule attaches to the fibril end, part of this ordered water is expected
to be released to bulk solution and to contribute favourably to the overall entropy
of the system. In order to investigate whether this contribution can account for the
sometimes very large value of T∆S (Figure 4.7 and Tables at the end of the chap-
ter), the average entropy of activation per core residue (T∆S
n
, where n is the number
of amino acid residues that are located in the most highly structured region of the
amyloid fibrils; this information is taken from the literature, see Tables at the end
of this chapter) was plotted against the average free energy of transfer from water
to octanol (after Fauchere and Pliska, [88]) of these core amino acids (Figure 4.8 b),
and see Experimental chapter for details). This free energy of transfer of a solute
from aqueous solution to a hydrophobic solvent is a measure of its hydrophobicity,
and as the hydrophobic effect is thought to be mainly entropic in nature under the
conditions of the experiments [192], a correlation of these hydrophobicity values with
the measured entropic values might therefore be expected. Indeed, a correlation be-
tween hydrophobicity and favourable entropy of activation seems to exist (Figure
4.8 b); this finding indicates that the transition state ensemble, corresponding to
the very first interactions between the soluble precursor and the fibril end, shows
characteristics of a favourable transfer of the hydrophobic segments of the precursor
sequence into the fibril core. This reasoning is valid even when the likely presence
of some residual water in the amyloid core [193] is taken into account, as any such
bound water molecules are likely to have a very different behaviour from molecules
in the bulk solution. The correlation observed here is all the more remarkable for
the fact that the data plotted for the different polypeptides were acquired under
very different solution conditions, as mentioned before.
In order to give an additional illustration of the plausibility of the argument, that en-
tropy associated with water plays a prominent role as one of the major determinants
of the free energy of aggregation, the average free energy of transfer and therefore
hydrophobicity, for surface exposed residues, for all residues, and for residues in the
interior of proteins of mesophilic bacteria were indicated on the top of Figure 4.8
(see Methods section for the computation). The core residues of all polypeptides
examined in this study, apart from the yeast prion Ure2p, are more hydrophobic
than the typical amino acids located on the surface of a native protein, therefore
making the tendency to bury these residues inside the fibrils a strong driving force
for amyloid growth, similar to the situation observed in protein folding, and this ef-
fect appears already to be strongly developed in the transition state of the reaction.
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The fact that it was possible to discover this correlation between hydrophobicity
and the entropy of activation, while neglecting any contributions stemming from
conformational entropy, strongly indicates that the degree of conformational free-
dom must be very similar in the amyloidogenic precursor and the transition state
ensemble.
However, this reasoning raises the following question. Correlations are observed be-
tween residual structure and the enthalpy of activation of amyloid growth on the
one hand, and between hydrophobicity and the entropy of activation on the other.
It appears therefore that the two determining quantities of the overall free energy
barrier of amyloid growth T∆S‡ and ∆H‡, are strongly coupled through entropy-
enthalpy compensation (see Figure 4.7), but have different physical origins, structure
and desolvation. In order to investigate this apparent paradox further, and also to
exclude the possibility that the correlation between enthalpy and structure is in fact
only a correlation between size and structural stability [11], the 3-dimensional plot
shown in Figure 4.10 was produced.
In this plot, the enthalpy of activation has been divided by the total number of
residues in the sequence, therefore normalizing the data for the size of the protein.
This quantity is now plotted against the same coarse structure parameter (differen-
tiating only between systems without significant residual structure and those with
secondary structure and with tertiary structure) as in Figure 4.8 a), and against the
hydrophobicity of the core residues (as in Figure 4.8 b), the free energy of trans-
fer [88] is used) of the polypeptide sequences in the second dimension. An overall
trend of increasing ∆H
‡
n
is observed in both dimensions, even though the contribution
of structure is less dominant after the normalization step, revealing the well-known
correlation between protein size and structure-forming propensity [11].
Despite the difficulty to obtain a numerical value for the enthalpy of activation of the
small peptide Aβ (25-35), the results that indicate a small temperature dependence
and therefore a small value for ∆H‡ can still be compared with a prediction made
from the ensemble of conclusions drawn above. A low enthalpy of activation would
be expected due to the complete lack of structure and the moderate hydrophobicity
(the fragment (25-35) of Aβ is considerably less hydrophobic than the entire core
region of the (1-42) peptide), in agreement with the experimental data.
The enthalpy of activation for amyloid fibril elongation therefore stems in large part
from the breakage of interactions (presumably mainly hydrogen bonds) associated
with the solvation and internal structure of the polypeptide chain. The generation
of entropy-enthalpy compensation can be understood in a straightforward manner,
as both desolvation and breakage of structure lead to enthalpic and entropic contri-
butions to the free energy. This finding leads back to the intrinsic character of the
presented data set, namely that amyloid formation can only be observed from those
polypeptides that show clear evidence of compensation, i.e. those systems where
the entropic gain from desolvation is large enough to make up for the unfavourable
enthalpic contributions to the transition state ensemble.
These findings therefore readily explain and quantify in large part which physico-
chemical parameters govern the overall amyloidogenicity of amino acid sequences [39;
194] and build connections between protein folding on the one hand and misfolding
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Figure 4.10: Three dimensional plot illustrating that both the degree of residual
structure and the hydrophobicity of the soluble precursor polypeptide contribute
to the overall enthalpic barrier for amyloid formation. The average free energy of
transfer is plotted as a measure of the hydrophobicity of the residues that form the
core of the amyloid structure in one dimension and the structural category in the
other dimension. The average enthalpy of activation per residue is in large part
determined by these two factors, at least for the proteins investigated in the present
study.
and aggregation on the other. These processes can be described in terms of dy-
namical behaviour on the same overall free energy surface, governed by the same
fundamental driving forces.
The tables on the following two pages give the full list of important parameters
for the proteins of this study, such as sequence length, charge, solution conditions
employed etc. In additon, it gives the kinetic pre-factors calculated according to
Equation 4.10 and the measured values for the actual fluxes of monomer onto the
fibril ends. From these quantities, the free energy barriers are computed.
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Peptide/Protein number
of
residues
pH ionic
strength
[M]
structure of
amyloidogenic
precursor
charge
of amy-
loidogenic
precursor
reff [m] diffusional
prefactor
at 1 mM
[s−1]
flux at 298K
± std [s−1]
bovine PI3K-SH3 84 2 0.01 unfolded [195] +12 2.46E-011 7394.5 2.2 ± 2.0
human α-synuclein 140 7.4 0.15 unfolded [196] -9 1.90E-011 5727.7 30.9 ± 18.3
human Aβ (1-42) 42 7.4 0.1 some secondary
structure [197]
-3 3.47E-011 10457.4 1622.9 ±
727.2
human lysozyme
reduced
130 1.2 0.2 secondary struc-
ture [Fig. 4.9]
+21 1.97E-011 5943.9 182.8 ± 170
human lysozyme
native
130 1.2 0.2 tertiary struc-
ture [Fig. 4.9]
+21 1.97E-011 5943.9 0.42 ± 0.29
bovine β-LG native 162 2 0.2 secondary struc-
ture [198]
+21 1.77E-011 5324.6 0.023 ± 0.015
bovine insulin 51 2 0.01 tertiary struc-
ture [199]
+5 3.15E-011 9489.9 1.1 ± 0.6
bovine α-LA 123 ca.
1.2
0.2 molten globule
[200]
+17 2.03E-011 6110.7 44.1 ± 40
bovine insulin B-
chain
30 2 0.01 some secondary
structure [201]
+3 4.11E-011 12373.3 30.3 ± 14.0
Yeast Ure2p Sc 70 (354) 8.4 0.25 prion domain
unfolded [202]
0 (-7) 2.69E-011 8100.2 285.8 ± 223.7
human glucagon 30 2 0.03 unfolded [203] +5 4.11E-011 12373.3 22.4 ± 15
human β-2-
microglobulin
100 2 0.04 molten globule
like [204]
+18 2.25E-011 6777.1 47.3 ± 18
Yeast Het-s ca. 70
(289)
7 0.12 prion domain
unfolded [205]
0 (-6) n/a n/a n/a
human IG light
chain
122 7.4 0.11 tertiary struc-
ture [206]
+1 n/a n/a n/a
human stefin B 98 4.75 0.165 tertiary struc-
ture [207]
+8 n/a n/a n/a
human α-
chymotrypsin
245 7.0 0.15 tertiary struc-
ture [208]
+4 n/a n/a n/a
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Peptide/Protein free
energy
of acti-
vation
[kJ/mol]
lower
bound
of free
energy
of acti-
vation
[kJ/mol]
upper
bound
of free
energy
of acti-
vation
[kJ/mol]
enthalpy
of activa-
tion ± std
[kJ/mol]
entropy
of activa-
tion TS
at 298K
± std
[kJ/mol]
number
of core
residues
entropy of
activation
per core
residue
± std
[kJ/mol]
free
en-
ergy of
trans-
fer per
core
residue
bovine PI3K-SH3 20.1 18.5 26.1 42.1±8.5 22.0±16.0 84 [25] 0.26±0.19 1.33
human α-synuclein 12.9 11.8 15.2 71±5.6 58.1±9.0 79 [132] 0.76±0.11 1
human Aβ (1-42) 4.6 3.7 6.1 66.1±8.1 61.5±10.5 27 [27] 2.34±0.39 3.86
human lys reduced 8.6 7.0 15.2 68±12 59.4±20.2 77 [84] 0.79±0.28 0.97
human lys native 23.7 22.4 26.6 167.7±14.7 144.0±18.9 77 [84] 1.89±0.25 1.33
bovine β-LG native 30.6 29.4 33.2 83.7± 9.6 53.1± 13.4 122
[133]
0.45±0.12 2.51
bovine insulin 22.5 21.4 24.4 102.5±4.2
[76]
80.1±7.2 46 [209] 1.71±0.15 3.35
bovine α-LA 12.22 10.6 18.1 107±10 94.8±17.5 123
[210]
0.80±0.11 2.03
bovine insulin B-chain 14.9 14.0 16.4 35.0±10.0 20.1±12.5 25 [209] 0.88±0.50 2.89
yeast Ure2p 8.3 6.9 12.1 27±10 18.7±15.2 70 [211] 0.29±0.22 -0.28
human glucagon 14.9 14.2 16.0 20±15 5.1±16.8 29 0.18±0.57 1.59
human β-2-microgl. 12.3 11.5 13.5 48.3±8.6 36.0±10.6 68 [212] 0.53±0.16 1.59
yeast Het-S n/a n/a n/a 16±2 [172] n/a n/a n/a n/a
human IG light chain n/a n/a n/a 153±12
[165]
n/a n/a n/a n/a
human stefin B n/a n/a n/a 112.9±20.9
[168]
n/a n/a n/a n/a
human α-
chymotrypsin
n/a n/a n/a 208±17
[167]
n/a n/a n/a n/a
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Chapter 5
Electrostatic effects in protein
aggregation
This chapter is based to a large extent on the article ”Non-specific electrostatic effects
in protein aggregation”, Buell et al., in preparation. Contributions of co-authors will
be appropriately indicated.
In the last chapter, it was shown that accurate kinetic measurements of amyloid
fibril elongation can yield fundamental insight into the regions of a protein’s free
energy surface that form the barriers between the soluble and the aggregated state of
a protein. The free energy of activation of amyloid elongation was decomposed into
its enthalpic and entropic contributions. The physical origin of large parts of these
energetic contributions was identified and the major determinants of the amyloido-
genicity of a polypeptide defined. However, it was already outlined that electrostatic
interactions, that were not taken into account in the previous chapter, do play an
important role in protein aggregation. In this chapter, a systematic approach will be
outlined that allows for the complex effects of salts on protein-protein interactions
to be studied by kinetic measurements of protein aggregation. Indeed, as in the last
chapter, the work presented here has relevance that goes beyond the specific reac-
tion of amyloid fibril elongation, due to the identification of general principles that
govern the interaction between proteins and the influence of solution ionic strength
on these interactions.
The seminal contributions of Debye and Hu¨ckel [113] on the one hand and Derjaguin,
Landau [213], Verwey and Overbeek [214] on the other hand to the understanding
of the interactions of particles (ions, molecules or colloids) in solutions containing
salts are still largely unchallenged in terms of their use in the toolbox of the prac-
tical scientist working on the interface between physics, chemistry and biology. An
outline of Debye-Hu¨ckel theory will be given in the appendix at the end of this
chapter, due to reference to this concept in the remainder of the chapter. Over
the last decades, it has become clear that these theories fail to account for many
observed effects that are clearly due to the presence of certain ions in solution, or
do so only when several fitting parameters are invoked (see extensive discussion
in [215]. The deviations between simple theories and experiments are particularly
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obvious for biologically relevant salt concentrations where purely electrostatic in-
teractions are largely screened [215]. Despite the strong screening in this regime,
the presence of the ions cannot be neglected and other types of interactions such as
dispersion or hydration forces can become important [216]. For proteins the study
of electrostatic interactions has proven to be particularly challenging, even in solu-
tions where screening is less efficient than under physiological conditions. Proteins
are polyelectrolytes that can carry many charges of both signs simultaneously at
a large range of pH values and therefore their interaction with any given type of
ion is not straightforward to predict [215]. As an example, specific interactions
between certain proteins and salts can even change the overall sign of the protein
charge [217; 218]. For protein misfolding and aggregation salts have been shown
to influence various stages on the pathway from soluble protein to insoluble aggre-
gates. The reported results of systematic studies of the effects of various salts on
amyloid formation differ qualitatively, ranging from reported acceleration of the re-
action [170; 171; 195; 219; 220; 221; 222] to a decrease in rate [66; 223]. Also, in
some cases, salts seem to follow the Hoffmeister series [219; 224], and in other cases
rather the electroselectivity series [221; 225]. This multitude of findings makes the
search for general features in the electrostatics of protein aggregation appear to be
a daunting task. The origin of this confusing appearance of the field is the fact
that most of these studies treat different proteins, under different pH conditions,
and exploring very different concentration ranges of salts. In this chapter, it will
be shown how a very systematic approach, starting from the simplest possible sit-
uation, namely protein aggregation under condition where the proteins only have
positive charges in the presence of small concentrations of simple halide salts, can
yield insight into the importance of electrostatics in protein aggregation, and can
identify common features that are independent of the protein and the salt under
study. The use of seed fibrils from the same batch or even of a constant ensemble of
seeds in series of experiments at different ionic strength ensures that the observed
differences in kinetics can directly be related to a modulation of the electrostatic
forces acting between the seed and the soluble precursor, as the seed imposes the
structure of the aggregate to the soluble protein in most cases [226; 227]. In addition,
this approach also minimizes complications stemming from the observation that dif-
ferent solution conditions can induce the formation of structurally very different
aggregates [195; 221].
5.1 The effect of changes in ionic strength on pro-
tein aggregation
In the previous chapter, it was established that quartz-crystal microbalance mea-
surements can provide highly accurate data on the elongation rates of amyloid fibrils.
Surface-bound seed fibrils can be incubated with solutions of soluble protein under
different conditions (variable temperature in the previous chapter) and relatively
subtle effects on the kinetics of elongation can be measured to high accuracy. These
results suggest that the same measurements could be used as well in order to study
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the influence of small variations in ionic strength on the elongation rate. At the
same time, the full equivalence of the surface-bound methods, such as QCM and
SPR and of the solution based assays, such as ThT fluorescence and light scattering
has not been clearly established before. The present study presented an excellent op-
portunity to do that and the influence of low concentrations of NaCl (concentration
range 0-20 mM, not far from the region of strict validity of the simple Debye Hu¨ckel
theory [228]) on the elongation of pre-grown bovine insulin seed fibrils was therefore
probed with the four different experimental methods mentioned above (Figure 5.1).
Experimental details for each of these four different assays of insulin fibril elon-
gation are presented in the Experimental chapter. Here just the main characteristics
are given. The first experimental difficulty arose from the fact that the final flu-
orescence levels were not the same for samples containing identical quantities of
fibrillar and monomeric protein, but different salt concentrations. In the Experi-
mental chapter, it is demonstrated that this phenomenon arises from an enhanced
binding of ThT to insulin amyloid and/or enhanced fluorescence efficiency of bound
ThT due to an increase in ionic strength, rather than a difference of the final free
monomer concentration due to a change in thermodynamic stability induced by
the presence of salt. The origin of this enhanced binding is presumably itself the
screening effect of the salt; both the protein and the ThT molecules are charged
positively under these acidic solution conditions. Therefore, in order to be able to
use ThT fluorescence to study the elongation rate of insulin amyloid at different
ionic strengths (Figure 5.1 a), the raw fluorescence data has to be normalized to
the same final fluorescence level. As a label free alternative kinetic assay in bulk
solution, the elongation of a homogeneous population of very short, pre-sonicated
seed fibrils (ca. 100 nm, see section on Method development) was monitored by
dynamic light scattering (DLS). Under the scattering conditions in our DLS set-up
(Malvern zetasizer), and the aspect ratio of the seed fibrils (see Methods), rotational
diffusion can be neglected [112] and the correlation function is quasi mono-modal.
In this case, the apparent hydrodynamic radius from the fit to a single exponential,
together with the thickness of the fibrils from AFM measurements, can be converted
into the length of the fibrils in a straightforward manner [147]. At the end of the
experiment, this conditions is not fulfilled any more; however, as discussed in the
relevant section in the Method development Chapter, this does not render the assay
impossible. It is crucial to optimize the experimental condition such that the initial
ensemble of seed fibrils has a relatively narrow length distributions that is projected
onto a similarly narrow distribution of final lengths, the average length of which does
not differ by more than an order of magnitude from the initial average length. The
minimal length of insulin fibrils that can be achieved by sonication is determined
by the mechanical strength of the fibrils [149]. Therefore, this parameter cannot be
minimized beyond the limits imposed by the high strengths of amyloid fibrils. The
rate of elongation of the seed fibrils in the length interval from ca. 100 to 500 nm,
corresponding to an increase in apparent hydrodynamic diameter from ca. 60 to 100
nm (Figure 5.1 b) was measured.
As surface based methods, not only QCM was explored, but also surface plasmon
resonance (SPR), a technique that has been employed previously for the study of
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Figure 5.1: Raw data of experiments designed to study the influence of sodium
chloride concentration on insulin amyloid fibril elongation rate in 0.01 M HCl, and
35-45 , using 4 different experimental techniques: a) Thioflavin T (ThT) fluores-
cence (raw data, not normalized on the final fluorescence level), 40 b) dynamic
light scattering (DLS), 45 c) quartz crystal microbalance (QCM) measurement,
35 d) surface plasmon resonance (SPR) measurement, 40. e) Debye-Hu¨ckel (DH)
plot (lg of the reaction rate [in arbitrary units] against the square root of the ionic
strength of the solution) of the effect of sodium chloride on the amyloid fibrils elon-
gation kinetics of bovine insulin in 0.01 M HCl. The fibrils elongate faster at higher
ionic strength. The kinetics have been measured using 4 different experimental tech-
niques, two surface-based (QCM, SPR) and two solution based (ThT fluorescence
and DLS). The good agreement between all 4 techniques (see inset for a compar-
ison of the slopes) confirms that the process of fibril elongation along a surface is
indistinguishable from the equivalent process in bulk solution, validating the surface-
based biosensing approach. The linearity of the plots indicates that the salt induced
screening of the positive charges operates according to a simple mechanism.
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protein aggregation [96; 98; 229]. For both QCM and SPR, the same protocol was
used for the attachment of the seed fibrils to the gold coated sensors, and that is
described in detail in the section on Method development. The elongation of the
surface-bound seeds was then monitored via their increase in hydrodynamic mass,
using the QCM devices D300 and E4 (Figure 5.1 c) (Q-Sense, Va¨stra Fro¨lunda,
Sweden) or the shift in resonance angle of surface plasmon excitation (”response
units”, see Figure 5.1 d), using a Biacore 3000 (see Experimental chapter).
A summary of the results of these experiments is shown in Figure 5.1 e), where the
logarithm to the basis 10 of the fibril growth rate is plotted against the square root
of the ionic strength of the solution, taking into account the hydrochloric acid, but
neglecting the contribution from the protein itself. In the following, it will be demon-
strated why this is a natural way to present such data of the reaction rate of ionic
species in solution. It follows from a simple combination of the analytical expression
of the rate equation for amyloid elongation (see Chapter 4) with the Debye-Hu¨ckel
theory of electrolytes in solution ([113] and see appendix to this chapter). The
starting point for the derivation is the rate equation of amyloid elongation:
Φ =
Dreffc
1 + (Dreffc)τR
e−βG
‡
(5.1)
To first order approximation, the frequency factor Dreffc
1+(Dreffc)τR
is independent of
ionic strength and will therefore be called Γ for simplicity. The free energy barrier
can be decomposed into an electrostatic and a non-electrostatic part (which was
discussed in detail in the last chapter). The influence of salt on the non-electrostatic
contribution to the free energy of activation is neglected and the expression derived
by Debye and Hu¨ckel is used for the electrostatic part of the interaction energy:
G‡ = G‡ne + Ve = G
‡
ne +
z1z2e
2
4pi0rr‡
e−κr
‡
= G‡ne + VCe
−κr‡ (5.2)
Further, the assumption is made that the separation between the fibril end and
the soluble precursor in the transition state, r‡, is smaller than the Debye length,
κ−1, such that the exponential function can be expanded for small κr‡:
e−κr
‡ ≈ 1− κr‡ (5.3)
This assumption seems reasonable, as the Debye length λ = κ−1 varies between
3 and 1.7 nm for the range of ionic strength employed in the present measurements.
The lower end of this range is comparable in size with the hydrodynamic radius
of the proteins used here; the transition state separations can be expected to be
of the same order as the radii. This reasoning, however, does not put the general
contribution of a Debye-Hu¨ckel type screening mechanisms into question, as the
transition state separation is unlikely to be small enough to exclude ions entirely
from the contact region of the protein monomer and fibril end. One therefore obtains
for the rate of amyloid formation:
Φ = Γe−β(G
‡
ne+VC(1−κr‡)) (5.4)
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The unscreened Coulomb part VC of the potential energy is to first order approx-
imation independent of solution ionic strength (see further below for an extension
of this simplified model), and can be summarized with all other independent factors
into a constant C:
Φ = CeβκVCr
‡
(5.5)
The inverse Debye screening length κ is given by
κ =
√
2NAe2I
0rkBT
(5.6)
Therefore the exponent βκVCr
‡ can be written as:
βκVCr
‡ =
1
kBT
√
2NAe2I
0rkBT
z1z2e
2
4pi0rr‡
r‡ =
√
2NAI
30
3
r(kBT )
3
e3z1z2
4pi
(5.7)
which makes the square-root dependence on ionic strength apparent. Hence we
obtain the following expression for the natural logarithm of the aggregation rate:
ln(Φ) = ln(C) +
√
2NA
30
3
r(kBT )
3
e3z1z2
4pi
√
I = D + Ez1z2
√
I (5.8)
with the numerical value of the constant E =
√
2NA
30
3
r(kBT )
3
e3
4pi
= 0.075 m
3/2
mol1/2
at
298K. We therefore recover the same expression as in the theory that simply com-
bines the activity coefficients of the reactants and the transition state [230]. Usually,
the logarithm to the basis of 10, log10, is used, and the units of concentrations are
mol/l. Carrying out this conversion yields E = 1.03 l
1/2
mol1/2
. As predicted by this sim-
ple derivation, linear behaviour is found (Figure 5.1 e) and, importantly, the slopes
of the straight lines are the same within error for the data sets acquired with all four
different techniques (see inset of Figure 5.1 e). This finding confirms that all four
techniques are indeed probing the same molecular process, and that this process
can be modelled as a bimolecular reaction between two charged species and is there-
fore strongly influenced by solution ionic strength. The absolute values of the rates
have no importance here, and they were not determined, in contrast to the study
described in the previous chapter. Only the relative change in rate with a change in
ionic strength is considered in the following analysis. According to equation 5.8, the
slope of such a plot is proportional to the product of the effective charges of the two
reacting species: log10k = D + 1.03 · zA · zB
√
I, as derived above. As a first order
approximation, it will be assumed that the fibril end carries the same charge as the
soluble pre-cursor and the square root of the product zA · zB will be taken as the
effective charge of the protein. In this case, we obtain 10.0±1.0 for the slope and
therefore 3.16± 0.17 for the effective charge. This is less than the absolute charge
of insulin at this pH (+5, calculated under the assumption of independent pka’s),
consistent with the idea that only part of the total charge is relevant in the aggre-
gation mechanism. In order to get some independent insight into the overall charge
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state of both soluble and fibrillar insulin under these conditions, ζ-potential mea-
surements were performed (see Experimental chapter). The ζ-potential of sonicated
fibrils and soluble protein was measured in the absence of any added salt and values
of +35.5±10.0 mV for monomeric insulin and +40.0±5.0 mV for sonicated fibrils
were obtained, in support of the assumption that soluble protein and aggregates have
similar charge densities. This finding is in disagreement with recent reports that pro-
teins have to be neutral in order to incorporate into amyloid aggregates [116]. In the
case of the soluble insulin molecules, we can roughly estimate the surface charge of
the molecule (bovine insulin is mainly monomeric under the mildly acidic conditions
employed here) from the ζ-potential, given the effective hydrodynamic radius of the
soluble protein (∼ 1.7 nm), according to the formula [231]: Q = 4pirp(1 + κrp)ζp,
where  is the dielectric constant of the solution, rp is the hydrodynamic radius of
the protein and κ is the inverse Debye screening length (∼ 3 nm at I = 0.01 M).
This calculation, which is strictly valid only for ζ < kBT
e
≈ +25 mV, yields a rough
estimate for the surface charge of ∼+4-5, a value close to the absolute charge of
the molecule. Together with the finding that the ζ-potentials of fibrils and soluble
protein are not significantly different, we therefore have strong evidence that the
protein does not change its charge state significantly when incorporating into an
amyloid fibril.
5.2 Non-specific electrostatic screening
The satisfactory establishment of the equivalence of the two solution-based and
the two surface-based experimental techniques for the study of amyloid elongation,
therefore allowed to acquire the data shown in the remainder of this chapter by
means of surface based measurements due to their accuracy, rapidity and ease of
use. In order to test how general the screening mechanism described in the first
section is, equivalent experiments to the ones shown in Figure 5.1 c) were performed
to study the influence of small concentrations of a range of different simple halide
salts on the amyloid fibril elongation of bovine insulin and of another protein that
forms amyloid fibrils under very similar solution conditions, bovine PI3K-SH3. A
series of mono-valent and also some di- and trivalent halides were tested (Figure
5.2 a) and b), and the picture that emerged from these measurements is that the
mechanism of screening of electrostatic repulsion identified here is not restricted
to insulin. Indeed, for PI3K-SH3 a qualitatively very similar behaviour is found,
with indistinguishable slopes (within error) of the Debye-Hu¨ckel (DH) plots for all
mono-valent salts. The slopes are higher than in the case of insulin by a factor of 2
(20±2), leading to an effective charge of 4.5±0.3, consistent with a higher maximum
net charge (+12). The difference between the effective charge for the aggregation
reaction and the total charge is much larger for PI3K-SH3 compared to insulin,
suggesting that the existing charges could be placed in such a way as to have a
smaller impact on the aggregation mechanism. Indeed, it was shown previously for
this protein that subtraction of a charge only accelerates the kinetics by a factor
of two; addition of a charge, however, can slow down the reaction to a much larger
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degree [188].
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Figure 5.2: Debye-Hu¨ckel-plots plots for a) bovine insulin and b) bovine PI3K-SH3,
obtained from QCM and SPR measurements. The data confirm that a non-specific
screening mechanism exists that does not depend on the chemical nature of the
anions and cations studied, but only on the valency of the cation. The dependence
on the valency is opposite to the predictions of theory, where multivalent salts are
predicted to be more efficient screeners than mono-valent salts at a given ionic
strength [232]. Such a behaviour can most readily be explained by chemically non-
specific ion pair formation (see detailed discussion in text).
Most interestingly, when probing the effect of simple multivalent salts, it is found
that for both proteins, the corresponding DH plots are less steep than for the mono-
valent salts, with the difference in slopes being more pronounced in the case of
PI3K-SH3. Therefore, the multivalent salts are less efficient in screening the inter-
molecular repulsion that forms part of the energy barrier for the bimolecular reaction
of amyloid fibril elongation. This finding, which is opposite to what an extension
of Debye Hu¨ckel theory to multivalent electrolytes predicts [232], indicates that an
analysis of the slope as the square of the effective charge for aggregation is an over-
simplification. Assuming that the mechanism of aggregation does not change when
the valency of the salt is changed, an explanation of the observed trend requires
the inclusion of an additional term into the expression for the rate equation of amy-
loid elongation as a function of ionic strength. The simplest extension is to include
binding of the salt ions to the protein in such a way as to change the global charge
of the protein without interfering with the non-electrostatic contribution to the free
energy landscape. It has been known for many decades, that ions can bind to pro-
teins more tightly than the loose association of the ionic cloud interacting with the
surface charges of the protein according to the Debye-Hu¨ckel mechanism [233; 234].
In the following, it will be demonstrated, how the inclusion of non-specific ion bind-
ing can lead to the observed behaviour. As a simple approach, it is assumed that
the change in charge of the protein in the presence of an ion can be described by a
single average ”binding constant”, neglecting any dependence of the binding on the
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charge state of the protein. For the general case of a salt ABi, one obtains for the
charge of the protein:
Q = Q0 + ieKi[A
i+]− eK−[B−] (5.9)
where Q0 is the (hypothetical) charge in the absence of any ion binding, Ki and
K− are the binding constants for the cations (with charge +i) and anions (with
charge -1), e is the elementary charge and [X] are the concentrations. Before pro-
ceeding further, it needs to be established why it is justified to write the variable
charge in this form, using the Ki as defined above. Assume that there are n inde-
pendent binding sites on the protein where ions can attach. These binding sites are
taken to be non-interacting, excluding even simple electrostatic interactions. The
following treatment will therefore only be valid for a small total number of bound
ions. At each binding site the equilibrium:
K =
[PX]
[P ][X]
(5.10)
exists, where [P] is the protein concentration, [X] the concentration of the ion,
and [PX] the concentration of ion pairs. The fraction f of ion pairs can then be
written:
f =
[PX]
[P ] + [PX]
=
K[P ][X]
[P ] +K[P ][X]
=
K[X]
1 +K[X]
(5.11)
Therefore, the protein charge changes due to these n binding equilibria by:
δq = nief = nie
K[X]
1 +K[X]
(5.12)
This expression can be written for small K[X] as δq = nieK[x], where i is the
charge of the ion. The Kis from equation 5.9 can therefore be identified with nK.
But under what circumstances is it legitimate to simplify equation 5.12? The answer
is if there are many binding sites (n large) and if the binding to each binding site
is weak (K[X] small). This situation is probably fulfilled, as the lack of chemical
selectivity of the observed ion binding suggests that the ions are unlikely to attach to
fixed, well defined binding sites with a high affinity, but rather are loosely attached
to varying parts of the protein.
All the experiments have been conducted in 0.01 M HCl, and the chloride anions from
the HCl will be taken into account for the total concentration of anions, together
with the anions from the added salt. Any hypothetical binding of the free protons
will be ignored as, even if there is an interaction between protons and the protein
other than direct protonation, the extent of this binding will be the same for all
samples of one protein and the effect will be a shift in Q0. In order to have only
one independent variable, the concentrations of the ionic species are expressed as a
function of the total ionic strength of the solution, I. There is a unique relationship
between I and [X] for each of the valencies. Mono-valent:
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[A+] = I − 0.01; [B−] = I (5.13)
Q(I) = Q0 + eI(K1 −K−)− e0.01K1 = Q0 + eI(K1 −K−)− eI0K1 (5.14)
where I0 = 10
−2M is the concentration of HCl.
divalent:
[A2+] =
I − I0
3
; [B−] =
2(I − I0)
3
+ 0.01 (5.15)
Q(I) = Q0 + eI(
2
3
K2 − 2
3
K−)− eI0(2
3
K2 +
1
3
K−) (5.16)
and trivalent:
[A3+] =
I − I0
6
; [B−] =
3(I − I0)
6
+ 0.01 (5.17)
Q(I) = Q0 + eI(
1
2
K3 − 1
2
K−)− eI0(1
2
K3 +
1
2
K−) (5.18)
Next the expression of the variable charge is inserted into the equation 5.1 that
describes the aggregation rate:
Φ = Γe−β(G
‡
ne+Vel) (5.19)
with
Vel =
Q(I)2
4pi0r‡
e−κr
‡
(5.20)
In this expression, both the charge Q and κ are functions of ionic strength. In
order to simplify that expression, the normalized rates will be considered:
log(
Φ(I)
Φ(I0)
) =
Q(I0)
2
4pi0r‡kBT
e−κ(I0)r
‡ − Q(I)
2
4pi0r‡kBT
e−κ(I)r
‡
(5.21)
The experimental data suggests a linear dependence of the rate on the square
root of ionic strength for all valencies, therefore Q(I)
2
4pi0r‡kBT
e−κ(I)r
‡
can be expanded
around I0 in
√
I and only the linear term will be kept. This expansion has to be done
separately for each valency, due to the different relationships between ionic strength
and ion concentration. The detailed calculation is shown for the mono-valent case,
the higher valencies are treated analogously. It is convenient at this point to make
a variable change from I to x=
√
I:
Vel(I) =
(Q0 + eI(K1 −K−)− eI0K1)2
4pi0r‡
e−κ(I)r
‡
=
(Q0 + ex
2(K1 −K−)− eI0K1)2
4pi0r‡
e−axr
‡
= g(x)
(5.22)
where κ = a
√
I. The series expansion is then given by:
g(x0 + δx) = g(x0) +
∂g(x)
∂x
∣∣∣
x0
· δx+ 1
2
∂2g(x)
∂x2
∣∣∣
x0
· (δx)2 + ... (5.23)
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Evaluating g(x) and ∂g(x)
∂x
at x = x0 =
√
I0 yields:
g(x0) =
(Q0 − eI0K−)2
4pi0r‡
e−a
√
I0r‡ =
Q(I0)
2
4pi0r‡
e−a
√
I0r‡ (5.24)
and
∂g(x)
∂x
∣∣∣
x0
=
2(Q0 + ex
2(K1 −K−)− eI0K1)2ex(K1 −K−)
4pi0r‡
e−axr
‡
∣∣∣
x0
(5.25)
+
(Q0 + ex
2(K1 −K−)− eI0K1)2ar‡
4pi0r‡
e−axr
‡
∣∣∣
x0
(5.26)
=
e−a
√
I0r‡
4pi0r‡
[4Q(I0)e
√
I0(K1 −K−)−Q(I0)2ar‡] (5.27)
Therefore:
log(
Φ(I)
Φ(I0)
) =
Q(I0)
2
4pi0r‡kBT
e−a
√
I0r‡ − Q(I)
2
4pi0r‡kBT
e−a
√
Ir‡ (5.28)
≈ e
−a√I0r‡
4pi0r‡kBT
[Q(I0)
2ar‡ − 4Q(I0)e
√
I0(K1 −K−)] · (
√
I −
√
I0) (5.29)
and analogously for divalent salts:
log(
Φ(I)
Φ(I0)
) ≈ e
−a√I0r‡
4pi0r‡kBT
[Q(I0)
2ar‡ − 4Q(I0)e
√
I0(
2
3
K2 − 2
3
K−)] · (
√
I −
√
I0)
(5.30)
and trivalent salts:
log(
Φ(I)
Φ(I0)
) ≈ e
−a√I0r‡
4pi0r‡kBT
[Q(I0)
2ar‡ − 4Q(I0)e
√
I0(
1
2
K3 − 1
2
K−)] · (
√
I −
√
I0)
(5.31)
Comparing these expression with the experimental data, it can be noticed that
the slopes on the DH plots for divalent and trivalent ions are very similar, and
smaller than for mono-valent ions, and that the only difference between the terms
above for the different valencies is the expression involving the Ki. Hence, the
following inequalities result from the above expressions:
2
3
(K2 −K−) > K1 −K− (5.32)
and
1
2
(K3 −K−) > K1 −K− (5.33)
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From the experiments, it is clear that the binding constant of any given ion does
not depend on its chemical nature, but only on its charge. A priori, none of the 4
binding constants Ki (i = 1,2,3) and K− can be neglected. However, two extreme
scenarios can be distinguished:
1) K− >> Ki. Here, the difference between the Ki becomes irrelevant, and the less
efficient screening of poly-valent salts is readily explained by the smaller number
concentration in anions at any given ionic strength, compared to mono-valent salts.
2) K− << Ki. In this case, we deduce from the above inequalities that K2 > K1
and K3 > K1. Therefore, the less efficient screening is explained by an increase of
the charge of the protein by a binding of multivalent ions. This a priori counter-
intuitive possibility of an efficient binding of a multiply positively charged ion to a
multiply positively charged protein could be rationalized by the presence of neutral,
polarizable patches even in globally positively charged protein molecules.
In Figure 5.3, linear fits for both proteins are shown where all the data points for
one valency are taken together. The fits are forced to go through (
√
I0, 0), the point
around which the expression for the rates was expanded.
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Figure 5.3: According to the theoretical analysis described in the text, the three
data sets for mono-, di- and trivalent salts are separately fitted to linear functions
that are forced to go through (
√
I0, 0), where I0 is the ionic strength of the HCl and
around which the rate was expanded in
√
I. a) bovine insulin b) bovine PI3K-SH3.
Based on the kinetic data only, it is not possible to unambiguously discriminate
between the two alternatives, anion or cation binding. At the end of the next section,
this problem will be discussed based on previously published data.
5.3 Specific effects
The results described in the previous section were qualitatively confirmed for two
additional polypeptides that both form amyloid under similar solution conditions
(HCl 0.01 M), human glucagon and human β2-microglobulin: in both cases, divalent
chlorides were less efficient in screening than mono-valent chlorides. However, it
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has been reported before for both glucagon [221] and β2-microglobulin [220], that
iodide ions are more efficient in accelerating amyloid growth than chloride ions.
This result suggests a difference between the proteins described in detail in this
chapter and glucagon and β2-microglobulin. In order to confirm this difference,
experiments were performed with these two proteins. The published results could
be confirmed even for the smaller, less polarizable bromide ions (see QCM raw data
in Figure 5.4 a and b); it can thus be concluded that chemically more specific ion
binding must start to play a significant role here, as opposed to the combination
of Debye screening and non-specific binding described above. In order to explain
this difference between insulin and PI3K-SH3 on the one hand and glucagon and
β2-microglobulin on the other hand, the charge density of the four proteins was
computed in the simplest possible way: the theoretical maximum charge at this
pH (in 10−2M HCl, the difference to the actual charge should not be large) was
divided by the total number of amino acids. The following values are obtained:
bovine insulin: +5/51 = 0.10; bovine PI3K-SH3: +12/84 = 0.14; human glucagon:
+5/29 = 0.17; human β2-microglobulin: +18/100 = 0.18. Therefore the resolvable
specific interactions with bromide coincide in both cases with a higher average charge
density. This difference in charge density might also rationalize the finding that
systematically higher ionic strengths had to be used for both glucagon and β2-
microglobulin in order to observe growth rates comparable to insulin and PI3K-SH3.
In the absence of any added salt for example, fibril elongation could not be detected
with the QCM for both glucagon and β2-microglobulin. The bromide ion is softer
and more polarizable than the chloride ion and therefore has a stronger tendency
to associate with soft alkylammonium groups on proteins. Potentially, the overall
charge density determines the extent to which this association, which seems to be
chemically more specific than the type of interaction described above for insulin and
PI3K-SH3, can manifest itself. It cannot be excluded that subtle differences exist
in the association of simple halides to insulin and PI3-SH3 as well, that we cannot
resolve with our kinetic measurements. Future studies will establish if there really
is a qualitative difference between these groups of proteins.
In order to further bridge the gap between this study and existing literature
on the effect of salts on protein aggregation that is discussed in the introduction
to this chapter, the effect of the more complex anions nitrate and sulphate on the
elongation of PI3K-SH3 fibrils (Figure 5.4 c) was also investigated. In agreement
with studies on other proteins, it was found that sulphate is by far the most efficient
anion in accelerating amyloid growth. This effect can easily be explained through
a tight binding between the structured sulphate ion (and to a lesser extent the
nitrate ion) and the protein. However, such effects will be very susceptible to the
particular protein under study and are therefore less well suited to identify very
general principles governing the electrostatic interactions of macromolecules. The
overall findings of this study are summarized in the schematic representation of
Figure 5.5.
This chapter will be ended with a short discussion of the most likely origin of
the less efficient screening of poly-valent salts compared to mono-valent salts at
identical ionic strength. The question of ion binding to proteins has been under
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Figure 5.4: QCM-measurements, confirming that for a) human glucagon and b)
human β2-microglobulin, specific electrostatic effects can already be observed for
simple halides, here bromide. c) Strong specific effects are exhibited for more com-
plex ions, such as nitrate and sulphate. Debye Hu¨ckel plots are shown for PI3K-SH3.
The lines are in this case not fits, but connect the first two points, for comparison
and due to the lack of data points at higher sulphate concentrations.
study for many decades now. It is interesting to put the work described in this
chapter into context with the early work of two great protein scientists, George
Scatchard and Charles Tanford. It has been known for a long time that the pH of
solutions containing protein can be changed by adding a salt that does not change
the pH of pure water. It was understood that the origin of this effect was the direct
electrostatic effect of bound ions on the protonation equilibria of acidic and basic
groups on the protein. Many experimental efforts have been undertaken to quantify
this binding and to determine a protein’s effective charge. The methods used were
conductometric [233], or potentiometric [233], later also ultracentrifugation [235] and
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Figure 5.5: Schematic illustration of the proposed mechanisms of acceleration of
amyloid fibril elongation by dissolved ions. a) Hypothetical unscreened mechanism,
characterized by high repulsive electrostatic forces in addition to a non-electrostatic
contribution to the free energy barrier. b) Debye Hu¨ckel type mechanism in conjunc-
tion with chemically non-selective binding. The electrostatic repulsion is screened
by a diffuse cloud around the charged macromolecules, the charge of which can be
modulated by ion pair formation that does not depend on the chemical nature of
the ion, but only on its charge. c) Specific binding of some anions, such as sulphate,
to the positively charged proteins decreases the effective charge more efficiently, and
may even be able to change the structure of the precursor protein, and therefore
also of the non-electrostatic part of the free energy barrier.
capillary electrophoresis [236] were used. The most recent experimental advance is
to measure the ζ-potential from dynamic light scattering in the presence of rapidly
oscillating AC fields, such as the measurements described in the Methods section.
One of the main conclusions from these experiments was that ion binding can lead
to a substantial alteration of the protein’s net charge, with dozens of ions being
able to bind to a single protein molecule [233]. It was demonstrated that anions
have in general a higher affinity to proteins than cations, even under conditions
where the protein carries charges of both signs. It should be noted, however, that in
cases where proteins require the strong binding of ions to be functional, cations are
more often the binding partners, such as is the case for iron and haemoglobin and
magnesium and chlorophyll. This established knowledge on preferential non-specific
anion binding, together with the fact that the proteins used in the present study
carry only positive charges strongly suggests that the data discussed above is most
readily explained by the smaller number concentration of anions at equivalent ionic
strength of poly-valent salts.
The work presented in this chapter, apart from being a systematic study of the
influence of salt on amyloid formation can also be regarded as an extension of the
ground breaking work of Scatchard and Tanford. Whereas their experiments, being
measurements of transport properties (conductivity), depended in a linear manner
on the charge of the protein, the measurements of aggregation rates presented in this
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chapter rely on the exponential dependence of the aggregation rates on the square of
the net charge of the protein. This strong dependence allows to resolve very subtle
differences in the overall charge state of a protein in the presence of different salts.
Therefore, the results from these experiments have relevance that extends beyond
the medically relevant question of ordered protein aggregation into the more general
field of electrostatic interactions in protein science.
5.4 Appendix: Debye-Hu¨ckel-theory
A derivation of Debye-Hu¨ckel theory is given below. The derivation follows closely
the one described in [237].
In a solution of ions, around an arbitrarily chosen central ion, there will always be
statistically more ions of opposite charge than of equal charge, due to the electro-
static interactions between the ions. Due to the condition of overall electroneutrality
of the solution, the excess of opposite charge around the central ion is equal in magni-
tude to the charge of the central ion. Under the following assumptions, the variation
of the electrostatic potential around the central ion can be calculated:
- only electrostatic interactions are considered. The inclusion of other interactions,
such as van-der-Waals interactions is considered in extended theories, such as DLVO
theory [213; 214]
-in the range of concentrations considered, the electrolyte is entirely dissociated
(strong electrolyte)
-the dielectric constant of the solvent is not perturbed by the presence of the ions
-ions are rigid spheres with a spherically symmetric potential at all times
-the electrostatic interactions are smaller than kBT
The number density Ni(r) of the ionic species i at a distance r from the central
ion is given by the Boltzmann distribution:
Ni(r) = N
∞
i e
−zieΦ(r)
kBT (5.34)
where Φ(r) is the electrostatic potential at a distance r from the central ion,
and Φ(∞) has been set to 0. N∞i is the average number density of ions i. Then
the overall charge density around the central ion is the sum over all ionic species in
solution:
ρ(r) =
∑
i
zieNi(r) =
∑
i
zieN
∞
i e
−zieΦ(r)
kBT (5.35)
if the last of the above-mentioned hypotheses is valid (i.e. zieΦ << kBT ),
Equation 5.35 can be linearised to become:
ρ(r) =
∑
i
zieN
∞
i
(
1− zieΦ(r)
kBT
)
(5.36)
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The condition of electroneutrality of the solution,
∑
i zieN
∞
i = 0 leads to the
desired linear relationship between the potential and the charge density:
ρ(r) = − e
2
kBT
(∑
i
N∞i z
2
i
)
Φ(r) (5.37)
The Poisson equation is the differential equation relating the spatial variation of
the potential to the charge density:
divE = −∇2Φ = ρ
0r
(5.38)
In spherical coordinates, the natural coordinates for this problem, this differential
equation reads:
∂2Φ(r)
∂r2
+
2
r
∂Φ(r)
∂r
= − ρ
0r
(5.39)
Using Equation 5.37, this equation can be written:
∂2Φ(r)
∂r2
+
2
r
∂Φ(r)
∂r
=
e2
0rkBT
(∑
i
N∞i z
2
i
)
Φ(r) = κ2Φ(r) (5.40)
where
κ2 =
e2
0rkBT
∑
i
N∞i z
2
i (5.41)
In order to solve Equation 5.40, the following identity can be used:
∂2[rΦ(r)]
∂r2
=
∂
∂r
(
∂[rΦ(r)]
∂r
)
=
∂
∂r
(
r
∂Φ(r)
∂r
+ Φ(r)
)
= r
∂2Φ(r)
∂r2
+ 2
∂Φ(r)
∂r
(5.42)
Hence
∂2[rΦ(r)]
∂r2
= κ2[rΦ(r)] (5.43)
Setting y = rΦ(r) yields the simple differential equation:
∂2y
∂r2
= κ2y (5.44)
with the solution y = rΦ(r) = C1e
−κr + C2eκr. It remains to calculate the two
integration constants C1 and C2. As lim
r→∞
Φ(r) = 0, C2 = 0. The total integral of
the charge density around the central ion has to be equal to the charge of the ion:∫ ∞
0
4pir2ρ(r)dr = −zce (5.45)
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where the minimal distance of approach of the other ions to the central ion has
been set to 0. Combining Equations 5.37 and 5.41 yields:
ρ(r) = −Φ(r)0rκ2 = −C10rκ
2
r
e−κr (5.46)
Therefore:
4piC10rκ
2
∫ ∞
0
e−κrrdr = zce (5.47)
from where C1 =
ze
4pi0r
. Finally, this leads to the expression for the potential:
Φ(r) =
zce
4pi0r
e−κr
r
(5.48)
which is the expression used in the analysis and discussion of this chapter.
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Chapter 6
Interactions between small
molecules and amyloid
This chapter is based to a large extent on the article ”Interactions between amy-
loidophilic dyes and their relevance to studies of amyloid inhibitors”, Buell et al.,
Biophys. J. 2010, [238]. Contributions of co-authors will be appropriately indicated.
The results of the last two chapters demonstrate, that the surface based biosensing
methods described in detail in the Experimental chapter can provide kinetic data of
amyloid formation accurate enough to obtain new insight into the factors governing
protein-protein interactions. In this final chapter, the field of kinetic measurements
of amyloid formation will be left, and some characteristics of amyloidophilic dye
molecules that still serve as the most widely used labels in bulk solution kinetic
studies of amyloid formation will be more closely examined.
The question about the interactions between small molecules and amyloid fibrils is
not only of interest due to the use of such molecules as labels, but also because of the
therapeutic potential that small molecule inhibitors of amyloid formation possess.
In the last decade, a multitude of studies have been published on the inhibitive effect
on amyloid formation of various synthetic and naturally occurring small molecules.
However, for most of these compounds, the evidence that they interact with the
fibrillar form of the proteins is scarce. In cases where inhibitory effects have clearly
been demonstrated, the origin of such effects can be different from the intended
selective binding to the amyloid scaffold that blocks further elongation. Indeed, re-
cent studies clearly demonstrate, that in many cases, the reported inhibitory effects
can be explained by a colloidal aggregation of the small molecule compound and
an interaction between the soluble amyloidogenic molecule and the colloidal aggre-
gates [239; 240]. The therapeutic use of such effects is obviously very limited.
In Table 6, a few examples are given of small molecules that have been specifically
reported to bind to amyloid. This table serves the purpose to illustrate that not
many methods exist that can unambiguously demonstrate an interaction between
amyloid structures and small molecules, and that therefore the development of such
methods is a useful contribution to the applied aspects of protein misfolding and
aggregation studies.
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Molecule effect of binding to be
exploited
experimental techniques
used in the characteriza-
tion of the compound
PiB (derived
from ThT)
radiolabelling of amyloid in
vivo for PET [241]
filtering assay with radioac-
tively labelled (125I) [242]
Chrysamine G
(derived from
CR)
radiolabelling of amyloid in
vivo
competition experiment
with other radioac-
tively labelled (14C)
compounds [243]
small aromatic
molecule RO-47-
1816/001
accelerates aggregation compound fluorescence
upon binding and kinet-
ics of incorporation of
biotinylated peptide [244]
Crystal violet discrimination between τ
and Aβ (1-42) aggregates
Thioflavin S fluorescence
and TEM analysis of τ fil-
aments [245]
NYGAILSS
peptide
inhibition of human islet
amyloid polypeptide aggre-
gation
membrane binding assay,
ThT fluorescence, turbidity,
CD, TEM [246]
Propranolol inhibition of PrP polymer-
ization
SPR binding assay and
anti-prion activity assay in
scrapie-infected neuroblas-
toma (ScNB) cells [229]
Table 6.1: A short list of some small molecules (plus a short peptide) that have been
reported to bind to amyloid structures.
In many cases, where the interactions of small molecules with amyloid has been
examined, label molecules, such as ThT and Congo red (CR) are used, that pre-
sumably often bind to amyloid according to a similar mechanism as (potentially)
the molecule under study, occupying the very same binding sites on the fibrils. This
reasoning stresses further the need for label-free approaches to the study of amyloid.
6.1 Fluorescent probes of amyloid
The use of fluorescent probes to measure chemical and physical processes in bio-
logical systems is well established [247]. The fluorescent entities can be intrinsic to
the molecule under study, for example tryptophan in proteins [248], covalently at-
tached to it, as in fluorescence resonant energy transfer (FRET) experiments [249]
or can interact non-covalently with the structures of interest, as in Thioflavin T
(ThT) fluorescence assays of amyloid fibril formation and growth [250]. In order
to gain insight into any process under study using fluorescence probes, knowledge
is required of the fundamental steps that link the observed fluorescence signal with
the molecular events that are taking place. The study of amyloid fibril formation
100
CHAPTER 6. SMALL MOLECULES AND AMYLOID
is a particular case where fluorescent dyes, such as ThT have been used as probes
for many decades, although despite extensive experimental [251; 252; 253; 254] and
computational [255; 256; 257] studies, there is no final definitive agreement as to the
exact mechanism, stoichiometry and mode of binding to these supra-molecular pro-
teinacious fibrils [258]. Several distinct binding sites for ThT on amyloid fibrils have
been identified that can differ in their affinities and binding modes. For example, it
has been reported that ThT binds in the forms of large micelles [251], but also that
it binds in monomeric form [252]. Molecular dynamics simulations [256; 257] seem
to suggest that the binding occurs in monomeric form. However, it is difficult to
simulate high concentrations of dye molecules which might lead to a bias towards
monomeric forms of the dye. In the last two years, efforts have increasingly focused
on the study the origin of the increased fluorescence efficiency of ThT upon binding
to amyloid [259; 260; 261; 262]. The origin of this enhanced fluorescence quantum
yield of the dye when bound [261] or confined in viscous solution [259] seems to be
a hindered rotation around the central C-C bond; this movement is responsible for
the efficiency of non-radiative decay of the excited state [262].
Whereas the shift in Congo red (CR) absorption spectrum and its induced bire-
fringence upon binding is commonly used as a qualitative test for the presence of
amyloid structures [263], ThT fluorescence assays have been established as a more
quantitative method for kinetic studies in particular (see Experimental chapter and
data in Chapters 4 and 5). When ThT binds to β-sheet rich amyloid fibrils, its
absorption maximum and fluorescence spectrum undergo a red-shift [67] and the
fluorescence emission at 480 nm upon excitation at 440 nm is within certain limits
commonly assumed to be proportional to the quantity of amyloid fibrils present.
This property can then be used to follow time-courses of amyloid growth and such
kinetic studies give valuable insight into the molecular mechanism of amyloid for-
mation. Moreover, reduction in ThT fluorescence is often taken to be an indication
of the inhibition of this macromolecular self-assembly process. The quest for po-
tent inhibitors is a very active research direction [239], due to the close connection
between amyloid formation and neurodegenerative and other diseases([40] and see
introduction). Congo red is an example of a compound the inhibitory properties
of which have been studied, but published results on its effects have given rise to
very different conclusions [80; 240; 264; 265; 266; 267]. Moreover, in the context of
studies of potential inhibitors of amyloid formation, it has been shown recently that
inhibitor candidates that are themselves fluorescent can interfere with the ability of
dye fluorescence to reflect accurately the quantity of amyloid present [268].
In order to explore avenues that avoid such interference effects, the label-free bio-
sensing approaches to studying amyloid growth and that are described in the pre-
vious chapters have been developed. SPR has also been used to study the bind-
ing of amyloidophilic dyes to surface-bound protein aggregates [229; 269]. Equi-
librium binding constants describing the interaction between amyloidophilic dyes
and protein aggregates, as well as their kinetics of binding have been widely stud-
ied [251; 258; 270; 271; 272]. In the following, the binding of ThT and Congo red to
surface-bound amyloid structures will be studied, in order to probe if the binding of
these dyes is really independent and to elucidate the origin of the conflicting results
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on the inhibitory effects of Congo red.
6.2 Interactions between amyloidophilic dyes and
binding of the dyes to amyloid fibrils
In order to study the binding of small molecules to amyloid fibrils, short, freshly
grown Aβ (1-42) amyloid fibrils were attached to the gold surface of a QCM-crystal,
following established protocols ([97], and Method development chapter). The AFM
images in Figure 3.1 suggest that the surface bound protein is mainly fibrillar in
nature; however, it cannot be excluded that in this step, small oligomers could
also attach to the QCM-sensor surface. However, in order to maximize the signal
resulting from the binding of the dye molecules specifically to fibrillar material, the
surface was further incubated with a solution of soluble Aβ (1-42) to increase the
length of the attached fibrils and therefore the mass of fibrillar material on the
sensor. During this step, it is highly likely that the peptide predominantly adds on
to the pre-existing seed fibrils as opposed to creating new aggregates; indeed, the
incubation of a sensor surface that has no attached fibrils shows less than 5% of the
frequency shift of a sensor with attached seeds (Figure 3.1).
Figure 6.1 a) shows the result of a QCM measurement probing the binding of the
dye CR to amyloid fibrils formed from Aβ (1-42). Contact of the biosensors with a
dilute solution of the dye (50 µM in 100 mM PB pH 7.4 ) leads to a frequency shift
of several Hz. In a control experiment where no fibrils were attached to the surface
(top AFM-image in Figure 6.1), no change in resonant frequency was observed upon
contact with the dye solution.
The observed frequency shift in the presence of fibrils, therefore, stems from the
binding of dye molecules to the amyloid fibrils. With the Sauerbrey mass sensitivity
of 17.7 ng Hz−1 cm−2) of the QCM crystals this shift would formally correspond
to a surface density of approximately one dye molecule per nm2. Considering that,
according to the AFM images, only part of the surface is coated with amyloid fibrils,
this result indicates either that the dye binds in the form of large clusters or that
a significant part of the frequency shift arises from a change in the hydrodynamic
mass of the crystal (i.e. from coupling to the liquid [105]) rather than simply in
the inertial mass of the bound dye molecules. Indeed, it was demonstrated in the
Method development chapter that this latter mechanism contributes significantly to
the signal stemming from fibril elongation. The binding of CR is saturable, as the
change in resonant frequency is complete within 2 min, and the frequency remains
constant even when the injection of dye solution is continued. The finding that the
binding of CR to surface-bound amyloid fibrils can be monitored in real time led
to the design of the sequence of experiments in Figure 6.1 b). These experiments
allow first the binding of ThT to surface-attached amyloid fibrils to be probed and
second, any competition between the two dyes for binding sites on the protein fibrils
to be detected. Previous studies have reported that ThT and CR have very different
stoichiometries of binding to fibrils [273] and occupy different binding sites [242]. It
can be seen that binding of ThT (100 µM solutions in 100mM PB pH 7.4) to the
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Figure 6.1: a) QCM measurements probing the binding of the amyloidophilic dye
Congo red to surface-bound Aβ (1-42) fibrils (the vertical line indicates the injection
of dye solution). The binding gives rise to a frequency shift of several Hz (red
trace; shown is the frequency response of the overtone N=3). In the absence of
amyloid fibrils (the AFM image above), no frequency response is detected (blue
trace). b) The binding of ThT to the surface-bound fibrils can be detected in
an analogous way. The presence of bound ThT does not prevent the binding of
CR. Renewed contact with a ThT-solution leads to a drastically increased drop
in resonant frequency, compared to the response to the initial contact with ThT;
this decrease in frequency can be reversed by subsequent contact with CR solution.
These observations strongly suggest that ThT and CR do not bind independently
to the fibrils.
fibrils can also be detected and gives rise to a smaller frequency shift than that
from CR binding. The corresponding control experiment, where a sensor without
fibrils was exposed to a solution containing ThT was carried out and confirmed that
the presence of fibrils is necessary to observe a significant change in the resonant
frequency. The observed difference in the magnitude of the frequency shifts between
CR and ThT binding can be rationalized based on several factors. The signal is
dependent on the surface density of fibrils, as well as the stoichiometry of binding.
Also, the exact mode of binding is likely to influence the frequency response of the
QCM: if the dye binds in the form of large micelles, the overall roughness of the
surface increases more strongly compared to the situation where the dye binds in
monomeric form. The dye concentrations in these QCM experiments were for both
CR [274] and ThT [251; 252] above the critical concentration for the formation of
supra-molecular structures; however, the size of the dye molecule clusters can differ,
leading to a different increase in roughness for an equivalent amount of binding
and therefore to a differential QCM-response [105]. The raw frequency shifts can
therefore not readily be converted to accurate stoichiometries.
The binding of ThT can be seen from the present data to be partly reversible, as
revealed by the increase in frequency upon flushing the surface with fresh buffer.
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It is interesting to note that this experimental set-up allows the creation of a non-
equilibrium situation within the QCM cell through the continuous flushing with
buffer for several minutes and therefore of favourable conditions for measuring the
dissociation of high affinity binders such as ThT [256].
A subsequent incubation with 50 µM CR solution also shows binding, similar to that
shown in Figure 6.1 a). Surprisingly, however, when the ThT solution is injected
again into the liquid cell, a large drop in resonant frequency is observed. Even
more remarkably, renewed contact with the CR solution leads to an apparent loss in
mass that is approximately equal to the original mass associated with the addition
of ThT. These observations, that have been confirmed in multiple repeats of these
experiments, lead to the conclusion that the binding of the two dyes to the amyloid
fibrils is not independent, but rather the presence of CR has a strong effect on the
binding of ThT. This conclusion may be drawn even under the assumption that only
part of the frequency shift directly stems from rigidly attached inertial mass of dye
molecules; under the assumption of independent binding sites, the frequency shifts
induced by the binding of the dyes should be additive regardless of whether or not
a change in rigidly attached mass or hydrodynamic mass gives rise to the change in
frequency.
In order to obtain independent experimental insight into the potential interaction
between the two dyes revealed by the QCM experiments, dynamic light scattering
experiments were performed, shown in Figure 6.2 a), with solutions of the individual
dyes and with a mixture of the two molecules (see Methods section for details). The
DLS measurements indicate that in the latter situation structures are formed that
are of considerably larger size than the monomers or small oligomers observed in
the corresponding pure dye solutions. Such an intermolecular interaction can be
attributed at least in part to the ionic nature of the two dyes: CR is negatively
charged at physiological pH, because of its sulphonic acid groups and the reduced
basicity of its amines due to the partial delocalization of the nitrogen lone pairs,
whereas ThT, being a quaternary ammonium cation, is positively charged (Figure
6.2 c). The large frequency shift during the QCM experiment described above is
consistent with the formation of such CR-ThT clusters on the surface of Aβ (1-42)
amyloid fibrils. Indeed, the binding of CR is likely to increase the negative surface
charge density of the Aβ (1-42) fibrils (the net charge per peptide monomer at pH
7.4 is -3) as every dye molecule carries a net negative charge, therefore facilitating
the binding of the positively charged ThT molecules.
To explore further the significance of this result, ThT fluorescence experiments
with Aβ (1-42) amyloid fibrils in the presence or absence of CR (Figure 6.2 b) were
performed. The fluorescence was first measured in the absence of CR, then CR
was added and the fluorescence was immediately measured again. The fluorescence
spectra obtained in these experiments indicate that the presence of CR leads in
this case to a substantial suppression of ThT fluorescence. Similar phenomena have
been observed previously [240; 273; 275] and were interpreted either as fluorescence
quenching or as displacement of the ThT from the fibrils. However, this potential
interference with ThT fluorescence does not seem to be widely known or taken into
account when inhibition data is analyzed. It is interesting to note, that this effect
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Figure 6.2: a) DLS measurements probing the interactions of CR and ThT. The
results of four independent particle size distribution measurements are shown: 100
mM PB pH 7.4, (dark line), 30µM ThT solution in PB, 50µM CR solution and
a 1:1 (by volume) mixture of the ThT and CR solutions. The data for the ThT
solution are indistinguishable from buffer, indicating that the scattering intensity
from monomeric/oligomeric ThT is too weak at this concentration to be detected.
A mixture of CR and ThT shows the presence of structures of considerably larger
size than both components separately. In b) the fluorescence of a solution of ∼
2 µM Aβ (1-42) and 1.2 µM ThT was measured (excitation wavelength: 440 nm,
ThT background signal subtracted). Then, CR was added to the sample to obtain
a concentration of ∼ 1.2 µM and the fluorescence was again immediately measured.
As a result the observed fluorescence drastically decreases, an effect attributable to
the quenching of ThT fluorescence or the displacement of ThT by CR (see text).
c) The chemical formulas of Congo red and Thioflavin T are shown. The molecules
carry opposite charges at pH 7.4, therefore making an interaction between them
plausible.
already occurs at concentrations of both ThT and CR that are below the respective
critical concentrations for the formation of supra-molecular aggregates.
Because the experimental system used here is not reliant on optical detection, it is
possible to study the effects of the presence of CR on the rate of elongation of the
Aβ (1-42) fibrils (Figure 6.3) without the interference of CR on the signal used to
evaluate the kinetics. The fibrils were first exposed to the soluble Aβ (1-42) peptide
in the absence of CR, then the fibrils were brought into contact with a solution of
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CR and finally with a mixture of peptide and CR.
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Figure 6.3: a) Probing the influence of CR on the elongation of Aβ (1-42) amyloid
fibrils. The surface-bound fibrils were exposed to a 2 µM solution of peptide, and
then to a 50 µM solution of CR. Subsequently, they were brought into contact with a
solution containing both CR and Aβ (1-42) and the slopes of the resulting frequency
shifts, proportional to the elongation rates, were compared. Within experimental
error, the fibrils grow with the same rate in the presence or absence of CR. b) AFM
image of the QCM crystal after the experiment, showing the absence of non-fibrillar
aggregates, confirming that the fibrils grow in the presence of CR.
It can be seen in Figure 6.3 that the elongation rate in the presence (0.46 Hz/min)
or absence (0.49 Hz/min) of CR was identical within error and therefore it can be
concluded that the presence of CR does not interfere with the process of elongation
of the fibrils. Recent work of Lendel et al. shows that soluble Aβ (1-42) peptide
can interact with CR micelles [80]. It appears, however, that these interactions are
not strong enough to prevent the peptide from incorporating into the fibrils; fib-
ril formation therefore competes successfully with the weaker interactions between
peptide and dye; an observation in agreement with the data in [80].
In order to determine, whether the findings described above also apply for proteins
other than Aβ (1-42), similar QCM experiments were carried out with bovine insulin.
As in the case of the Aβ (1-42) experiments, first surface-bound seed fibrils (Figure
6.4 a) were allowed to elongate further, in order to maximize the total amount of
fibrillar material on the surface. This aim was for example achieved by using the
QCM-sensors that had served for a study of the influence of ionic strength on the
elongation rate of insulin fibrils (see Chapter 5) for subsequent dye binding exper-
iments. During the fibril elongation experiments that the sensors had undergone,
on average more than 100 Hz frequency shift was induced, corresponding to a dense
coverage of the sensor surface with insulin fibrils, as can be seen in Figure 6.4 a).
Prior to use in the dye binding experiments, the fibrils were stored for several hours
in HCl at pH 2.0, and the liquid cell of the QCM was flushed with HCl periodically,
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in order to ensure that residual ions from the previous experiments were washed out
of the fibril layer. The poor solubility of CR in HCl at pH 2.0 did not allow, how-
ever, to carry out the dye binding experiments under the solution conditions, where
insulin amyloid fibril elongation most readily occurs. It was therefore investigated
if the surface-bound insulin fibrils were stable under conditions more favourable for
the dissolution of CR. A QCM sensor covered with insulin amyloid was incubated
with 100 mM phosphate buffer (PB) at pH 7.4, and after the experiments described
further below had been carried out, the liquid cell of the QCM was again filled with
0.01 M HCl. At the end of the experiment, the surface was dried and imaged by
AFM (6.4 b)). The image demonstrates that the fibrils have not been dissolved due
to the change in solution conditions and indeed, no clear change in morphology is
observed. Therefore, the change in solution conditions to probe the binding of CR
and the potential inhibition of fibril elongation caused by this binding can be safely
carried out and provides a valid way to circumvent the problem of limited solubility
of CR at acidic pH values.
a) b)
Figure 6.4: a) QCM sensor surface covered with insulin amyloid fibrils at the end
of an experiment probing the influence of a change in ionic strength on the amyloid
elongation rate (see chapter 5). These fibrils were only in contact with solutions
of pH 2. b) QCM sensor with a similar history to the one in a), but it had been
subsequently brought into contact with 100 mM phosphate buffer at pH 7.4, and
then CR binding and inhibition experiments similar to the ones shown in Figure 6.5
have been carried out. At the end, the sensor has been incubated again with 0.01
M HCl, dried and imaged.
When surface-bound insulin fibrils were brought into contact with 100 mM phos-
phate buffer at pH 7.4, a strong drop in resonant frequency occurred, that ranged
from the order of 30 Hz to more than 150 Hz, (compare Figure 6.5 a and b), with
higher surface densities of fibrils showing larger drops in frequency. This strong
decrease in resonant frequency, indicating a structural rearrangement of the protein
fibrils or a change in coupling to the solution due to a change in the charge of the
fibrils, was generally followed by a slower increase in frequency that indicated the
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loss of some surface-bound material. This increase in resonant frequency did not
scale with the magnitude of the previous drop, but was in all cases of the order of
10 Hz, suggesting that it corresponds to the detachment of a small amount of non-
specifically absorbed protein, rather than dissociation of the surface-bound fibrils.
The upper panel of Figure 6.5 demonstrates that the overall interaction pattern be-
tween the two amyloidophilic dyes CR and ThT and insulin amyloid fibrils is very
similar to what had been observed for Aβ (1-42) and is described above. The binding
of CR can be detected and, even more pronounced than in the case of Aβ, enhances
the binding of ThT. Indeed, in the absence of any bound CR, no binding of ThT
can be detected at all. This finding could be rationalized as follows. A calculation
assuming independent pKa values indicates that insulin and Aβ (1-42) have a very
similar net charge of ∼ -2 at pH 7.4, suggesting that charge cannot explain a very
different binding behaviour of ThT to the fibrils. However, the fibrils have under-
gone different treatments; the Aβ fibrils have formed at this neutral pH, whereas
the insulin fibrils have formed at pH 2.0 and have subsequently been brought to pH
7.4. As this big change in solution conditions does not dissociate the insulin fibrils it
is possible that not all the acidic protons on or in the fibrils will be taken up by the
buffer. It is likely that some of the charges are not solvent exposed and therefore
less easily removed by the buffer; this effect can potentially be increased due to
the surface attachment of the fibrils. In this case, the net charge of surface-bound
insulin amyloid fibrils could be positive, even at neutral pH, leading to the binding
of the Thioflavin T cation to the amyloid fibrils to be less favourable than in the
case of Aβ.
Similar as in the case of Aβ (1-42), a subsequent incubation of the fibrils with
CR, after the fibrils had been in contact with ThT leads to an increase in frequency,
indicating that the interaction between the two dyes is strong enough to remove the
ThT from the fibrils. At this point, as a general control and in order to ensure that
the observed phenomena do not arise from interactions of the two dyes within the
flow system of the QCM and therefore are independent of the presence of fibrils, the
experiment illustrated in Figure 6.5 c) was performed. Here, a QCM sensor that
had no fibrils attached to it, but was only passivated by a SAM of methoxy-PEG
thiol was repeatedly incubated with solutions of the dyes in PB. It can be seen that
the contact of the passivated surface with a solution of ThT leads to a very small
amount of non-specific absorption. Subsequent contact with CR seems to remove
the adsorbed ThT, confirming once more that a strong interaction exists between
the dyes. In this experiment, the contact of the surface with CR does not influence
the later behaviour in contact with ThT, contrarily to the situation where fibrils are
attached; this finding unambiguously confirms that the presence of fibrils is indeed
necessary to yield a significant amount of CR binding.
Having thus confirmed the similarities in the interaction behaviour, the effect of
bound CR on the rate of insulin elongation (Figure 6.5 d) was tested, in analogy to
the experiment in Figure 6.3. Due to the necessity to destabilize the native state of
insulin sufficiently to enable fibril formation at a low temperature, the solution in
contact with the fibrils had to be changed back to 0.01 M HCl. Very interestingly,
upon bringing the fibrils back to pH 2, the initial change in resonant frequency when
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Figure 6.5: a) A QCM sensor covered with insulin amyloid fibrils is incubated with
solutions of CR (50 µM) and ThT (100 µM) in PB at pH 7.4 after the solution
in contact with the fibrils had been changed from 0.01 M HCl to PB pH 7.4. The
resulting frequency changes demonstrate that similar to what has been observed for
Aβ (1-42) described earlier, the CR and ThT interact such that CR can remove
bound ThT. b) Contact of a ThT solution with a QCM sensor that is covered with
a very high density of insulin fibrils (as judged from the previous elongation rates
and total frequency shifts in the experiments where the sensor had been used) shows
that the presence of bound CR is necessary to observe any ThT binding. c) Control
experiment, demonstrating that a passivated QCM sensor that has no insulin fibrils
attached only shows a very small degree of non-specific ThT adsorption, that can
be removed through contact with a CR solution. The enhancement of ThT binding
through previous CR binding clearly requires the presence of fibrils. d) Experiment
designed to probe the inhibitive effect of CR binding on insulin amyloid fibril elon-
gation. The presence of bound CR does not influence the steady state elongation
rate; however, it induces some non-specific protein absorption upon the first contact
with insulin monomer.
the pH had been increased from 2 to 7.4 was only fully reversible in cases where the
fibrils had not been in contact with CR. If CR was bound, the reversibility was in
some cases entirely eliminated; however, a small increase in frequency of the order
of 10 Hz was observed in all cases. This frequency increase can be attributed to the
differences in density and viscosity between HCl at pH 2.0 and 100 mM PB at pH
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7.4 (Figure 6.5 b), as suggested by the observation that a passivated empty control
sensor showed the same change in frequency upon exchange of buffers (not shown).
Obviously, it is not possible to deduce if during this change of buffer some or all
of the CR is washed off based on the observed frequency shift alone. However,
the subsequent incubation with monomer lead to a different signature in frequency
change if the fibrils had been in contact with CR (see Figure 6.5 d) compared to
an equivalent experiment where the fibrils had been brought to pH 7.4 and back to
pH 2.0 without intermediate contact with CR (not shown). The second period of
contact with insulin monomer in Figure 6.5 d) is characterized by a high initial rate
of frequency change that is followed by the usual linear steady state behaviour. In
the steady state phase, a rate of frequency change is measured that is very similar to
the one observed before the first contact with PB, indicating that neither the change
in solution condition, nor the presence of bound CR has any inhibitory effect on in-
sulin fibril elongation. The first few minutes of contact with monomer reproducibly
show a different rate of change of frequency. The most likely explanation is that the
fibril-bound CR facilitates lateral association of insulin monomer onto the fibrils via
a partial neutralization or screening of the charges on the fibrils.
Taken together, therefore, these results show that the use of Thioflavin T to detect
amyloid growth requires careful controls if it is to be used in quantitative studies.
In particular, care has to be taken to exclude interactions with ThT that can in-
terfere with its potential to reflect accurately the quantity of amyloid present at
a given time point. Monitoring a quantity more directly related to the incorpora-
tion of soluble peptide into fibrils, the shift of resonant frequency of a biosensor in a
quartz crystal microbalance, is therefore a powerful and independent method for the
study of amyloid growth. In addition, the same procedure can be used to probe the
interaction between small molecules and amyloid fibrils. This biosensor approach
therefore enables a detailed study of the mechanism of small molecule/amyloid in-
teractions and has the potential to contribute significantly to an effective search for
inhibitors of amyloid formation.
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Conclusions
Several conclusions can be drawn from the work presented in this PhD thesis.
It was demonstrated that label-free surface-bound measurements of amyloid elon-
gation kinetics provide a convenient and highly accurate way to measure the effects
that changes of external conditions have on the kinetics. Small changes in elonga-
tion rate of less than 50% can be easily resolved, allowing very subtle modifications
of a protein’s free energy landscape to be quantitatively investigated. It was shown
that the methods are applicable to a wide range of solution conditions and peptide
sequences, therefore allowing to explore almost the entire variety of amyloidogenic
sequence-space.
Application of these methods allowed the free energy barriers that separate the sol-
uble states of a range of polypeptides from their ordered aggregated state to be
determined. In addition, the unique features of the surface-bound techniques in
conjunction with an analytical kinetic theory describing amyloid fibril elongation
as a diffusive process, allowed the free energy barriers to be decomposed into their
respective enthalpic and entropic contributions. A correlation of these energetic
contributions with structural and sequence parameters of the respective polypep-
tides enabled an understanding of the origin of large parts of the overall free energy
barrier. The residual structure and the hydrophobicity of the soluble form of the
protein are the single most important factors.
On the background of these contributions to the free energy barriers, electrostatic
interactions can modify the elongation kinetics by more than an order of magnitude.
The presence of ions in the solution has a twofold effect, even in the simplest situ-
ation studied in this work. In addition to a classical Debye-Hu¨ckel type screening
mechanism, where the Coulomb repulsion between equally charged reaction partners
is screened by a diffuse ionic cloud of counter-ions, chemically non-specific ion asso-
ciation of salt ions with the protein macro-ions can change their net charge relevant
for the aggregation reaction.
In addition to being able to extract such fundamental knowledge about protein-
protein interactions and their modulation by external and sequence parameters, the
methods and results presented in this thesis have important consequences for more
applied aspects of the field of protein aggregation. In the last chapter, it was shown
how the quartz crystal microbalance with surface-bound amyloid can be used to
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probe the interaction between amyloid and small molecules. These experiments can
be combined with studies of the inhibitory effect of the small molecule binding on
amyloid fibril elongation. This highly systematic approach is an important contri-
bution to the overwhelmingly large field of study of small molecule drug candidates
for protein misfolding diseases, that is full of apparently contradictory reports on
the effects of many candidate molecules.
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Future directions
The work presented in this thesis opens up manifold avenues that are worthwhile
to pursue. It was clearly demonstrated, that highly accurate measurements of the
influence of external factors on the kinetics of amyloid fibril elongation can provide
fundamental insight into the free energy surface. Factors other than temperature
and ionic strength that have important effects on the dynamics of protein folding and
misfolding are the solvent composition and the presence of small molecules known
to shift the relative stabilities between folded and unfolded states, such as osmolytes
and denaturants. If the influence of these factors on the kinetics is systematically
studied, it will be possible to characterize structural and energetic features of the
transition state ensembles to even higher detail than achieved in this work. In ad-
dition, a systematic variation of the amino acid sequence of a polypeptide along the
lines of Φ-value analysis of protein folding [276] should be able to provide detail on
the exact reaction mechanism on a single residue detail.
However, in order to approach the final aim of a full characterization of the protein’s
free energy landscape, including the regions that correspond to ordered aggregation,
and to further unify the concepts of folding and misfolding, the energetics of the
final fibrillar state have to be characterized in as much detail as the barriers in this
work. The free energy differences between soluble polypeptides and their aggregated
counterparts have only recently been measured for a large variety of amyloidogenic
systems [34]. However, in this work, the free energy values have not been decom-
posed into their respective enthalpic and entropic contributions. If this decomposi-
tion could be achieved, it would be possible to follow the evolution of the relative
energetic contributions along the reactive trajectories from soluble to aggregated
state. This analysis would provide an even more thorough understanding of the
driving forces for protein aggregation and of the fine balance between folding and
misfolding.
Several experimental routes exist towards this goal; the temperature dependence of
the equilibrium between soluble and aggregated states can be measured, according
to:
∂ ln(K)
∂T
=
∆H0
RT 2
(8.1)
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where K is the equilibrium constant and ∆H0 is the difference in enthalpy be-
tween the two states. Therefore, a measurement of the change in relative concen-
trations of soluble and aggregated states with temperature will provide the required
quantity. Alternatively, the enthalpy release upon addition of a monomer onto a
fibril end can be directly measured by highly sensitive calorimetric methods.
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Figure 8.1: The enthalpy that is released when soluble insulin incorporates into
an insulin seed fibril is measured, using isothermal titration calorimetry (ITC, see
Experimental Chapter for details). Seed fibrils are titrated into the ITC sample cell
that was filled with soluble insulin, at two different temperatures. The integral of the
curves yields the released enthalpy. The smaller signal around 35 min corresponds to
a second injection of seeds to probe if all the monomer in the cell has been consumed.
The heat release presumably stems from the heat of dilution of the seed fibrils. The
experiment suggests that ∆H0 is of the order of 10 kJ/mol.
This has been reported before for individual polypeptides [116; 119; 120]. Pre-
liminary experiments were carried out in the framework of this thesis, that are
presented in Figure 8.1, and it was therefore demonstrated that this method can be
extended to other proteins. Being able to measure the same quantity with two very
different experimental methods will allow to assess the validity of the results. The
result of the experiment in Figure 8.1 suggests, that insulin fibrils are enthalpically
only marginally stable (of the order of 10 kJ/mol) compared to soluble protein. In
the light of the high enthalpy of activation measured (100 kJ/mol, see Chapter 4),
this indicates that the stabilizing interactions that form when the soluble protein
incorporates into the fibril are very similar in magnitude to the sum of the inter-
actions in the reactants. This finding could indicate that both the transition state
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and the final fibril are stabilized by an increase in entropy. These highly interesting,
but still quite speculative findings deserve further investigation.
For the more applied aspects of protein aggregation, it should be worthwhile to
re-assess many of the small molecule inhibitors that have been reported in the liter-
ature to bind to amyloid and to inhibit fibril elongation. The systematic label-free
nature of the techniques presented here will most certainly reveal that Congo red is
not the only small molecule the inhibitory effect of which has been misinterpreted
in the past. Small molecules that selectively bind to amyloid, either to report on
its presence (diagnostics) or to inhibit its progression (cure) form a huge part of the
pharmaceutical industry’s efforts to fight neurodegenerative diseases. Therefore, the
need for such systematic approaches cannot be stressed enough.
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